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ABSTRACT 
 
Recombinant bovine odorant binding protein (bOBP) is a very promising 
platform for building protein-based biosensors. The protein possesses a broad binding 
specificity for hydrophobic molecules with affinities in the sub-micromolar range. 
Previous work has shown non-covalent binding of 1-aminoanthracene (1-AMA) in the 
internal cavities of bOBP that results in a large enhancement of fluorescence intensity. 
We have shown fluorescence titrations of recombinant bOBP with 1-AMA yielded a 
single type of binding site with a Kd of 0.16 ± 0.023 µM. Competitive displacement 
assays between 1-AMA and other ligands such as thymol were established and the 
results indicated their binding to bOBP. The strategy of competitive binding with 1-
AMA was thus employed to quantify thymol concentration for the bOBP biosensors. 
Ten different solid supports for the bOBP biosensors were examined for their 
biocompatibility with bOBP function using 1-AMA as a probe. The result was that 
nitrocellulose was chosen as the best membrane for immobilization, probably due to 
its 3-D micro-porous matrix (sponge structure) that provides a much larger surface 
area for protein binding compared with 2-D surfaces. It was found that the optimum 
operating concentrations of bOBP and 1-AMA and the method for the immobilization 
was incubation of nitrocellulose with the complex of 100µM bOBP and 100µM 1-
AMA solution. The amounts of the total and functional protein binding to 
nitrocellulose were 7 ± 0.1 and 7 ± 0.4 nmol bOBP per cm
2
 of membrane, 
respectively. 
A fibre-optic biosensor based on bOBP has therefore been constructed. It has 
been an extrinsic sensor with bOBP immobilized on a nitrocellulose membrane placed 
at the tip of a probe of a bifurcated fibre-optic bundle that was in turn connected to the 
LLS-385 LED light source and the HR2000 spectrometer. The light emitted by 
fluorescent 1-AMA bound bOBP was detected by 2048-element CCD array of the 
spectrometer. The LODs for thymol in the liquid phase were found to be 14 ± 6 µM 
(calculated as S/N = 3), which is less than the guideline values considered to be toxic 
to humans. Moreover, this fibre-optic bOBP biosensor was also capable of sensing 
thymol vapour, and some potential uses of this sensor will be described. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
1.1 Biosensors 
 
Biosensors are powerful analytical devices used for the detection of target molecules 
in a sample by converting a biological response into a processable and quantifiable 
signal. In a biosensor, a biological recognition element e.g. binding proteins, 
antibodies, antigens, enzymes, nucleic acids, tissues, microorganisms, interact 
preferably specifically with a given analyte that is based on molecular recognition of 
the target. Where the chemical structure of the target is unchanged, the sensor is an 
affinity sensor and where there is a transformation of the analyte, the sensor is a 
catalytic sensor. The biological component is combined with a transducing (detecting) 
device that transforms the interaction of the analyte with the biological recognition 
element into a signal that can be further processed and displayed (Figure 1.1) [1]. 
Common transducer technologies are optical, electrochemical, acoustic, or 
calorimetric.  
 
Biosensors are employed in the identification, quantification and final screening of 
specific molecules, as presented in complex mixtures from moderate to very low 
concentrations, and thus they provide advantages in many research fields, such as 
analytical research, clinical diagnosis, food and pharmaceutical industry, and 
environmental control and process monitoring [2]. Biosensors have been developed as 
a result of the demand of fast, routine, and low cost analysis of samples with 
robustness, sensitivity and reproducibility [3]. In addition, biosensor properties include 
miniaturization, simple instrumentation, and automatic processing [2, 4]. 
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Figure 1.1: Schematic design of a generic biosensor. The selective binding of the 
analyte to form an analyte-protein complex induces the generation of an analytical 
signal which is converted to a readout [5]. This image has been reproduced with the 
permission of the rights holder, Springer. 
 
Although current biosensors have been developed for the identification of an analyte 
that provides the desired specificity, each device is unique and requires considerable 
development time and optimization. To overcome this limitation, protein engineering 
techniques are being employed to adapt the signal-transduction properties of biological 
molecules to the detector instruments instead of adapting instruments to the unique 
requirements of each natural molecule. This can be accomplished by incorporating 
functional groups that provide simple signal-transduction mechanisms, such as optical 
or electrochemical changes into the proteins themselves. The ultimate goal is to obtain 
families of molecules that vary in their binding site, but keep a constant signal-
transduction function, therefore generating generic biosensors that use the same 
detector instrumentation and measure a broad range of analytes [2, 6]. 
 
One of the most widely used detection instruments is based upon fluorescence. 
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1.2 Fluorescence 
 
1.2.1 Basic principles of fluorescence 
 
Fluorescence is process of light emission that occurs during molecular relaxation from 
an electronic excited state to the ground state by molecules that absorb light. The 
emitted light has a longer wavelength and therefore lower energy than the absorbed 
light [7-13].  
 
The various energy levels involved in the absorption and emission of light by a 
fluorophore are classically presented by a Jablonski diagram (Figure 1.2). The 
fluorescence process is controlled by three important events, all of which occur on 
different timescales. When a fluorescent molecule absorbs light energy in the form of 
photons, this leads to excitation of photons at a stable ground state by a shift of 
electrons in the fluorescent molecule to a higher energy, unstable excited state; this 
happens in femtoseconds (10
-15
 seconds). Then, the molecule quickly relaxes to the 
lowest vibrational level of the excited electronic state. This vibrational relaxation 
process removes some of the energy in the fluorescent molecule gained from the 
photon absorption by converting it into heat. This process is known as internal 
conversion or vibrational relaxation; this generally occurs in picoseconds (10
-12
 
seconds). The excited molecule then exists in this state for periods of nanoseconds (10
-
9
 seconds), and defines as the fluorescence lifetime. Next, energy is released again by 
emitting a photon of light and the molecule returns to the ground state.  
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Figure 1.2: Jablonski energy diagram showing the basic principles of 
fluorescence. Photon absorption and excitation to a vibrationally excited state is 
represented in green arrows. Vibrational relaxation and internal conversion are 
illustrated in yellow arrows. Fluorescence emission (or radiative decay) is depicted in 
red arrows, and non-radiation relaxation (or non-radiative decay) is shown in blue 
arrow. Radiative processes are shown in straight arrows, whereas non-radiative 
processes are shown using wavy arrows. Indicative timescales are shown, although 
are molecule dependant. For each electronic energy state (S0, S1 and S2), vibrational 
energy levels are present as indicated by the closely packed horizontal lines – the 
higher energy states being at the top of the figure. This image has been reproduced 
from the reference [11] with the permission of the rights holder, Olympus America 
Inc.by Michael W. Davidson. 
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The resulting emitted photon is less energetic and has a longer wavelength than 
original photon. This phenomenon called Stoke’s Shift is the difference in wavelength 
or equivalently in the energy between the maxima of the excitation and the emission 
spectra (Figure 1.3) [7-13].  
 
 
 
Figure 1.3: Stoke’s Shift demonstrating the difference between the maximum 
wavelengths of fluorescence excitation and emission spectra.  
 
 
In addition, molecules in the excited electronic states can also relax by non-radiative 
processes where excitation energy is not converted into photons but dissipated by 
thermal processes such as vibrational relaxation and collisional quenching [7-13]. 
Then, the total decay rate can be described by the sum over all rates: kd = kr + knr, 
where kd is the total decay rate, kr is the radiative decay rate and knr is the non-
radiative decay rates [9]. In general knr is sensitive to environment e.g. protein binding. 
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Most fluorophores have a propensity of photobleaching, which is the excited state 
degrades either spontaneously or through reaction with other molecules presented. 
Despite this, the excitation and emission cycle can be repeated for many hundreds to 
thousands of times before the highly reactive excited state molecule is photobleached. 
For instance, the well-studied probe fluorescein isothiocyanate (FITC) can undergo 
excitation and relaxation for about 30,000 cycles before the molecule no longer 
responds to incident illumination [11]. 
 
Because of the extremely sensitive emission profiles, spatial resolution, and high 
specificity of fluorescence, this technique has become an important tool in genetics 
and cell biology, and in the context of this thesis; chemical sensors [11, 14, 15]. 
 
 
1.2.2 Principles of Förster resonance energy transfer (FRET)  
 
FRET is a photophysical process that involves energy transfer between two 
chromophores. The excitation energy transfers from a donor molecule in its 
electronically excited state to an acceptor molecule via a non-radiative transmission 
[16, 17]. In other words, the donor molecule that initially absorbs the energy does not 
emit a photon, but transfers the energy to the acceptor molecule [17]. These coupled 
transitions involved in FRET are illustrated by the Jablonski diagram (Figure 1.4).  
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Figure 1.4: FRET Jablonski diagram illustrating the coupled transitions (dashed 
lines) involved in resonance energy transfer (a violet arrow). The donor 
fluorophore can transfer excited state energy directly to the acceptor without emitting 
a photon. Absorption and emission transitions are indicated by straight vertical arrows 
(blue, green and red), while vibrational relaxation is represented by wavy yellow 
arrows. This image has been reproduced from the reference [18] with the permission 
of the rights holder, Michael W. Davidson. 
 
 
Several fundamental conditions are required for generating FRET. The donor and 
acceptor molecules must be in close proximity within a range of 1 to 10 nanometres of 
each other. The fluorescence emission spectrum of the donor molecule must overlap 
the absorption spectrum of the acceptor molecule (Figure 1.5). The relative orientations 
of the donor and acceptor transition dipole moments must be approximately parallel 
[19].  
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Figure 1.5: Spectral overlap region (the gray area) of absorption and emission 
spectra of cyan fluorescent protein (CFP, the donor) and red fluorescent protein 
(DsRFP, the acceptor). Absorption spectra for both fluorescent proteins are 
presented as red curves, while the emission spectra are illustrated as blue curves. This 
image has been reproduced from the reference [20] with the permission of the rights 
holder, Olympus America Inc.by Michael W. Davidson. 
 
 
The efficiency of this energy transfer depends basically on the distance between the 
donor and acceptor fluorophore, which is proportional to the inverse sixth power of the 
distance between donor and acceptor molecules [17, 21]. The distance relationship 
between energy transfer efficiency and the separation of the donor and acceptor 
molecules is illustrated in Figure 1.6.  
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Figure 1.6: Relationship between energy transfer efficiency and the distance 
separating the donor and acceptor molecules. The ability of the donor fluorophore 
to transfer its excitation energy to the acceptor by non-radiative interaction decreases 
as the sixth power of the distance separating the two molecules. Subsequently, the 
energy transfer efficiency between donor and acceptor molecules decreases 
dramatically with increasing distance between the molecules.  
 
 
Due to its extreme sensitivity to small distances, FRET is thus a valuable technique for 
studying interactions between molecules, such as protein-protein interactions, protein-
DNA interactions, and protein conformational changes [22, 23].  
 
 
1.3 Protein-Based Fluorescent Biosensors 
 
Based on the construction method, the protein-based fluorescent biosensors can be 
classified into two types: the genetically encoded fluorescent biosensors and the 
chemically constructed biosensors. Firstly, a genetically encoded fluorescent biosensor 
makes use of fluorescent proteins (FP) such as green fluorescent protein (GFP) or its 
variants as signal transducer(s), which change in their fluorescence intensity or 
excitation/emission wavelengths [24]. FP-based biosensors can be endogenously 
expressed in cells or tissues simply by transfection with the plasmid DNA encoding it 
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and with the possibility of controlling the localization of the biosensors to sites of 
interest within the cell. This can be achieved by introducing organelle-specific 
targeting signals. Many kinds of FP-based biosensors have been developed by fusion 
of FP with appropriate protein scaffolds that act as the recognition platform [25, 26], 
and which are useful for imaging and sensing important molecules and key events in 
living cells [27, 28]. This type of biosensor has been a powerful tool for in vivo 
applications [25, 26]. 
 
An example of a fluorescent protein biosensor is a green fluorescent protein-based 
bacterial biosensor for benzene, toluene, ethylbenzene, and related compounds in 
aqueous solutions that was constructed and characterized. The biosensor was produced 
from Pseudomonas fluorescens strain A506 carrying the toluene-benzene utilization 
(tbu) pathway transcriptional activator. Its promoter PtbuA1 was fused with a 
promoterless gfp gene on a broad-host-range promoter probe vector. TbuT was 
constitutively expressed by being fused to the neomycin phosphotransferase (nptII) 
promoter. After induction periods of 3 h, fluorescence emission from the cells 
correlated well with toluene, benzene, ethylbenzene, and trichloroethylene 
concentrations. Each inducer had a unique minimum concentration for induction (Kapp 
values that ranged from 3.3 ± 1.8 μM for toluene to 35.6 ± 16.6 μM for 
trichloroethylene), and maximal fluorescence response [29]. 
 
The second class of fluorescent protein biosensor is chemically constructed and 
consists of a protein used as the molecular-recognition platform, conjugated with a 
synthetic fluorescent molecule to provide the signal transducer function. In order to 
control the modification sites and numbers, the site-specific incorporation of 
fluorophore is regularly required. Typical approaches that have been employed to 
yield fluorescent biosensors are shown in Figure 1.7. Usually, reactive residues like 
cysteine are introduced into the desired location by site-directed mutagenesis, or 
chemistry-based protein labeling techniques, and then followed by selective 
modification with functional fluorophore [24]. 
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Figure 1.7: Representative scheme for construction of chemically assembled 
fluorescent biosensors. (A) Genetic modification is performed to construct mutated 
protein that is subsequently incorporated with an artificial fluorophore. In many 
cases, this strategy requires advanced skills for gene manipulation. (B) Chemical 
modification can directly combine artificial fluorescent molecule on the protein [24]. 
This image has been reproduced with the permission of the rights holder, John Wiley 
and Sons. 
 
 
An example of the construction of a chemically modified fluorescent protein-based 
biosensor involves the applications of nanomaterials, such as quantum dots (QDs), 
semiconductor nanoparticles (NPs), or nanofibres conjugated with proteins. In these 
systems, competitive binding assays have been largely used for the signal read-out. In 
general, a fluorescently labeled protein is bound to the ligand linked with another 
fluorophore. The reaction occurs after an analyte is added to this complex. If the 
analyte has a stronger affinity for the protein, the bound ligand is displaced, leading to 
a change in the intermolecular fluorescence resonance energy transfer (FRET) signal, 
which is related to the affinity and concentration of the analyte [24].  
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A model of this type of sensors is demonstrated in Figure 1.8. A solution-phase hybrid 
nanosensor based on FRET has been created for the specific detection of the explosive 
2,4,6-trinitrotoluene (TNT), a security threat and contaminant, in aqueous 
environments. The hybrid nanosensor consists of luminescent QDs conjugated to 
antibody fragments (anti-TNT) at which the pre-binding of a dye-labeled TNT 
analogue in the antibody binding site quenches the QD photoluminescence via 
proximity-induced FRET. Addition of soluble TNT displaces the quencher-labeled 
TNT analogue, abolishing FRET and resulting in a concentration-dependent recovery 
of QD photoluminescence [30]. 
 
 
 
 
Figure 1.8: Schematic diagrams showing binding mechanism of a hybrid 
QD−antibody fragment FRET-based nanosensor for the detection of the 
explosive TNT. The solution-phase hybrid nanosensor has been built by self-
assembling anti-TNT specific antibody fragments onto a hydrophilic QD via metal-
affinity coordination. This conjugate generates a substantial rate of FRET when pre-
assembled with a dye-labeled TNT analogue. Exposure to soluble TNT displaces the 
analogue quencher away from the QD−anti-TNT conjugate, resulting in a systematic 
and concentration-dependent QD photoluminescent recovery [30].This image has 
been reproduced with the permission of the rights holder, American Chemical Society. 
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FRET-based competition assays can also be used in a fibre-optic format. For example, 
glucose biosensors have been based on FRET competitive reactions for a fluorescent 
glucose-receptor protein (concanavalin A labeled with rhodamine; Rh-ConA) between 
glucose and a fluorescent glucose analog (dextran labeled with FITC; FITC-dextran). 
Addition of Rh-ConA to a solution of the FITC-dextran shows quenching of the FITC 
fluorescence and sensitization of the rhodamine fluorescence, whereas when glucose is 
added to this solution, the FITC fluorescence intensity increases as FITC-dextran is 
released from the Rh-ConA and is replaced by glucose. Therefore, glucose 
concentrations can be determined directly from the level of FITC 
quenching/rhodamine emission. The fibre-optic glucose biosensors has a working 
range up to 2.00 mg/ml of glucose [31]. 
 
 
1.4 Vertebrate Odorant Binding Protein (OBPs) 
 
Vertebrate odorant-binding proteins (OBPs) are low-molecular-weight soluble 
extracellular proteins belonging to the lipocalin family [32-37], which are highly 
concentrated in the nasal mucus [38-40]. Although this class of proteins has a very low 
sequence homology, it is characterized by two conserved domains composed of an 
eight-stranded antiparallel β barrel that form the ligand binding site, and a carboxy 
terminal α helix [41-43]. OBPs generally bind small, hydrophobic molecules [36], and 
are able to bind a large number of volatile odorous compounds, belonging to different 
chemical classes [44]. Perhaps due to their broad ligand specificity, OBPs have been 
believed to play a fundamental role in odour perception by transporting, selecting, 
and/or deactivating odorant molecules toward specific olfactory receptors on sensory 
neurons across the aqueous compartment of the nasal mucus [45-48]. Figure 1.9 shows 
schematically three models that have been proposed the physiological functions of 
OBPs in olfaction. These are buffer, carrier, and transducer. Buffer: OBPs would work 
more efficiently by trapping high concentrations of odorants and diminishing binding 
with neuron receptors. Carrier: OBPs could bind and carry odorant molecules to the 
membrane receptors of the olfactory neurons; alternatively, OBP could remove the 
odorant molecules from the receptors. Transducer: OBPs could specifically and 
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selectively bind odorants and carry the relative information (but not the odorants) to 
the membrane-bound receptors [36]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Three proposed models for the role of OBP [36]. The red square are 
represented as odorants. The green circles are depicted as OBP. The yellow objects 
are shown as receptor neurons.  
 
 
The initial events in odour detection exist in a specialized olfactory neuroepithelium 
(Figure 1.10) located in the nasal cavity [49]. Odours are supposed to bind with 
specific receptors on the cilia of olfactory sensory neurons, generating the signals 
propagated by olfactory neuron axons to the olfactory bulb [50, 51]. Although, the 
mechanisms of OBPs in signal transduction are still not fully understood [38, 52], a 
pathway of olfactory signal transduction (Figure 1.11) has been suggested. In this 
model, the binding of an odorant molecule to an odour-specific transmembrane 
receptor activates specific G proteins, leading to the release of the GTP-coupled α 
subunit of the G protein, which then stimulates adenylyl cyclase to produce elevated 
levels of cAMP. The increased cAMP opens cyclic nucleotide-gated cation channels, 
Cytoplasm 
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Aqueous 
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 Air 
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thus generating membrane potential changes that is propagated along the olfactory 
sensory axon to the brain [50, 51].  
 
 
 
 
Figure 1.10: The olfactory neuroepithelium [50]. This image has been reproduced 
with the permission of the rights holder, Elsevier. 
 
 
 
33 
 
Figure 1.11: A pathway of olfactory signal transduction [50]. This image has been 
reproduced with the permission of the rights holder, Elsevier. 
 
 
1.4.1 Bovine odorant binding protein (bOBP) 
 
In contrast to other OBPs that are normally monomeric, the structure of bOBP 
revealed a striking feature of a homodimer in which each monomer has 159 residues, a 
molecular weight of 19 kDa, and consists of an eight-stranded antiparallel β barrel 
flanked by an  helix at the C-terminal end of the polypeptide chain [43]. A bOBP 
dimer is formed by domain swapping whereby two monomers exchange the domain of 
a C-terminal  helix over the β barrel domain of the other, resulting in a protein with 
an elongated shape conformation (40 × 40 × 70 Å
3
) [53] (Figure 1.12). Inside the β 
barrel of each monomer of bOBP, a large buried cavity of about 407 Å
3
 are mostly 
composed of hydrophobic residues, which are the general binding site for different 
types of small hydrophobic molecules including odorants [52-54]. Whereas the native 
porcine OBP (pOBP) as isolated is devoid of ligand, the binding site of purified bOBP 
has been shown to harbour a naturally occuring ligand; 1-octen-3-ol, a typical volatile 
component of bovine breath and an extremely potent olfactory attractant for many 
insect species [54] (Figure 1.13).  
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Figure 1.12: Secondary structures of the bOBP dimer. They are depicted by 
cylinders (-helices), and arrows (β-strands). Top: colour coding shows the domain 
swapping phenomenon; monomer A is yellow, B is pink. Bottom: colour coding is 
corresponding to the secondary structure; -helices, violet; β-strands, blue; other 
motifs, brown. Pseudo-atoms presented in the two buried cavities are red [48]. It is 
note that this crystal structure (PDB ID. 1OBP) has been determined at a resolution of 
2.00 Å by X-ray diffraction. This image has been reproduced with the permission of 
the rights holder, Elsevier. 
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Figure 1.13: The internal ligand binding site of bOBP containing its natural 
ligand (1-octen-3-ol).  Crystal structure of bOBP displayed the two buried cavities 
complexed with its natural ligand (1-octen-3-ol). It is note that this crystal structure 
was created with Swiss PDB Viewer from PDB ID. 1G85, which was determined at a 
resolution of 1.80 Å by X-ray diffraction. 
 
 
With regard to its ligand binding property, bOBP has one unique characteristic of 
having broad specificity with modest to low affinity in the micromolar range [52, 55] 
that can bind not only to the odorants but also to other chemical substances having no 
odour [56]. Some odorants are not recognized by the protein while others are bound 
with various degrees of strength, indicating a certain capability of discrimination by 
bOBP [34]. Some examples of strong ligands and non-ligands for bOBP are 
represented in Figure 1.14. The strong ligands usually bind with dissociation constants 
between 0.1 and 1 µM, while non-ligands have been classified as compounds that do 
not bind considerably at concentrations around 100 µM [36]. It is observed that more- 
or-less planar compounds, such as thymol, pyrazines, and thiazoles, are among the 
best ligands. The compounds that have been reported to bind tightly to bOBP include 
green-smelling compounds in a series of thiazoles, and floral and green odorants, all 
belonging to the classes of 2-tetrahydropyranyl ethers or 2-tetrahydrofuranyl ethers 
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[57]. In addition, other molecules of different structures, such as retinol, benzyl 
benzoate, and tricyclic musky-smelling compounds were found to be good ligands for 
bOBP [36].  
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Figure 1.14: Binding of odorants to bOBP. The strong ligands have dissociation 
constants between 0.1 and 1 µM. The non-ligands do not show significant binding at 
the concentration of 100 µM [47, 58]. 
 
 
Pelosi et al. have summarized that the characteristics of good ligands for bOBP are 
medium-sized molecules with one polar group, such as hydroxy, carbonyl, or the 
heteroatom of an heterocycle and an extended hydrophobic area capable of assuming a 
planar or rather flat conformation [36]. Later, the characterization of the binding 
properties of pOBP [59] as well as bOBP [38] in solution and in the crystal has 
revealed common binding behaviours. X-ray structural analysis of binding interaction 
showed that odorant molecules interacted with a common set of residues forming the 
cavity wall, which do not exhibit specific interactions. Moreover, there are no 
significant conformational changes involving protein loops or backbone upon 
interaction with all odorants [38]. They have established that the main requirement for 
a ligand to match the β-barrel cavities is a high degree of hydrophobicity with a 
molecular mass between 160 and 200 daltons, regardless of its odorous properties, 
chemical class and molecular structure, particularly there is no special characteristic 
attributing to the good binders [38, 59].  
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1.5 bOBP as a Potential Biosensing Element 
 
bOBP has been chosen in this project, because its scaffold can be considered as a 
potential platform for building robust, reliable, and inexpensive biosensors. The other 
useful characteristics of bOBP are as follows. This particular protein is well-
characterized in its three-dimensional structures either alone [48, 52, 53] or in 
complexes with odorant molecules [38]. It can bind many structurally unrelated 
ligands, which means that a biosensor generally detects many different classes of 
compounds, and provides unique pattern recognition for each individual ligand 
compound [38]. This protein can also be expressed and purified in high yields from 
Escherichia coli [46] as well as eukaryotic systems [60, 61], therefore making its 
production easy and economical. In addition, the amino acid sequence of bOBP does 
not contain cysteine residues, which facilitates designing and engineering cysteine at 
any desired position through site-directed mutagenesis in order to conjugate with a 
fluorophore and/or to immobilize on a modified solid surface. This protein also 
tolerates point mutations even when they involve residues positioning in protein 
structure stabilization [46, 62]. Next, bOBP and its mutants are highly thermostable, 
since they can withstand temperatures up to 70-80
o
C for mt-bOBP, and 75-85
o
C for 
wt-bOBP [63]. Moreover, it is very stable to environmental conditions that might 
degrade or denature the proteins. Its compact fold consisting of a β-barrel makes it 
very durable to proteolytic degradation. Finally, the presence of the ligands in their 
interior cavity enhances protein stability [64]. These advantageous characteristics of 
bOBP will allow the possibility of using this protein as a sensing element for the 
creation of protein-based biosensors for the detection of chemical substances.  
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1.6 Inventory of Devised Biosensors Based on bOBPs 
 
Biosensors using binding proteins instead of enzymes have rarely been reported (other 
than antibodies). Despite the fact that this type of biosensors could be beneficial in a 
more extensive range of applications due to no requirement for any reaction to occur 
on the analyte, but only a reversible interaction with the binding protein. Nevertheless, 
the main difficulty in their design is in the strategy to adopt for transducing all the 
necessary information about the analyte into output electrical signal that could be 
easily processed, leading to a direct result in monitoring and interpretation [65]. 
 
Until now there have been only a few reports on the invention of biosensors based on 
bOBP. M. Ikematsu has had two published patents on devising two chemical sensors 
for detection of a chemical substance contained in a sample. Firstly in 2002, the bOBP 
sensor was in a multi-well microplate by introduction of air containing odorants into 
the reaction solutions containing bOBP, the bonding of bOBP with the odorants has 
been detected by the internal fluorescence when irradiating bOBP with light [56]. 
 
In the second one in 2003, the bOBP sensor was in a cartridge layered with an 
immobilizer. A solution containing a sample and bOBP was fed into the micropassage 
of the cartridge and immobilized to the immobilizer. The chemical substance 
contained in the sample was detected on the basis of the quantity of immobilization of 
bOBP binding to the sample was compared with the reference value that is bOBP 
alone [66].  
 
Then in 2008, Ramoni et al. presented nano-biosensors based on a mutant form of 
bOBP immobilized onto carbon nanotubes. The colour on/colour off bOBP-based 
biosensor is the application of the resonance energy transfer (RET) process for 
monitoring the addition of an odorant molecule to the bOBP–AMA complex, which 
displays the displacement of AMA from the binding site by which the carbon 
nanotubes become colourless [67]. 
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Finally in 2010, a surface acoustic wave (SAW) biosensor system based on a 
recombinant bOBP for detection of the natural ligand (1-octen-3-ol) has been 
designed, fabricated and tested. bOBP was deposited on gold/aluminum multilayered 
interdigital transducers (IDTs) on ST-cut quartz. The differential frequency shift, due 
to the SAW velocity changes as consequence of odorant concentration, was measured 
by a Network Analyzer and showed a resolution of 44 ppb and a sensitivity of 314 
Hz/ppm [68].  
 
 
1.7 Aim of the Project 
 
The aim of this project is to develop biosensors that have applications in broad 
detection of diverse chemical substances by using the recombinant bOBP as the 
biorecognition element. 
 
The proposed bOBP-based biosensors will be generic biosensors that are hybrid 
devices comprising bOBP, a biological component acting as the analyte-binding site 
(receptor), and a signal transducer that converted the binding interaction with the 
analyte into a measurable signal which correlated to the concentration of the analyte 
target (Figure 1.15). Thus, the association of the optical transducer with bOBP is 
crucial for the biosensors in capable of inducing the optical signal in response to the 
detection of target. In this work, a fibre-optic is used as a transmitter. 
 
 
 
 
 
  
41 
 
 
Figure 1.15: Schematic representation of the proposed biosensors based on 
bOBP. bOBP ( ), label ( ), solid surface (  ). 
 
  
The proposed approach will involve expression and purification of both wild type 
bOBP and cysteine mutants. Two alternative strategies were used; in the first, mutant 
bOBPs previously engineered via site-directed mutagenesis were used for site specific 
labelling with a probe. The proteins were characterized in their binding interaction 
with a number of ligands in order to select a labelling probe. A second approach used 
competitive displacement of 1-AMA (fluorescence when bound) by other ligands. 
bOBP was then be immobilized on a solid surface and characterized before being 
developed into a fibre-optic format. Finally, the fibre-optic bOBP biosensor was 
characterized.  
 
 
1.8 The Application of Biosensors Based on bOBP to Thymol 
Determination 
 
As a model analyte, thymol was chosen to demonstrate the application of the 
biosensors based on bOBP. Thymol is natural plant chemical that is largely extracted 
from Thymus vulgaris (thyme plant; a member of the mint family) and various other 
kinds of plants. It has a pleasant aromatic odor and strong flavor of thyme with 
antiseptic properties because of its phenolic structure [69, 70]. Thymol has been used 
as a pesticide agent [71], and as an antiseptic in mouthwash. It is an active ingredient 
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in Listerine
®
 that is presented at the concentration of 0.64 mg/ml (4.3 mM) [72]. It is 
also the active antiseptic ingredient in some toothpaste e.g. Euthymol [73]. Thymol is 
also used as a preservative in an inhalational anaesthetic such as halothane 
(trademarked as Fluothane) [74]. Thus, detection of thymol by this biosensor could be 
performed as quality control tests of these items. Another application may be useful 
for increasing crop production by monitoring plant stresses. Aziz et al. presented that 
Thymus vulgaris plant which is under stress conditions releases the higher relative 
percentage of thymol [75].  
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
 
2.1 Materials  
 
2.1.1 Bacterial strains and plasmid 
 
Bacterial strains 
E.coli BL21(DE3) [F
-
ompThsdSB(rB
-
MB
-
)gal dcm(DE3)] from Novagen (Nottingham, 
UK) was used as a host cell containing the T7 RNA polymerase gene that is essential 
for expression of recombinant proteins encoded by the pET series of plasmids. 
E. coli DH5 [F- Ф80d lacZ ΔM15 Δ(lacZYA-argF) U169 endA1 recA1 hsdR17(rK
-
mK
+
) deoR thi-1 supE44 λ- gyrA96 relA1] was obtained from Invitrogen (Paisley, UK) 
and used as a general cloning host.  
 
Plasmid  
pET24(a)+ vector from Novagen (Nottingham, UK) carrying the bobp genes used in 
this project were provided by Dr. Chung-Pei Ou. Wild type and mutant sequences 
were confirmed by DNA sequencing prior to protein expression. pET24(a)+ contains a 
N-terminal T7 promoter and a C-terminal His10 tag sequence for purification of the 
recombinant protein of an IMAC (Immobilized Metal Affinity Chromatography). This 
vector also carries a kanamycin resistance gene, a lacUV5 promoter, and lacI 
promoter. The lacUV5 promoter controls expression of the T7 RNA polymerase in E. 
coli strain BL21(DE3), and lacI promoter further regulates expression of the 
recombinant protein from both promoters is induced by addition of IPTG. A plasmid 
map of the bOBPwt gene is shown in Figure 2.1. 
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Figure 2.1: Plasmid map of the bOBPwt gene 
 
 
2.1.2 Chemicals 
 
2.1.2.1 General Chemicals 
Yeast extract, peptone from casein (tryptone), bacterial agar, antibiotics, isopropyl-β-
D-thiogalactoside (IPTG), sodium chloride, nickel sulfate, ethylenediaminetetraacetic 
acid (EDTA), dithiothreitol (DTT), imidazole, urea, DMSO and absolute ethanol were 
obtained from Sigma (Dorset, UK). PBS was from Fisher Scientific UK 
(Loughborough, UK). InstantBlue
TM
 Coomassie staining was from Expedeon 
(Cambridgeshire, UK). Guanidine hydrochloride, potassium dihydrogen phosphate, 
glycerol were from VWR (Leicestershire, UK).  
 
pET24a-G110
5823 bp
HIS10
OBP.G110T116
lac operator
LACI
T7 Tag
T7 P
SD SEQ
F1 ORI
ORI
BamHI (520)
ClaI (4380)
EcoRI (1)
HindIII (5805)
NcoI (466)
Sma I (4563)
XmaI (4561)
Ava I (4561)
Ava I (5790)
ApaLI (1366)
ApaLI (3301)
ApaLI (3801)
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2.1.2.2 Main Chemicals 
Ellman’s reagent or DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)) was purchased from 
Sigma-Aldrich  (Dorset, UK). Its structure is shown in Figure 2.2.  
 
 
Figure 2.2: Structure of Ellman’s Reagent 
 
 
IANBD amide (N,N’-dimethyl-N-(iodoacetyl)-N’-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)ethylenediamine) was purchased from Invitrogen (Paisley, UK). Its structure is 
shown in Figure 2.3.  
     
Figure 2.3: Structure of IANBD amide 
 
 
1-Aminoanthracene
 
(1-AMA) was purchased from Sigma (Dorset, UK). Its structure is 
shown in Figure 2.4.  
 
Figure 2.4: Structure of 1-AMA 
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2.1.2.3 Ligands 
Thymol, bromocresol green, malachite green, and methyl salicylate, were purchased 
from Sigma (Dorset, UK). Stock solutions of these chemicals were prepared either in 
DMSO (bromocresol green and malachite green) or in absolute ethanol (thymol and 
methyl salicylate), and then further diluted in PBS with 1mM EDTA supplement, pH 
7.4. Their structures are shown in Figure 2.5 A-D. 
 
 
 
 
 
(A) Thymol     (B) Bromocresol green 
 
 
 
 
 
 
(C) Malachite green    (D) Methyl salicylate 
 
Figure 2.5: Structures of ligands. (A) Thymol, (B) Bromocresol green, (C) Malachite 
green, and (D) Methyl salicylate. 
 
 
2.1.2.4 Chromophores 
DTNB, bromocresol green, cibacron blue, thionin, benzohydroxamic acid, nickel(II) 
chloride, p-nitroaniline, potassium permanganate, 1,2-phenylenediamine 
dihydrochloride, potassium chromate, 3,4-dinitrotoluene, copper(II) nitrate, iodine, 4-
nitrophenol, and 1-aminoanthracene were obtained from Sigma (Dorset, UK). 
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2.1.3 Culture media, stock solutions, and buffers 
 
All solutions were prepared in water purified by reverse osmosis ion exchange and 
carbon filtration in a MilliQ water purification system. 
LB medium 
 1% bacto-tryptone, 1% NaCl, 0.5% yeast extract, autoclaved. 
LB agar 
 LB medium with 1.5% agar, autoclaved. 
SOC 
0.5% Yeast Extract, 2% Tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 
10 mM MgSO4, 20 mM Glucose 
Kanamycin solution (Km) 
 25 mg/ml in water, sterilized by filtration through 0.2 µM membrane 
Isopropyl--D-thiogalactopyranoside (IPTG) 
 1 M in water, sterilized by filtration through 0.2 µM membrane 
Binding buffer 
 20 mM imidazole, 500 mM sodium chloride, 100 mM phosphate buffer pH 7.2 
Washing buffer 
 50 mM imidazole, 500 mM sodium chloride, 100 mM phosphate buffer pH 7.2 
Elution buffer 
 600 mM imidazole, 500 mM sodium chloride, 100 mM phosphate buffer pH7.2 
Stripping buffer 
 6 M guanidine HCl, 0.2 M acetic acid 
Recharging buffer 
 100 mM Nickel sulphate 
Phosphate buffer saline (PBS) 
 PBS with 1 mM EDTA supplement, pH 7.4 
4×SDS-PAGE loading buffer 
0.2 M Tris-Cl pH 6.8, 0.4 M 2-mercaptoethanol, 0.4% (w/v) bromophenol 
blue, 8% (w/v) SDS, 40% (w/v) glycerol.   
Denaturing buffer 
8 M urea in PBS, pH 7.4, containing 1 mM EDTA 
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Ellman's reagent solution 
10 mM (4.0 mg/mL) DTNB in absolute ethanol 
 
 
2.1.4 Apparatus 
 
A HisPrep™ FF 16/10 column that was prepacked with pre-charged Ni Sepharose™ 6 
Fast Flow and used for preparative purification of histidine-tagged recombinant 
bOBPs was from GE Healthcare. PhastGel Gradient 8-25 and Strips SDS were 
obtained from Amersham (Buckinghamshire, UK). Microplate Microfluor 1, 96 well 
flat bottom polystyrene solid black well plates were from Thermo Scientific. The 
Lambda 25 UV/Vis spectrometer was from Perkin-Elmer (Massachusetts, USA). The 
SpectraMax
TM
 Gemini XS microplate spectrofluorometer was from Molecular Devices 
(Sunnyvale, USA). Data was analysed using Softmax Pro Version 3.1.1 software.  
 
The instruments for engineering the fibre-optic biosensor based on bOBP are shown in 
Figure 8.6. The instrumental configuration consisted of an bOBP immobilized 
membrane, an excitation light-emitting diode (LED) light source (LLS-385, Ocean 
Optics; 3.86mW at 385nm), a tight bundle of 7 pure silica optical fibres in a stainless 
steel ferrule (6 illumination fibres around 1 read fibre) (Ocean Optics; 2m long, 
400µm diameter), a 2048-element CCD array detector system (Sony, product no. 
ILX511) of a high-resolution spectrometer (HR2000, Ocean Optics; 200-643nm 
grating, a 50µm entrance slit, an L2 detector collection lens), the reflection probe 
(Ocean Optics; 76.2 mm long for probe ferrule), and a laptop (HP 6360b) with the 
SpectraSuite software. 
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2.2 Methods  
 
2.2.1 Production of the recombinant bOBPs 
 
2.2.1.1 Expression of the Recombinant bOBPs 
 
2.2.1.1.1 Transformation of plasmid DNA  
50 l of competent cells were mixed with 1-2 ng of plasmid DNA, incubated on ice 
for 30 minutes, and heat shocked at 42˚C for 45 seconds in a water bath. They were 
then placed on ice for 1 min, after that they were added to 200 L of SOC medium and 
incubated at 37˚C with shaking at 200 rpm for 1 hour. The cells were transferred on 
LB agar plates with 10 g/ml kanamycin and spread with sterilised plastic rods. The 
plates were then incubated at 37˚C overnight (approximately 16 hours) for growth.   
 
2.2.1.1.2 Extraction of plasmid DNA  
The plasmid extraction and purification were performed using QIAprep Spin Miniprep 
Kit (QIAGEN, West Sussex, UK) according to the manufacturer’s instructions. 
 
2.2.1.1.3 Expression of protein  
3 ml scale expression 
Small-scale protein expression was carried out to examine the protein expression by 
inoculating a single colony of E. coli BL21(DE3) encoding the recombinant bobpwt 
gene into 3 ml of LB
Km
 medium. It was grown overnight at 37C with shaking at 200 
rpm. Expression of proteins was induced by addition of IPTG to a final concentration 
of 1 mM. 100 l aliquots of induced and non-induced cells were collected at 2 hour 
intervals after induction and centrifuged at 12,000 rpm to collect the cell pellet. The 
packed cells were then lysed in 30 l of SDS gel-loading buffer, and heated at 100C 
for 3 min. The protein expression was assessed by SDS-PAGE.  
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7 l scale expression 
A colony showing good protein expression was selected and inoculated into 70 ml 
LB
Km
 medium and grown overnight. The cells were then used to inoculate 7 litres of 
LB
Km
 medium, and incubated at 37
o
C with shaking at 200 rpm. When the OD600 of 
cell culture reached 0.6, IPTG was added to a final concentration of 1 mM. The 
induced cells were incubated at room temperature for overnight before harvesting the 
cells by centrifugation at 5,000 rpm for 30 minutes. The supernatant was discarded, 
and the packed cells were stored at -80
o
C until use. 
 
 
2.2.1.2 Purification of the Recombinant bOBPs 
 
2.2.1.2.1 Cell lysis 
The cell pellet was resuspended in 40 ml binding buffer before being lysed by using a 
French Press operated at a pressure of around 11,000 psi. The procedure was repeated 
for 2-3 rounds for obtaining the clear and slightly viscous solution. The lysed solution 
was then centrifuged at 18,000 g for 30 min to separate the soluble and insoluble 
fraction of the recombinant protein. Cell debris and inclusion bodies remained in the 
pellet. The supernatant was further filtered by passing through a 0.2 µm disk filter in 
order to prevent blocking the purification column.  
 
2.2.1.2.2 Chromatographic column preparation 
The purification of bOBP involves using an Amersham Pharmacia XK16/20 column 
and a nickel-chelated nitrotriacetate (NTA) resin as a chromatographic medium. The 
column was attached to a P1 pump that controlled the flow rate. The column was filled 
with NTA resin to a final volume of 30 ml. Before purification, fresh Ni-NTA resin 
was packed in the column, washed with 3 volumes of filtered purified water, and 
equilibrated with 3 volumes of binding buffer before use. After purification the used 
resin was regenerated with 2 volumes of stripping buffer, and washed with 5 volumes 
of water before and after being washed with 2 volumes of recharging buffer. 
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2.2.1.2.3 Protein purification 
The filtered solution was applied to the resin, and allowed to circulate in the column 
overnight in which the outlet of the XK16/20 column was connected with the inlet of 
the P1 pump with a flow rate of 20 ml/min. After that five column volumes of binding 
buffer were flowed through the resin. Another five volumes of washing buffer was 
then applied to elute low-affinity binding molecules. The protein was eluted by 
applying elution buffer. The collection of the protein was monitored with an online 
UV detection at 280 nm and then SDS-PAGE. The eluted protein solution was then 
concentrated and desalted using a Vivaspin 20 column from Sartorius Stedim Biotech. 
The purified protein was divided into small aliquots (50 µl) and kept at -80
o
C.  
 
2.2.1.2.4 Protein electrophoresis (SDS-PAGE) 
Protein samples were analysed by SDS-PAGE using the PhastSystem (GE Healthcare, 
Amersham, UK). The samples were resuspended in 1×SDS-PAGE loading buffer, 
heated at 100C for 3 minutes before loading into pre-cast gradient gels with an 
acrylamide concentration either 10-15% or 8-25%.  Denaturing SDS buffer strips and 
Sigma low molecular weight marker (97k, 66k, 45k, 30k, 20k, and 14.4k) were used. 
The gel was stained using the Coomassie based protein stain InstantBlue (Expedeon, 
Cambridgeshire, UK). 
 
2.2.1.2.5 Estimation of protein concentration  
Concentrations of the protein samples were determined by means of their absorbance 
spectra obtained with a NanoDrop
®
 ND-1000 UV-Vis Spectrophotometer and using 
the extinction coefficient of the wt bOBP (ɛ280 = 47,000 M
−1
 cm
−1
) as derived from the 
aromatic residue content [76]. 
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2.2.2 CD spectroscopy of thymol binding to bOBP 
 
2.2.2.1 Near-and Far-UV CD Measurements 
The circular dichroism (CD) spectra were recorded on a Jasco J-715 
spectropolarimeter, equipped with a Peltier cell holder thermostatted at 20°C, using 
1mm pathlength quartz cells. Each spectrum was an average of at least three 
accumulated scans with subtraction of the baseline recorded for 0.01X PBS solution 
[10mM potassium phosphate and 10µM EDTA (pH 7.4)] that was solvent of the 
protein and ligand solutions.  
The near-UV CD spectra were scanned from 240−340nm. The concentration of the 
protein and ligand used was 200µM bOBP for the reaction of free bOBP, and 200µM 
bOBP and 200µM thymol for the reaction of thymol-bound bOBP complexes in 300µl 
total volume. In case of the far-UV CD, the spectra of reactions were scanned from 
185−260nm. The concentration of the protein and ligand used was 5µM bOBP for the 
reaction of free bOBP, and 5µM bOBP mixed with 100µM thymol for the reaction of 
thymol-bound bOBP complexes in 300µl total volume.  
 
2.2.2.2 Thermal Denaturation  
Thermal unfolding of bOBP in the presence and absence of thymol was studied by 
recording the CD signal at 195nm as a function of temperature every 2°C from 20°C 
up to 98°C with the heating rate of 45°C/hr. Simultaneously, far-UV CD spectra 
between 185 and 260nm were also collected. The protein concentration was 5μM 
bOBPwt and the ligand concentration was 100µM thymol, by that they were dissolved 
in 0.01X PBS with 10µM EDTA supplement, pH 7.4. The quartz cuvette was 1mm 
pathlength. The thermal unfolding curves were analysed by either direct fitting the 
data to the Boltzmann sigmoidal function (Equation 5.1) or from the first derivative of 
the data using either SciDAVis or OriginPro8.5 or Prism5.0. It is noted that mean 
values of thermodynamic parameters in this study were obtained from three 
independent CD measurements. 
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2.2.3 Characterization of the recombinant bOBPs with DTNB and 
IANBD amide 
 
2.2.3.1 Calculation of the Solvent Accessible Surface Areas (SASA) of 
Cysteine Residues in the Recombinant bOBPs 
 
The three-dimensional (3D) models of bOBP-WT, bOBP-I22C, bOBP-S24C, bOBP-
F54C, and bOBP-F91C were constructed on the basis of the crystallographic structures 
of complexes with each of eight different ligand complexes. The eight different files 
available in PDB were as following: 1). 1-octen-3-ol (PDB ID. 1G85), 2). 
Benzophenone (PDB ID. 1GT5), 3). a selenium containing odorant (PDB ID. 1PBO), 
4). Undecanal (PDB ID. 1GT4), 5). Unknown atom or ion (PDB ID. 1OBP), 6). 1-
Octen-3-ol and 1-Aminoanthracene (PDB ID. 1HN2), 7). 1-Octen-3-ol and 2,6-
Dimethyl-7-octen-2-ol (PDB ID. 1GT3), 8). 1-Octen-3-ol, 1-Aminoanthracene, and 2-
Isobutyl-3-methoxypyrazine (PDB ID. 1GT1). It should be noted that the DNA 
derived sequence of the recombinant bOBPs used in this thesis showed differences 
from the sequences of the native protein described in the papers. These are in addition 
to the cysteine mutations, a N-terminal T7 promoter and a C-terminal His10 tag. These 
differences are shown in Table 2.1. For each X-ray structure file, the ‘Mutate’ tool in 
DeepView was used to change all the residues to match the recombinant bOBP-
WTsequence by introducing the relevant cysteine mutation. Finally, the SASA of each 
cysteine residue was calculated using the UCSF Chimera program. 
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Table 2.1: Differences of DNA sequence between the native protein described in the papers and the sequences from the 
recombinant bOBPs used in work, excluding their N-terminal T7 promoter and C-terminal His10 tag. 
 
Position Amino acid in native bOBP derived from x-ray structure Amino acid in recombinant bOBP derived from 
DNA sequencing PDB ID (reference) 
1G85 
[54] 
1GT5 
[38] 
1PBO 
[77] 
1GT4 
[38] 
1OBP 
[53] 
1HN2 
[54] 
1GT3 
[38] 
1GT1 
[38] 
bOBP-
WT 
bOBP-
F54C 
bOBP-
I91C 
bOBP-
I22C  
bOBP-
S24C  
22 Ile Ile Ile Ile Ile Ile Ile Ile Ile Ile Ile Cys Ile 
24 Ser Ser Ser Ser Ser Ser Ser Ser Ser Ser Ser Ser Cys 
54 Phe Phe Phe Phe Phe Phe Phe Phe Phe Cys Phe Phe Phe 
91 Ile Ile Ile Ile Ile Ile Ile Ile Ile Ile Cys Ile Ile 
110 Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Ser Ser 
112 Thr Thr Lys Thr Thr Thr Thr Thr Lys Lys Lys Lys Lys 
116 Thr Thr Thr Thr Thr Thr Thr Thr Thr Thr Thr Ala Ala 
117 Gly Glu Gly Glu Gly Glu Glu Glu Gly Gly Gly Gly Gly 
154 Asn Asn Asp Asn Asp Asn Asn Asn Asn Asn Asn Asn Asn 
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2.2.3.2 Quantification of Free Thiol Groups Based on the Reaction with 
Ellman’s Reagent  
 
To test that no additional cysteine residue had been accidently introduced during the 
PCR amplification steps, the protein was reacted with Ellman’s reagent. It is necessary 
to expose the thiol group, which is buried in the interior of the protein. 5,000µM of the 
five recombinant bOBPs were therefore dissolved in denaturing buffer (8M urea in 
PBS, pH 7.4, containing 1mM EDTA). Each of the five bOBP sample reactions 
contained 99µl of 10µM bOBPs in denaturing buffer and 1µl of 10mM DTNB 
solution (4.0mg in 1ml absolute ethanol). The reference reaction consisted of 99µl of 
denaturing buffer and 1µl of 10mM DTNB solution. Therefore, the final concentration 
of resulting reactions was composed of 10µM bOBPs, 8M urea buffer, 100µM DTNB, 
and had 1% ethanol. The reactions were then mixed, recorded their absorbance at 
412nm at room temperature and monitored the measurement every 1min for 15min or 
until there was no further change. Absorbance measurements were carried out with a 
Perkin Elmer’s Lambda 25 UV/Vis spectrometer. The concentration of sulfhydryls in 
the samples was calculated from the molar extinction coefficient of TNB at 412nm 
(14,290M
-1
cm
-1
) for 8M urea buffer solvent. 
 
 
2.2.3.3 Reaction of IANBD Amide with Thiol 
 
2-mercaptoethanol as a thiol was used to react with IANBD amide. The experiments 
were carried out in black 96-well microtitre plates with 100µl total volume containing 
90µl of 10-fold molar excess 2-mercaptoethanol diluted in PBS with 10mM EDTA 
supplement, pH 7.4, and 10µl of various IANBD amide concentrations ranging from 
0–307.2µM (final concentration). Each reaction contained 1% DMSO final 
concentration and was added in triplicate in the plate. The reactions were incubated at 
room temperature for 1 hour with shaking at 50 rpm in the dark before being measured 
their fluorescence using the Gemini XPS microplate spectrofluorometer with the 
excitation at 480nm and emission at 550nm.  
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2.2.3.4 Reaction of IANBD Amide with bOBPwt 
 
The experiments were carried out in black 96-well microtitre plates with 100µl total 
volume containing 98µl of 20µM 2-mercaptoethanol diluted in PBS with 10mM 
EDTA supplement, pH 7.4, and 1µl of 2µM (final concentration) IANBD amide. Each 
reaction contained 1% DMSO final concentration and was added in triplicate in the 
plate. The reactions were incubated at room temperature for 1 hour with shaking at 
50rpm in the dark before adding 1µl of various bOBPwt concentrations ranging from 
0 – 40.96µM (final concentration). The reactions were then continued incubating at 
room temperature for another 1 hour with shaking at 50rpm in the dark before being 
measured their fluorescence using the Gemini XPS microplate spectrofluorometer 
with the excitation at 480nm and emission at 550nm. Titration curve was analyzed by 
fitting the data to an equation derived from simple binding equation (Equation 5.3) to 
yield the equilibrium dissociation constants (Kd). Analyses were carried out by using 
either SciDAVis or Origin 8.5 software. 
 
 
2.2.3.5 Determination of Molar Binding Ratio of IANBD Amide and 
bOBPwt 
 
100µM bOBPwt was incubated with a 10-fold molar excess of IANBD amide in PBS 
with 10mM EDTA supplement, pH 7.4 with 1% DMSO final concentration. The 
labeling reaction was carried out at room temperature for 1 hr in the dark, and 
terminated by addition of 2-mercaptoethanol to a final concentration of 1mM. The 
excess label in the labeling reaction was removed using a Vivaspin 500 centrifugal 
filter. The Vivaspin 500 column was first filled up with filtered deionised water to 
maximum volume (500μl) and spun at 12,000 x g for 2 minutes in a pre-rinsing step 
suggested by the manufacturer’s manual to remove trace amounts of glycerine and 
sodium azide on the membrane. The rinsed column was then equilibrated with 500μl 
of PBS by centrifugation at 12,000 x g for 2 minutes and residues (< 5μl) were 
removed before being loaded with the labeling solution, and centrifuged at 12,000 x g 
for 5 minutes to remove the unbound label. The columns were washed with 500μl PBS 
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for three times to remove the excess label and concentrate the labeled protein solution 
at the same time. The labeled protein was then subjected to absorbance measurement 
immediately at 280nm for the bOBP protein and at 480nm for the fluorophore IANBD 
amide by NanoDrop® ND-1000 UV-Vis Spectrophotometer.  A molar ratio of the 
reaction between the protein and the fluorophore was calculated using the Beer-
Lambert’s Law with the absorbance values measured, and the extinction coefficients 
of the bOBPwt; 47,000 M
-1
 cm
-1
 at 280nm [54] and IANBD amide; 25,000 M
-1
 cm
-1
 at 
480nm [78]. 
 
 
2.2.4 Fluorescence and absorbance spectroscopy of bOBP-ligand 
interactions 
 
2.2.4.1 Fluorescence Spectral Analysis of 1-AMA 
 
In order to determine the maximum emission wavelength of the bOBP/1-AMA 
complex, the excitation wavelength was fixed, and the emission wavelength was fixed 
when the maximum excitation wavelength was determined. Measurements were 
performed on a Gemini XS microplate spectrofluorometer. The fluorescence excitation 
and emission spectra of the bOBP/1-AMA complex were scanned by having recorded 
at 10nm intervals. Emission spectra were recorded from 400nm to 600nm. Excitation 
spectra were recorded from 320nm to 460nm. The reaction of the bOBP/1-AMA 
complex consisted of 100µM bOBP and 100µM 1-AMA (1:1) in PBS with 1mM 
EDTA supplement, pH 7.4. Free 1-AMA was used as a background. The DMSO 
concentration in the final solution was equal to 0.1% (v/v). Each reaction was added in 
triplicate with at least three repetitive separate experiments. 
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2.2.4.2 A Binding Assay Based on 1-AMA 
 
The fluorescence binding assay of 1-AMA to bOBPwt was carried out according to 
the method published by [54] with minor modifications. The stock solutions of 1-
AMA in DMSO were freshly prepared in the dark. The experiments were carried out 
in black 96-well microtitre plates with 100µl total volume containing 99µl solution of 
various 1-AMA concentrations ranging from 0 to 12.8µM in PBS with 1mM EDTA 
supplement, pH 7.4, with 0.1% DMSO, and 1µl of 50µM bOBPwt (final bOBP 
monomer concentration was 0.5µM) by which the 1-AMA solution without bOBPwt 
addition was used as a background for comparison. Each reaction was added in 
triplicate and incubated at room temperature for 1 hour in the dark to have a stable 
signal, before being measured their fluorescence using a Gemini XS microplate 
spectrofluorometer with the excitation wavelength at 390nm (9 nm-bandwidth). The 
formation of the bOBP/1-AMA complex was detected by the increase of the 
fluorescence emission intensity at 490nm (9 nm-bandwidth). All trials were run with 
at least three repetitive separate experiments. Intensities from bOBP/1-AMA complex 
were corrected for contributions from unbound 1-AMA. Based on the assumption that 
one molecule of 1-AMA per monomer of bOBP, the dissociation constant (Kd) value 
of the AMA-bOBPwt complex was determined by fitting the binding curve to a single-
site specific binding model; Y = Bmax * X / (Kd + X) (Equation 6.1). Data and error 
analysis were carried out by using either SciDAVis or OriginPro8.5 or Prism5.0. 
 
 
2.2.4.3 Competitive Binding Assays with 1-AMA 
 
The Kd values of complexes between the bOBPwt and the different ligands, 
particularly thymol, bromocresol green, malachite green, and methyl salicylate, were 
determined by competitive binding tests with the fluorescent ligand 1-AMA as 
previously described for other ligands [38, 46, 54, 59]. In the competitive binding 
assays, 1µM bOBPwt were incubated at room temperature for 1 hour with a fixed 
amount of 1µM AMA in the presence of increasing concentrations of each ligand (0–
100µM). The reaction was in PBS with 1mM EDTA supplement, pH 7.4 with the final 
  
59 
concentration of 0.1% (V/V) DMSO solvent and 0.1% (V/V) absolute ethanol. The 
binding of the competitors to bOBPwt was followed as a decrease of the fluorescence 
emission of the 1-AMA/OBP complex at 490nm upon excitation at 390nm. In order to 
obtain the apparent dissociation constants (Kd
app
) for the binding complexes, the 
competition curve for each ligand was analysed with the single-site specific binding 
model (Equation 6.1). The corrected Kd values were then calculated from apparent Kd 
using the formula [54] shown in Equation 6.3. Data and error analysis were carried out 
by using either SciDAVis or OriginPro8.5 or Prism5.0. The data reported were the 
average of triplicate from at least three determinations. 
 
 
2.2.4.4 Dual Ligand Titration with 1-AMA  
 
The analysis of the effect of two ligands, 1-AMA and thymol in competitive binding 
assay was carried out in order to estimate the equilibrium Kd values of thymol. The 
experimental set up involved with titration of a fixed amount of 0.5µM bOBPwt with 
varying 1-AMA and thymol concentrations. A set of the standard ligand titration of 
0.5µM bOBPwt with 1-AMA ranging from 0–12.8µM, was added with a 
concentration of thymol. The concentrations of thymol used in each set of experiments 
were 0, 0.1, 10, 25, 50, and 100µM. The reaction was in PBS with 1mM EDTA 
supplement, pH 7.4 with the final concentration of 0.1% (v/v) DMSO and 0.1% (v/v) 
ethanol. Each reaction was added in triplicate and incubated at room temperature for 1 
hour in the dark to have a stable signal, before being measured their fluorescence 
using a Gemini XS microplate spectrofluorometer with the excitation wavelength at 
390nm. The Kd value of the thymol - bOBPwt complex was followed as the formation 
of the bOBP·1-AMA complex in the presence of each thymol concentration, which 
detected by the increase of the fluorescence emission intensity at 490nm. The titration 
curves plotted between fluorescence intensities of the bOBP·1-AMA complex at each 
thymol concentration against 1-AMA concentrations were used to determine for the Kd 
values of the 1-AMA/bOBPwt complexes by fitting to a single-site specific binding 
model (Equation 6.1). Then, the curve plotted between -log Kd of the 1-AMA/bOBPwt 
complexes at each thymol concentration against their corresponding thymol 
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concentrations were calculated for the equilibrium Kd values of the thymol/bOBPwt 
complexes based on global nonlinear regression method of Lew and Angus; - log 
Kd
AMA
   =  - log ([L] + 10
log (Kd)
) + C (Equation 6.4) [79]. Data and error analysis were 
carried out by using either SciDAVis or OriginPro8.5 or Prism5.0. All trials were run 
for at least three repetitive separate experiments. 
 
 
2.2.4.5 Titration of Chromophore with bOBPwt 
 
The titration absorption spectra studies were performed by keeping constant the 
concentration of chromophore at 2µM while varying the protein concentration at room 
temperature. Initially, the blank buffer solution of PBS with 1mM EDTA supplement, 
pH 7.4 used as a reference was placed in the micro UV cuvette (8.5mm centre height 
of the light path), and then the first spectrum was recorded in the range 200-1,000 nm 
on a Perkin Elmer Lambda 20 UV/VIS spectrophotometer. During titration, 99µl of 
buffered bOBPwt solution at the concentration ranging from 0-19.2µM was added 
with 1µl of 0.2mM chromophore (giving 1% DMSO to the reaction). The solutions 
were mixed; the UV-vis absorption spectra and/or the absorbance at maximum 
wavelength were then recorded.  
 
 
2.2.4.6 Competitive Binding Assays with Chromophore  
 
The competitive binding studies with chromophore were performed by keeping 
constant the concentration of bOBP and chromophore while varying the thymol 
concentration at room temperature. The blank buffer solution of PBS with 1mM 
EDTA supplement, pH 7.4 used as a reference was placed in the micro UV cuvette 
(8.5mm centre height of the light path), and then the absorbance at maximum 
wavelength was recorded on a Perkin Elmer Lambda 20 UV/VIS spectrophotometer. 
In the competitive binding assays, 98µl of buffered 1.25µM bOBPwt solution was 
added with 1µl of 0.2mM chromophore in the presence of increasing concentration of 
thymol (0, 0.0001, 0.001,…100µM). The final concentration contained 1% (V/V) 
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DMSO solvent and 0.1% (V/V) absolute ethanol. The solutions were mixed, incubated 
at room temperature for 1 hour. The binding of the thymol competitor to bOBPwt was 
followed as a decrease of the absorbance of the chromophore/OBP complex at their 
maximum wavelength. 
 
 
2.2.5 Immobilization of bOBP on solid surfaces 
 
2.2.5.1 Screening of Solid Surfaces for Immobilization of bOBP 
 
Ten different commercially available solid surfaces were immobilized with wild type 
bOBP in order to examine their biocompatibility with bOBP function using 1-AMA as 
a probe. The details of the supports comprising their trade names, wettability, pore 
sizes, and particularly binding mechanisms are shown in Table 7.1. The 
immobilization on epoxysilane coated slide and 96-well nickel coated microtitreplate 
were performed according to the Nexterion
®
 Slide E protocols for protein application, 
and HIS-Select
®
 High Capacity (HC) technical bulletin, respectively. For coupling 
membranes, disks of 5mm in diameter were punched out of the membrane with the 
hole punch. 25µl of 100µM bOBP solution was supplied to the membrane placed in 
96-well microtitre plate for 5min. Adsorption occurs spontaneously at room 
temperature. After coupling, the membranes were washed in 25µl of PBS solution 
containing 1mM EDTA, pH 7.4. The membranes were then placed in 25µl of 100µM 
1-AMA for 5 min before being rinsed with 25µl of PBS solution containing 1mM 
EDTA, pH 7.4. It is noted that the final concentration of DMSO was 0.1%. 
Fluorescence measurements were performed with a SPECTRAmax GEMINI XS 
spectrofluorometer. Excitation was 390nm, and the fluorescence was measured at the 
emission maximum of 490nm. 
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2.2.5.2 Amount of bOBP Immobilized on Nitrocellulose 
 
The extent of total bOBP immobilized on nitrocellulose was estimated by the 
Protran
TM
 nitrocellulose membrane with 0.5-cm diameter was placed in 25µl of bOBP 
solution with each concentration of 0, 1, 10, 40, 70 and 100µM, and allowed binding 
for 5min. The volume and OD280 of the bOBP solution before and after immobilization 
were then measured. 
 
 
2.2.5.3 Titration of bOBP and 1-AMA on Nitrocellulose 
 
Optimum concentrations of bOBP and 1-AMA for immobilization on nitrocellulose 
were determined by titration of bOBP and 1-AMA. The Protran
TM
 nitrocellulose 
membrane (0.5-cm diameter) was placed in 25µl of a concentration of bOBP solution 
(0, 1, 10, 40, 70, 100µM) for 5min and then washed with 25µl of PBS solution 
containing 1mM EDTA, pH 7.4 in order to remove the unbound protein. Next, each 
concentration of the immobilized bOBP was incubated with 25µl of a concentration of 
1-AMA solution (0, 1, 10, 40, 70, 100µM) for 5min. After that the membranes were 
washed with 25µl of PBS solution containing 1mM EDTA, pH 7.4. The final 
concentration of DMSO was 0.1%. Finally, the fluorescence of each immobilized 
membrane was measured by using a SPECTRAmax GEMINI XS spectrofluorometer 
with excitation at 390nm and emission at 490nm. The fluorescence intensities of 
bOBP/1-AMA complex on nitrocellulose were thus plotted against respective 
concentration of bOBP as well as that of 1-AMA.  
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2.2.5.4 Amount of Functional bOBP Immobilized on Nitrocellulose 
 
The quantity of functional bOBP immobilized on nitrocellulose was determined by the 
Protran
TM
 nitrocellulose membrane (0.5-cm diameter) was immersed into 25µl of a 
concentration of bOBP solution (0, 1, 10, 40, 70 and 100µM) for 5min, and washed 
with 25µl of PBS solution containing 1mM EDTA, pH 7.4. The 25µl of the 
stoichiometric 1-AMA was then added to the membranes for 5min, and washed again 
with 25µl of PBS solution containing 1mM EDTA, pH 7.4. After that the membranes 
were measured the emission intensity at 490nm with a SPECTRAmax GEMINI XS 
spectrofluorometer at a fixed excitation wavelength of 390nm. It is noted that the final 
concentration of DMSO was 0.1%.  
The fluorescence calibration curve of the binding interaction between bOBP and 1-
AMA was performed in the solution phase by 99µl of 1-AMA was added with 1 µl of 
bOBP with the stoichiometric final concentration of 0, 1, 10, 40, 70, and 100µM. The 
final concentration of DMSO was 0.1%. The binding reactions were incubated for 
5min at room temperature. The fluorescence emission intensity at 490nm was recorded 
at a fixed excitation wavelength of 390nm using a SPECTRAmax GEMINI XS 
spectrofluorometer. Lastly, the corrected fluorescence intensities of the bOBP·AMA 
complex formation were derived by subtracting the fluorescence intensities of the 
backgrounds of individual bOBP and 1-AMA at their corresponding concentrations. 
 
 
2.2.5.5 Effect of Immobilization Method for bOBP and 1-AMA on 
Nitrocellulose  
 
Two different immobilization methods of bOBP and 1-AMA on nitrocellulose were 
performed in order to obtain the optimum immobilization method for the bOBP 
biosensor. The first method was individual immobilization of bOBP and 1-AMA step 
by step as the same as previously treated in section 7.1 – 7.4. The ProtranTM 
nitrocellulose membrane (0.5-cm diameter) was immersed in 25µl of 100µM bOBP 
solution for 5min and washed with 25µl of PBS solution containing 1mM EDTA, pH 
7.4. The immobilized bOBP was then immersed in 25µl of 100µM 1-AMA solution 
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for 5min and washed again with 25µl of PBS solution containing 1mM EDTA, pH 7.4. 
The second method was the immobilization of bOBP/1-AMA complex by which the 
solution of the mixture consisting of 25µl of 100µM bOBP and 25µl of 100µM 1-
AMA was added to the Protran
TM
 nitrocellulose membrane (0.5-cm diameter) for 
5min. Then, the membrane was washed with 25µl of PBS solution containing 1mM 
EDTA, pH 7.4. The influence of this factor was evaluated by measuring S/B ratio. 
There were three different backgrounds, including PBS (containing 1mM EDTA, pH 
7.4), 100µM 1-AMA, and 100µM bOBP backgrounds. The emission fluorescence 
intensity at 490nm was measured by a SPECTRAmax
TM
 GEMINI XS 
spectrofluorometer with excitation at 390nm.  
 
 
2.2.6 Development of fibre-optic sensor based on bOBP 
 
2.2.6.1 Construction of Fibre-Optic Biosensor Based on bOBP 
 
The fibre-optic biosensor based on bOBP was constructed as shown in Figure 8.6. 
This is an extrinsic sensor with bOBP immobilized on a nitrocellulose membrane disk 
and mounted to the front surface of the probe at the end of a bifurcated bundle of 
optical fibres that were in turn connected to the light source and the spectrometer. 
Light from the LLS-385 light-emitting diode (LED) light source (at 385nm) was 
directed through one leg of a bifurcated bundle of optical fibres to the probe tip where 
the bOBP immobilized membrane disk is located. The light intensity emitted by the 
bOBP immobilized membrane was monitored by transmission through the second leg 
of silica fibre and impinging onto the 2048-element CCD array detector system of a 
HR2000 high-resolution spectrometer covering a wavelength range of 200nm to 
643nm, with a 50µm entrance slit and an L2 detector collection lens. The HR2000 
spectrometer was connected to a laptop with the supplied SpectraSuite software. The 
fluorescence emission signal was collected at 490nm. The integration time was set at 1 
second. All experiments were carried out in the dark in order to avoid ambient light 
interference. For the reduction of possible photobleaching of 1-AMA, the light source 
was switched on only when readings were being taken.  
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2.2.6.2 Signal to Background Ratio of Fibre-Optic Biosensor Based on 
bOBP 
 
The fibre-optic bOBP biosensor initially had its S/B ratio determined for based on 
three different backgrounds, which were PBS containing 1mM EDTA (pH 7.4), 1-
AMA, and bOBP. The fibre-optic bOBP biosensor was compared to both the solution 
measurements and the membrane bound protein in a microplate reader. Solution-phase 
protein format consisted of 100µ1 of 1µM bOBP/1µM 1-AMA mixture solution and 
the signal was then measured by using the SPECTRAmax
TM
 GEMINI XS microplate 
spectrofluorometer. The signal of bOBP immobilized membrane format was obtained 
from 25µ1 of 100µM bOBP/25µ1 of 100µM 1-AMA mixture solution was 
immobilized on 0.5cm nitrocellulose disk and fluorescence intensity was detected by 
using the SPECTRAmax™ GEMINI XS microplate spectrofluorometer. The signal of 
fibre-optic bOBP biosensor format was obtained using 25µ1 of 100µM bOBP/25µ1 of 
100µM 1-AMA mixture solution to immobilize on 0.5cm nitrocellulose disk and 
fluorescence intensity was detected by using the fibre-optic system shown in Figure 
8.6.  
 
 
2.2.6.3 Limit-of-Detection (LOD) of Fibre-Optic Biosensor Based on bOBP 
for Thymol in Liquid Phase 
 
The limit-of-detection (LOD) for thymol in the liquid phase was determined to provide 
a quantitative comparison of the utility of the fibre-optic bOBP biosensor with other 
two bOBP biosensing formats. The competitive binding assays with thymol in the 
liquid phase have been accomplished on the solution-phase and the immobilized 
protein. Different concentrations of thymol solution ranging from 0-100µM were 
added to each biosensing formats in triplicate and then incubated for 1 hour at room 
temperature. The amounts of thymol-bound bOBP were determined by measuring 1-
AMA fluorescence at 490nm. bOBP solution phase format that composed of 100µ1 of 
1µM bOBP, 1µM 1-AMA, and thymol was monitored the fluorescence signal by 
SPECTRAmax™ GEMINI XS microplate spectrofluorometer. bOBP immobilized 
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membrane format was analyzed by incubating the immobilized membrane containing 
25µ1 of 100µM bOBP/25µ1 of 100µM 1-AMA mixture with 25μl of thymol, and 
detected by using SPECTRAmax™ GEMINI XS microplate spectrofluorometer. For 
the fibre-optic bOBP biosensor, the immobilized membrane containing 25µ1 of 
100µM bOBP/25µ1 of 100µM 1-AMA mixture was incubated with 25μl of thymol, 
and measured by using the fibre-optic system shown in Figure 8.6.  
 
 
2.2.6.4 Ability to Sense Thymol Vapour of Fibre-Optic Biosensor Based on 
bOBP 
 
The ability to sense thymol vapour of the fibre-optic biosensor based on bOBP was 
then investigated. A simple preliminary experiment was set up by 0.5-cm bOBP 
immobilized nitrocellulose membrane disk containing 25µ1 of 100µM bOBP/25µ1 of 
100µM 1-AMA mixture that was stuck at the lid of a 0.5-ml tube was incubated in 
triplicate for 1 hr at room temperature with thymol vapour produced from different 
concentrations of 50µl thymol solution ranging from 0-25mM at the bottom of the 
tube. Thymol solution was dissolved in PBS containing 1mM EDTA (pH 7.4) that had 
0.1% ethanol final concentration. Blank comprised of five separate measurements of 
the bOBP immobilized membrane at the top of the tube incubating with 50µl of PBS 
containing 1mM EDTA (pH 7.4) and 0.1% ethanol at the bottom of the tube. The 
bOBP immobilized membrane was then attached to the edge of the fibre bundle, and 
the emission fluorescence intensity was measured at 490nm.  
 
 
2.2.6.5 Analysis of Thymol Vapour by Fibre-Optic Biosensor Based on 
bOBP 
 
The photostability of the bOBP immobilized membrane was investigated by 
monitoring % fluorescence remaining of the bOBP immobilized membrane containing 
25µ1 of 100µM bOBP/25µ1 of 100µM 1-AMA mixture was mounted to the reflection 
probe at the end of the fibre bundle, and flashed using the fibre-optic system (Figure 
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8.6). The experiment was carried out in a dark room in order to avoid ambient light 
interferences. The LLS-385 LED light source (Ocean Optics; 3.86mW at 385nm) 
excited the membrane at 385nm, and was switched on only when readings were being 
taken. The emission fluorescence signal was collected at 490nm. The integration time 
was set at 1 second.  
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CHAPTER 3 
 
PRODUCTION OF THE RECOMBINANT BOVINE ODORANT 
BINDING PROTEINS (bOBPs) 
 
 
3.1 Expression of the Recombinant bOBPs 
 
E.coli BL21(DE3) transformed by pET24a containing the bobpwt gene (its plasmid 
map shown in Figure 2.1) was revived from -80
o
C storage by streaking on LB
Km
 agar 
plate. Then, the bobpwt gene was verified by DNA sequencing (Appendix). The 
verified clone was examined for its protein expression on a small-scale by inducing 
with 1 mM IPTG and growing at 37
o
C in comparison with the non-induced cells by 
using non-transformed and pET24a-transformed bacteria as controls. The result of the 
SDS-PAGE analysis are shown in Figure 3.1 and revealed an intense band from the 
recombinant clone at the expected size of the bOBP subunit, indicating that bOBP was 
over-expressed. The molecular weight of the bOBP band was around 20 kDa which 
was a little larger than the one reported as 19 kDa (159 residues) [80] because of extra 
amino acid residues of a T7 tag (11 amino acids) and some carry-over sequence from 
pET24a (4 amino acids) attached to the N-terminus, and a 10-his tag at the C-terminus, 
which produced the total of 184 residues of this recombinant bOBP. 
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Figure 3.1: SDS-PAGE of bOBP expression. M is prestained SDS-PAGE standards 
marker. 1 is E. coli BL21(DE3) lysate; 2 is E. coli BL21(DE3) transformed with 
pET24a lysate; 3 is E. coli BL21(DE3) transformed with pET24a carrying the bobpwt 
gene; -I is before induction; and +I is after induction. 
 
 
It was observed that both induced and non-induced cells over-expressed bOBPwt at 
37
o
C. Subsequently the expression of bOBPwt was then investigated at room 
temperature to determine whether the protein was expressed in the soluble form or as 
inclusion bodies by culturing the induced cells at room temperature overnight (or at 
33
o
C for 6 hr). The induced cells were then harvested, broken with French Press 
operated at the pressure of around 11,000 psi. The lysed solution was centrifuged to 
separate the soluble and insoluble fractions of the recombinant protein. It was found 
that bOBPwt expressed almost completely in the soluble form as shown in Figure 3.2.  
 
 
 
M      -I    +I      -I      +I      -I       +I     M 
 1                2                3 
 
~ 20 kDa  
Size of the bOBP subunit 
   
kDa 
210 
125 
101 
56.2 
35.8 
29 
21 
6.9 
  
70 
 
kDa 
210
125 
101 
56.2 
35.8 
29 
21 
6.9 
 
Figure 3.2: SDS-PAGE of bOBP expression in soluble form after induction at 
30
o
C. M is prestained SDS-PAGE standards marker. S is soluble form; B is inclusion 
bodies; and I is induction. 
 
 
3.2 Purification of the Recombinant bOBPs 
 
The large-scale recombinant bOBP expression and purification was then performed by 
expressing 7 litres of the bOBPwt cell culture. The cells were lysed and the lysate was 
applied into the Ni-NTA sepharose affinity chromatographic column, then recirculated 
the column overnight at the flow rate of 20ml/min, and eluted using linear gradient to 
100% elution buffer (600mM imidazole, 500mM sodium chloride, 100mM phosphate 
buffer, pH 7.2). The fractions eluting from the column were analysed by SDS-PAGE 
shown in Figure 3.3, demonstrating that no or insignificant traces of the target protein 
band were obtained from the flowthrough and washing fractions, indicating that bOBP 
in the lysate was tightly bound to the Ni-NTA resin. This is because bOBP fused with 
histidine tag, which binds to the nickel whereas non-specific proteins were eluted from 
the column with washing buffer containing low imidazole concentration (50mM 
imidazole). The histidine-tagged bOBP protein was eluted with buffer containing 
600mM imidazole. 
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Figure 3.3: SDS-PAGE of the purification of bOBP. M is SDS-PAGE standards 
marker. F is flowthrough fraction; W is washing fraction; and 1 - 9 are number of 
elution fractions.  
 
 
From Figure 3.3, it was observed that the concentrated bOBP solution showed more 
than one band in SDS-PAGE. This may have due to residual salts and/or imidazole. 
Therefore, fractions of the eluted proteins (E6 – E9) were pooled further desalted and 
concentrated using a Vivaspin20 centrifugal concentrator with 10-kDa MWCO 
membrane. The protein concentrations were estimated using a Nanodrop 
spectrophotometer. The purified protein was diluted to around 0.3 – 1.0 mg/ml for 
loading into the SDS-PAGE gel in order to get a sharp protein band without smears as 
shown in Figure 3.4. SDS-PAGE showed a single band at the expected size, indicating 
that the purified bOBP was obtained.  
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Figure 3.4: SDS-PAGE of the purified bOBP.  
 
 
Mutant bOBPs that were also produced by Dr Chung-Pei Ou and Dr. Melanie Fennah 
were expressed and purified by using the same procedures as those described above 
for bOBPwt. These mutant bOBP clones all have the C-terminal decahistidine tags and 
site mutations in the ligand binding cavity at different locations introducing a unique 
cysteine residue in the bOBP sequence, which could allow later site specific binding of 
the environmental sensitive thiol reactive probe, and therefore report the protein-
ligand binding events. The five cysteine bOBP mutants were as following: I22C, 
S24C, F36C, F54C, and F91C. The efficiencies of the bOBP expression and 
purification are shown in Table 3.1. 
 
 
Table 3.1: Yields of bOBP wild-type and cysteine mutants 
bOBP Total yield (mg) 
WT 368 
I22C 444 
S24C 691 
F36C 77 
F54C 13 
F91C 351 
 
~ 20 kDa Purified bOBP 
kDa 
 
 
97.4 
66.2 
45 
31 
21.5 
14.4 
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Sequence confirmed wild-type and five cysteine mutants of bOBP were expressed and 
purified to homogeneity. Yields were 13-691 mg (7-L cultures) and in the following 
chapter, the CD spectroscopic studies of bOBP in binding to thymol are described. 
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CHAPTER 4 
 
CD SPECTROSCOPY OF THYMOL BINDING TO bOBP 
 
 
In the previous chapter, the expression and purification of recombinant bOBPs were 
described. In this chapter, the interaction of wild type bOBP with thymol as a ligand 
was characterized by means of CD spectroscopy. 
 
Circular dichroism (CD) is the difference in the absorption of left-handed circularly 
polarized (LCP) light and right-handed circularly polarized (RCP) light which arises 
due to structural chirality. An ordered structure results in a spectrum which can 
contain both positive and negative signals, while the absence of regular structure 
results in zero CD intensity [81]. CD is dependent on the wavelength at which 
absorption occurs and therefore CD spectroscopy measures the differential absorbance 
as a function of wavelength. This technique is employed widely to study asymmetric 
molecules of all types and sizes, and it has found particular application in the study of 
large biological molecules [82]. Whilst experimentally the CD spectrum measures the 
differential absorption (∆A), this is often converted to ellipticity (θ). The relation 
between these two quantities can be derived as following: 
 
By applying Beer’s law 
AL  = ɛL ∙ C ∙ l 
AR  = ɛR ∙ C ∙ l 
So, ∆AL-R  = ∆ɛL-R ∙ C ∙ l 
Where ɛL and ɛR are the molar extinction coefficients for LCP and RCP light, C is the 
molar concentration, l is the path length in centimeters (cm), and ∆ɛ is the molar 
circular dichroism that is a function of wavelength. 
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Molar circular dichroism and molar ellipticity [θ] are readily interconnected by the 
equation  
[θ]  = 3298 ∙ ∆ɛ = 3298 ∙ ∆A 
            C ∙ l 
The linear dependence of solute concentration and pathlength is removed by defining 
ellipticity as 
θ  = 3298 ∙ ∆A 
 
CD is typically used to study macromolecules in solution, and thus it complements 
methods that study the solid state [83]. Its primary use is in analyzing the 
conformation (secondary, tertiary structure) or stability changes of macromolecules, 
particularly proteins with environmental conditions such as under stress or denaturants 
(temperature, chemicals (usually urea and guanidinium chloride) and extremes of pH 
(usually acidic)), or on protein-protein or protein-ligand interactions. In addition to 
structural information, thermodynamic and kinetics parameters of macromolecules can 
be acquired from CD spectroscopy as well.  
 
Characterization of bOBP by using CD spectroscopy in this project presents structural 
and thermodynamics information of the protein. 
 
 
4.1 Structural Information of Protein and Binding Interaction 
 
4.1.1 Tertiary structure 
 
The near-UV CD spectrum (250-300nm) of proteins provides information on the 
presence of tertiary structure. The signals obtained in this spectral region arise from 
the absorption, dipole orientation and the nature of the surrounding environment of the 
aromatic amino acids; tryptophan, tyrosine, phenylalanine, and cysteine (or S-S 
disulfide bonds) as following: 
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- Tryptophan: 280-300nm 
- Tyrosine: 270-290nm 
- Phenylalanine: 250-270nm 
- Disulfide bonds: broad weak signals throughout 250-300nm  
 
Generally, tryptophan will give the biggest signal, followed by tyrosine and then 
phenylalanine. The number of each type of aromatic amino acid present and the nature 
of their environment (H-bonding, polar groups) will determine the actual shape and 
magnitude of the near-UV CD spectrum of a protein [84]. The presence of significant 
near-UV signals is a good indication that the protein is folded into a well-defined 
structure. 
 
In order to investigate the binding of a ligand molecule with bOBP in solution phase, 
CD spectroscopy has been exploited to obtain information about the protein structure 
upon the binding to thymol; a ligand for bOBP [34, 36]. The tertiary structure of 
bOBP in the presence of thymol (200µM bOBP and 200µM thymol) has been 
analyzed in comparison with unbound bOBP (200µM bOBP) by measuring near-UV 
CD spectra at 240 − 340nm. The result in Figure 4.1 showed the near-UV CD spectra 
with a negative band at about 280nm of tryptophan residue of bOBP in the absence 
and presence of thymol were nearly superimposed spectral profiles. Some small 
changes in the intensity were observed, but the number and positions of the spectral 
bands remained unchanged, pointing to the absence of any significant change of the 
tertiary structure of bOBP likely due to no perturbations of thymol binding to the 
environment of the aromatic region in the folded structure of bOBP. 
 
Alternatively, the UV spectrum of thymol is shown in Figure 4.2, it has absorption in 
the same region as tryptophan (280nm) and tyrosine (270 - 290nm) residues in bOBP. 
It is possible that the bound thymol would show a CD spectrum in this region. It is 
probably overwhelmed by the strong signals of the four tryptophan and the five 
tyrosine aromatic residues in the protein itself.  
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However, it is interesting that this result found in bOBP in this study was also in a 
agreement with near-UV CD measurement of porcine OBP spectra in the presence of 
ligand (3,7-dimethyl-octan-1-ol; DMO). DMO, a molecule able to bind bOBP 
strongly, has the dissociation constant (Kd) value of 0.20 µM
 
to pOBP. It revealed that 
state of its aromatic residues does not show significant changes in the presence of 
DMO ligand. In this case, this probe does not interfere the intrinsic protein CD 
spectra, since it does not absorb in the near UV region [85]. 
 
 
 
 
Figure 4.1: Near UV CD spectra of bOBP in the absence (blue) and presence of 
thymol (red) demonstrated as ellipticity in millidegree unit. The protein 
concentration was 200μM bOBPwt and the ligand concentration was 200µM thymol, 
by which they were dissolved in 0.01X PBS with 10µM EDTA supplement, pH7.4. 
Data were collected in cell with 1mm pathlength, T = 20°C.  
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Figure 4.2: Absorption spectrum of 200μM thymol in 0.01X PBS with 10µM 
EDTA supplement, pH 7.4 at 25°C. 
 
 
4.1.2 Secondary structure 
 
Secondary structure can be estimated by CD spectroscopy in the far-UV range. Signals 
in the region from 180-250nm are attributable to the peptide bond and originate when 
it is located in a regular, folded environment. A characteristic shape and magnitude of 
the CD spectrum can be determined by alpha-helix, beta-sheet, or some other (e.g. 
random coil) structures. Figure 4.3 illustrates spectra of the three common different 
conformations. 
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Figure 4.3: Characteristic of far-UV CD spectra for an α-helix, a β-sheet and a 
random coil secondary structure of protein [86]. In general, the spectrum for an 
alpha-helix protein has two negative bands of similar magnitude at 222 and 208nm, 
and a positive band at ~190nm. The spectrum for a beta-sheet protein has mainly a 
negative band between 210 - 220nm and a positive band between 195 - 200nm. The 
spectrum for a disorderly (random) protein has a negative band of at around 200nm. 
This image has been reproduced with the permission of the rights holder, Alliance 
Protein Laboratories by Dr. John Philo. 
 
 
The far-UV CD spectroscopy (260–185nm) was also used to monitor changes in the 
secondary structure of bOBP in the presence of thymol. It was found that the spectrum 
of bOBP in the presence of thymol was similar to that of unbound bOBP (Figures 4.4), 
which showed the typical shape of a protein with characteristic of β structures that 
havve one maximum at 195nm and one minimum at 217nm, indicative of the 
comparable amount of secondary structure content.  
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Therefore, conclusions could be drawn that the protein-ligand binding interaction 
between bOBP and thymol was studied by using the near- and far-UV CD 
spectroscopy at the temperature of 20
o
C, and the structural information upon the 
binding was obtained. It has been shown that the secondary and tertiary structures of 
bOBP are largely maintained on binding to thymol, suggesting the presence of thymol 
in the interior cavity of bOBP did not perturb the protein structure.  
 
This finding was also in good agreement with several previous studies that reported on 
bOBP and pOBP; which are structurally similar. Mazzini and co-workers have shown 
that at acidic pH (2.5), bOBP loses its swapped dimeric conformation, but keeps its 
tertiary and secondary structure largely unaltered. This conclusion was based on size 
exclusion chromatography, 1-aminoanthracene (AMA) binding studies, CD 
spectroscopy, and molecular dynamics simulations [87]. Additionally, an absence of 
significant conformational changes involving protein loops or backbone upon the 
binding of odorant molecules also has been revealed by the crystal structures of both 
pOBP and bOBP [38]. Moreover, it has been shown that tryptophan in the pOBP 
structure is not involved in binding to the odorants 2-isobuthyl-3-methoxypyrazine 
(IBMP) and DMO by Fourier-transform infrared spectroscopy (FT-IR) and 
fluorescence spectroscopy [88]. Finally, it was found that the far- and near-UV CD 
spectra of pOBP at pH 6.6 demonstrate unchanged of the number and positions of the 
spectral bands compared to those in the presence of DMO, but some difference in the 
intensity level is observed [85].  
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Figure 4.4: Far-UV CD spectra of bOBP in the absence (blue) and presence of 
thymol (red) demonstrated as ellipticity in millidegrees. The protein concentration 
was all 5μM bOBPwt and the ligand concentration was 100µM thymol, which were 
dissolved in 0.01X PBS with 10µM EDTA supplement, pH 7.4. Data were collected in 
a cell with 1mm pathlength, T = 20°C. 
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4.2 Thermodynamic Information of Protein Unfolding and Binding  
 
4.2.1 Thermal stability  
 
When proteins are folded they have highly chiral secondary structure elements, such 
as α-helices and β-pleated sheets, which create unique characteristics in the CD spectra 
(Figure 4.3). When proteins unfold they lose these well-ordered structures and the CD 
bands alter. The changes in CD spectra obtained as a function of temperature can be 
used to determine the thermodynamics of unfolding (or more precisely change of 
state). For example, the midpoint of the unfolding transition (Tm) that is directly 
related to conformational stability. The enthalpy (ΔH), the free energy (ΔG), the 
entropy (ΔS) of unfolding, and the dissociation constants (Kd) of interacting proteins, 
that can also be estimated from data extraction. Additionally, analysis of CD spectra 
obtained as a function of temperature may be useful in determining whether a protein 
has unfolding or folding intermediates [89]. 
 
The effect of a bound ligand on thermal unfolding of bOBP was investigated with 
thymol to study the role of the ligand binding interaction on the protein thermal 
stability. Thermal unfolding of bOBP was carried out by following the far-UV CD 
signal at 195nm collected every 2°C from 20 to 98°C as shown in Figure 4.5 and 4.6. 
The thermodynamic parameters of unfolding could be determined from three 
independent CD measurements. The melting temperature (Tm) is the midpoint of the 
transition (unfolding curve), which was obtained by either approximately estimating 
from the first derivative equation of the data by which Tm is represented as the 
minimum of the curve (Figure 4.7-4.8) or direct fitting the data to the Boltzmann 
model (Equation 4.1).  
 
Y = BP + (TP - BP) / (1 + exp ((T - Tm) / dT))  
 
Equation 4.1: Boltzmann model. Where BP is bottom plato, TP is top plato, T is 
temperature, and Tm is melting temperature. 
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Figure 4.5: Far-UV CD spectra of 5µM bOBP at various temperatures of 20, 60, 
70, 74, 80, 82 and 90
o
C. The buffer was 0.01X PBS containing 1µM EDTA (pH 7.4). 
 
 
 
Figure 4.6: Far-UV CD spectra of 5µM bOBP in the presence of 100µM thymol at 
various temperatures of 20, 60, 70, 74, 80, 82 and 90
o
C. The buffer was 0.01X PBS 
containing 1µM EDTA (pH 7.4). 
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Figure 4.7: First derivatives of 5µM bOBP as a function of the temperature (the 
data in Figure 4.5 at 195nm). The minimum corresponds to the midpoints (Tm) of the 
unfolding/folding curves for the protein. 
 
 
 
 
Figure 4.8: First derivatives of 5µM bOBP in the presence of 100µM thymol as a 
function of the temperature (the data in Figure 4.6 at 195nm). The minimum 
corresponds to the midpoints (Tm) of the unfolding/folding curves for the protein-
ligand bound complex. 
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From calculating Tm by using two different methods, it was found that both methods of 
calculation gave the same Tm values. It was shown that the equilibrium unfolding 
transition curves fitting to the Boltzmann equation were sigmoidal (Figure 4.9). The 
Tm of bOBP in the absence of thymol was 74 ± 0.3°C and significantly shifted towards 
higher temperature to 82 ± 0.4°C for the one in the presence of thymol. The higher 
stability of bOBP evidenced by these data could be accounted for by the presence of 
thymol in the binding cavity of bOBP, which suggested that thymol induced protein 
stabilization.  
 
Additionally, CD spectroscopy as a function of temperature has also been used to 
detect temperature-induced effects on structural features. Figure 4.5 and 4.6 showed 
that the far-UV CD spectra of bOBP in the absence and presence of thymol as a ligand 
exhibited a maximum at 195nm and a minimum at 217nm with the overall 
maintenance of the β-barrel structure in a large range of different temperatures at 
which were stable up to 74
o
C for bOBP and 82
o
C for thymol-bound bOBP. At 
temperatures higher than their Tm, it was observed that their secondary structures did 
not completely convert to random coils, which indicated that some β-sheet structure 
remained. Thus, although differences in the far-UV CD spectra between the protein in 
the presence and absence of thymol was not found at 20
o
C (Figure 4.4), it was clearly 
seen that differences at 76 - 82
o
C, which were the temperatures between higher than 
the Tm of unligated bOBP and the Tm of thymol-bound bOBP. 
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Figure 4.9: Unfolding transition curves of the ellipticity at 195nm for unfolding of 
bOBP in the absence (black squares) and presence of thymol (red circles) as a 
function of temperature. The concentration of protein was 5µM bOBP and the 
concentration of ligand was 100µM thymol. The reactions were in 0.01X PBS with 
10µM EDTA supplement, pH 7.4, recorded by far UV–CD at a thermal scan rate of 
45°C/hr from 20 to 98°C during denaturation. The raw data were fit with Boltzmann 
equation. 
 
 
In this experiment, the typical change of ellipticity is shown as a function of 
temperature for bOBP in the absence and presence of thymol. These were used to 
determine the thermodynamics of unfolding. It was shown that bOBPwt was highly 
thermostable with Tm of the unfolding transition of 74 ± 0.3°C in the absence of 
thymol, which is considerably lower than that observed in the presence of thymol at 82 
± 0.4°C, suggesting a stabilizing role is played by bound thymol. The phenomenon 
found in this study was similar to those already described for the mutant bOBP that 
was investigated by using FT-IR and molecular dynamics simulations [64, 90], as well 
as natural pOBP that was shown by FT-IR and fluorescence spectroscopy [88]. 
Moreover, the Tm in this finding was in a similar range of temperature as two other 
reports of thermal denaturation of bOBPwt [63] and pOBP [85]. These were a heating-
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induced transition in bOBPwt detected at 75 - 85
o
C by means of difference infrared 
spectra, 2D-IR correlation spectroscopy and molecular dynamics simulations [63]. 
Secondly, the unfolding transition of pOBP has been shown at 69°C by the method of 
high-sensitivity differential scanning calorimetry (HS-DSC) [85].  
 
It appeared that, similarly to pOBP [88] and the mutant bOBP [64], the secondary 
structures of unbound and thymol-bound proteins showed a high resistance of its 
global structural organization to high temperatures, since its overall fold are practically 
unchanged in a wide range of temperature. The advantageous properties of bOBP 
shown by these obtained results will allow for a better use of this protein for the design 
of advanced protein-based biosensors for the detection of compounds. 
 
In next experiments, other thermodynamic parameters of unfolding; the enthalpy 
(ΔH), the free energy (ΔG), the entropy (ΔS) of unfolding and binding, and the 
dissociation constant (Kd) for the binding of bOBP to thymol are evaluated. 
 
 
4.2.2 Enthalpy (ΔH), free energy (ΔG), entropy (ΔS) of unfolding and 
binding 
 
Following changes in the CD of macromolecules, such as proteins as a function of 
temperature or denaturant is a very convenient method for obtaining the 
thermodynamics of unfolding or folding. It is based on the fact that the change in 
ellipticity is directly proportional to the change in concentration of native and 
denatured forms [91]. In the simplest case, a molecule undergoes an unfolding 
transition between two states: folded (F) and unfolded (U).  
 
From the CD spectra of bOBP obtained from section 4.2.1, it appeared that bOBP at 
high temperature did not have a fully unfolded state. The effect of ligand binding on 
stability can be modelled by a triangular three-state diagram, which includes a direct 
path from the folded (F) to the unfolded state (U), and the indirect route via the 
bOBP•Thymol complex (F•L) (Scheme 4.1).  
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                 ∆HU (unbound), ∆GU (unbound), ∆SU (unbound) 
              F    U   Scheme 4.1 
          
 
          F • L 
 
The equilibrium thermodynamic data can be described as shown in Equation 4.2 - 4.4. 
Since, ∆HU (unbound) = ∆HB  +  ∆HU (bound)      
So, ∆HB  = ∆HU (unbound)  -  ∆HU (bound)  4.2 
∆HB is the enthalpy of binding between bOBPwt and thymol, ∆HU (unbound) is the 
enthalpy of unfolding for unbound bOBP, and ∆HU (bound) is the enthalpy of unfolding 
for thymol-bound bOBP.   
 
Likewise, ∆GB  = ∆GU (unbound)  -  ∆GU (bound)  4.3 
∆GB is the free energy of binding between bOBPwt and thymol, ∆GU (unbound) is the free 
energy of unfolding for unbound bOBP, and ∆GU (bound) is the free energy of unfolding 
for thymol-bound bOBP.   
 
And, ∆SB  = ∆SU (unbound)  -  ∆SU (bound)  4.4 
∆SB is the entropy of binding between bOBPwt and thymol, ∆SU (unbound) is the entropy 
of unfolding for unbound bOBP, and ∆SU (bound) is the entropy of unfolding for thymol-
bound bOBP.   
 
For the purposes of thermodynamic calculations, bOBP was assumed to have the 
simple two-state transition upon heating as shown in Scheme 4.2. 
KU 
F  U       Scheme 4.2 
KU is the equilibrium constant of unfolding at a given temperature. 
 
KU = [U] / [F]   
[F] and [U] are the concentrations of the folded and unfolded forms, respectively.  
L 
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If α is defined as the fraction folded at a given temperature,  
 = [F] / [F] + [U] 
 
The concentrations can be written in terms of the ellipticity 
KU = (1 - ) /       4.5 
 
 = (θt – θU) / (θF – θU)     4.6 
θt is the observed ellipticity at any temperature, θF is the ellipticity of the fully folded 
form and θU is the ellipticity of the unfolded form [89, 91]. 
 
 
Additionally, the relationship between free energy (ΔG), enthalpy (ΔH), entropy (ΔS) 
and the equilibrium constant (K) for a chemical reaction at a specific temperature (T): 
ΔG = – R T ln K = ΔH – TΔS   4.7 
R is the gas constant that equal to 8.314 J/mol·K, and T is the absolute temperature 
(Kelvin). 
 
A process at constant temperature and pressure will be spontaneous in the direction in 
which free energy decreases (–ΔG). When Equation 4.7 is rearranged to remove ΔG, 
ln K is expressed in terms of ΔH, ΔS and T only: 
ln K   = −ΔH    +   ΔS      4.8 
 R • T        R 
 
During protein folding, the process is considered to have a favourable enthalpy change 
(ΔH < 0), as the amino acid residues come close together so forming non-covalent 
bonds. Denaturation only occurs when ΔG is negative, with which ΔH and ΔS are 
generally both positive [92, 93]. In order to analyse free energy (ΔG), enthalpic (ΔH), 
and entropic (ΔS) effects on the unfolded state of bOBP in the absence and presence of 
thymol as a function of temperature, those three independent CD data sets of section 
4.2.1 were used to obtain mean values of these thermodynamic parameters.  
 
  
90 
First, ΔH of unfolding (ΔHU) was determined by using the van’t Hoff plot, that is the 
natural logarithm (ln) of the equilibrium constant of unfolding (KU) was plotted as a 
function of 1/T where T is the absolute temperature (Kelvin). The plot should result in 
a straight line with a slope equal to (–ΔH/R). Thus, enthalpy, ΔH, is determined from 
the slope, but entropy, ΔS, is normally calculated from the Equation 4.8 instead of the 
graph. This is because the intercept of the y-axis appears when the ratio (1/T) = 0 (that 
is when T = ∞) [89]. KU were calculated based on the fraction folded data (α) by using 
Equation 4.5, with which α were determined by fitting the experimentally observed 
values of the change in ellipticity as a function of temperature (data of Figure 4.7) to 
Equation 4.6. The KU values could only be accurately determined through the 
transition region as shown in Figure 4.10-4.11. Additionally, ∆H of binding between 
bOBPwt and thymol (∆HB) was determined from Equation 4.2; ∆HB  =  ∆HU (unbound)  -  
∆HU (bound), The resulting values of ∆H are collected in Table 4.1.  
 
 
 
Figure 4.10: Change in fraction folded (α); α  =  (θobs - θunfold)/(θfold - θunfold)  of 
bOBP in the absence (blue diamond) and presence of thymol (red square) from 
the change in ellipticity as a function of temperature. Fraction folded data were 
used to calculate equilibrium constant of unfolding (KU). The protein concentration 
was 5μM bOBPwt and the ligand concentration was 100µM thymol. The reactions 
were in 0.01X PBS with 10µM EDTA supplement, pH 7.4. 
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Figure 4.11: Enthalpies of unfolding (ΔHU) for bOBP in the absence (blue 
diamond) and presence of thymol (red square) from the change in ellipticity as a 
function of temperature. Van’t Hoff plot of the thermal unfolding data for bOBP was 
created. The unfolding equilibrium constants were calculated according to Equation 
4.5 (KU = unfolded/folded) from the α data attained in Figure 4.10.  
 
 
Table 4.1: Summary of enthalpies of unfolding (∆HU) for bOBP in the absence 
and presence of thymol, and enthalpy of binding (∆HB) between bOBPwt and 
thymol determined from the van't Hoff analysis (Figure 4.11). The change in 
ellipticity as a function of temperature was monitored by CD. The protein 
concentration was 5μM bOBPwt and the ligand concentration was 100µM thymol. 
The reactions were in 0.01X PBS with 10µM EDTA supplement, pH 7.4. Each value of 
∆H is the average of three independent determinations. 
 
Thermodynamic parameters ∆H  (kJ/mol) 
Unfolding of bOBP in the absence of thymol 
Unfolding of bOBP in the presence of thymol 
Binding of bOBP and thymol 
217 ± 26 
451 ± 17 
-234 ± 31 
y = -56594x + 159.45 
y = -27798x + 80.10 
-2
-1.5
-1
-0.5
0
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2.5
3
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Next, free energies of unfolding (∆GU) for bOBP in the absence and presence of 
thymol were studied. Analysis of thermal unfolding exhibited a decreasing linear plot 
of ∆GU as a function of temperature in the transition zone. It was found that the CD 
data at lower temperatures did not contribute to a linear line or to unfolding. This is 
due to the limitation of the detecting instrument that was unable to distinguish very 
small changes of unfolding at low temperatures. So, only data within the temperature 
range of the linear part and affecting unfolding were analyzed. Then, the data above 
62°C for unbound bOBP and above 76°C for that in the presence of thymol were used 
in calculating ∆GU of bOBP in the absence and presence of thymol based on Equation 
4.7; ΔG  =  – R T ln K. The ∆GU results were shown as values of temperature 
dependence (Figure 4.12) that ∆GU of the both systems decreased during the unfolding 
reactions. In detail, ∆GU (unbound) and ∆GU (bound) were positive (∆GU more than 0) when 
less than 74°C for unbound bOBP and less than 82°C for in the presence of thymol. 
When T was more than Tm, ∆GU was negative (∆GU less than 0). This suggested that 
when T was less than Tm, unfolding reactions of unbound and thymol-bound bOBP 
were endergonic and non-spontaneous (or unfavourable), and became exergonic and 
spontaneous (or favourable), when T was more than Tm. In addition, ∆G of binding 
between bOBPwt and thymol (∆GB) was determined from Equation 4.3; ∆GB  =  ∆GU 
(unbound)  -  ∆GU (bound), by which ∆GU were obtained from data in Figure 4.12. Thus, the 
temperature dependence of ∆GB was calculated and found to be linear (Figure 4.13). 
∆GB was shown to have negative values (∆GB less than 0) with a tendency to be 
positive, pointing out that the binding of bOBP and thymol was prone to be non-
spontaneous (unfavourable) reaction at higher temperature. This is because the protein 
had more unfolded fraction, so the binding site to thymol was less existed. 
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Figure 4.12: Free energies of unfolding (∆GU) for bOBP in the absence (blue 
diamond) and presence of thymol (red square) from the change in ellipticity as a 
function of temperature. ∆GU were calculated from the data (Figure 4.9) above 62°C 
for unbound bOBP and above 76°C for that in the presence of thymol using Equation 
4.7; ΔG  =  – R T ln K.  
 
 
 
Figure 4.13: Plot of linear dependence of ∆G of binding (∆GB) between bOBPwt 
and thymol as a function of temperature; ∆GB  =  ∆GU (unbound)  -  ∆GU (bound). ∆GU 
were from data in Figure 4.12. 
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Entropy is a quantitative measure of the amount of disorder in a system. The entropy 
of the universe increases or remains contant for every change that occurs. This means 
that whenever something (a system) is organized, then there is an activity happening 
somewhere else (the surroundings) that produces more disorder. Entropies of 
unfolding (∆SU) for bOBP in the absence and presence of thymol, and entropy of 
binding (∆SB) between bOBPwt and thymol were estimated. By using Equation 4.7; 
ΔG  =  ΔH – TΔS, ∆SU was derived by using ΔHU and ΔGU data in Table 4.1 and 
Figure 4.12. While ∆SB was the difference of ∆SU between unbound and thymol-bound 
bOBP; ∆SB  =  ∆SU unbound  -  ∆SU bound. The results illustrated in Figure 4.14 were that 
∆SU (unbound) and ∆SU (bound) were positive (∆SU more than 0), indicating high extents of 
disorder in the system. This represented that the reactions of the unfolding for both 
unbound and thymol-bound bOBP were the processes that produced more disorder. 
Each unfolded protein molecule adopted multiple conformations, so making the 
systems disordered. Additionally, as the walls of the cavities of bOBP are largely 
comprised of hydrophobic residues [54], the positive ∆S also suggested hydrophobic 
interactions, which were attributed to the protein stability, were main driving forces in 
protein unfolding to thymol. This was in agreement with the spectroscopic and 
molecular dynamics simulation data, which revealed that the hydrophobic regions of 
the protein matrix are an important factor for the protein stability and integrity [64, 
94]. Moreover, it pointed to situations that minimized the area of contact between H2O 
and non-polar, i.e. hydrocarbon, regions of the protein, that was achieved by clustering 
non polar groups together [95-97]. Furthermore, ∆SB was found to be negative (∆SB 
less than 0) (Figure 4.14), implying that the binding process between bOBPwt and 
thymol resulted in the more orderly state due to the reduced conformational freedom. 
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Figure 4.14: Entropies of unfolding (∆SU) for bOBP in the absence (blue 
diamond) and presence of thymol (red square), and Entropy of binding (∆SB) 
between bOBPwt and thymol (green triangle) from the change in ellipticity as a 
function of temperature. The calculation was based on Equation 4.4 and 4.7; ΔG = 
ΔH – TΔS and ∆SB  =  ∆SU (unbound)  -  ∆SU (bound). 
 
 
4.2.3 Dissociation constants (Kd) of binding between bOBP and 
thymol  
 
The direct assessment of bOBP-thymol interaction carried out by CD yielded the 
values of binding parameters (ΔGb). This value can serve in calculating the 
dissociation constant, Kd, of binding. 
ΔGb = – R T ln Kb      4.9 
Kb is the binding constant of bOBPwt and thymol interaction, whereas Kb = 1/ Kd. 
 
The Kd value for thymol binding to the bOBPwt were estimated by using Equation 4.9 
at which the ΔGb was derived from the linear dependence plot in Figure 4.13. Thus, 
the Kd value of binding between bOBP and thymol was found to be 0.75µM. In the 
following chapter, the labelling of the cysteine residues is described. 
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In overall conclusion for the relationship of ΔH, ΔG, ΔS for the unfolding of bOBP in 
the absence and presence of thymol, and for the binding of bOBP and thymol, CD 
measurements indicated that the unfolding of bOBP in the absence and presence of 
thymol were entropically driven (+ΔSU) and energetically favourable (−ΔGU). The 
positive ΔH and ΔS in both cases were attributed to the release of ordered water 
molecules and the associated entropy gain (due to the hydrophobic effect). The data 
were consistent with the notion that exposing of the hydrophobic core of the β-barrel 
structure was the main driving force for bOBP thermal unfolding. The results implied 
systems, that strongly distorted the protein, had net unfavourable ΔH as the result of 
molecular strain, primarily associated with the bonding destacking, so ΔS were net 
favourable.  
 
While the binding interaction of bOBPwt with thymol was enthalpically driven (-ΔHB) 
with an unfavourable change of entropy (-ΔSB). Therefore, it can be concluded that the 
mechanism of binding of thymol to bOBP is not dominated by a hydrophobic effect 
related to any change in the hydration state of protein and ligand groups but, most 
likely, is driven by van der Waals and polar interactions, and hydrogen bonding. This 
finding is in agreement with that of pOBP either binding to IBMP (−97 kJ/mol) or 
DMO (−88 kJ/mol), which was characterized by isothermal titration calorimetry (ITC) 
[85]. 
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CHAPTER 5 
 
CHARACTERIZATION OF THE RECOMBINANT bOBPs WITH 
DTNB AND IANBD AMIDE 
 
 
The previous chapter described the purification of single site cysteine mutants of 
bOBP. Cysteine is very attractive for site-specific conjugation due to its low frequency 
of occurrence and is high reactivity as a nucleophile. Introduction of this residue can 
be achieved by site-directed mutagenesis, most often without perturbing the protein's 
function. The site-specific covalent labelling of proteins through cysteine residue with 
fluorophores and other moieties has permitted the development of an abundance of 
detection methods for biosensing [98, 99]. Such an approach is particularly effective 
when the cysteine residue is on the surface of the protein. 
 
Figure 5.1 is a simplified model showing the overview of labelling and ligand binding 
to bOBP.  A reporting probe is site-specifically conjugated to the cysteine residue on 
bOBP via covalent bonding. A targeted ligand is then recognised and bound inside 
internal cavity of bOBP binding site while the probe is still present at the attached 
position. The protein undergoes a conformational change, which results in an optical 
change (either absorbance or fluorescence emission signal). This event demonstrates 
the benefit of this type of specific labelling in creating reversibility of sensing, since 
the probe is fixed on the protein either with ligand bound or not bound, making the 
protein biosensor reusable.  
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Figure 5.1: Simplified model showing the overview of a reporting probe labelling 
and ligand binding to bOBP. OBPs ( ), 1-AMA ( ), ligands (     ). 
 
 
The five recombinant bOBPs; WT, I22C, S24C, F54C, and F91C were characterized 
by labelling with a number of probes in order to identify those that showed good 
properties. Several approaches were applied to understand the reactivity of the 
cysteine residues. These included calculation of the solvent accessible surface area 
(SASA), reactivity with Ellman’s reagent, and labelling efficiency with IANBD 
amide. 
 
 
5.1 Calculation of the Solvent Accessible Surface Areas (SASA) of 
Cysteine Residues in the Recombinant bOBPs 
 
The hydrophobic amino acids in the internal buried cavity of the protein core pay an 
effective role in protein folding. Information about SASA of the amino acid sequence 
of proteins is useful in many applications in protein design and structural biology. The 
calculation of SASA is a geometric measure of the extent to which an amino acid 
interacts with the solvent and the protein core, that is naturally proportional to the 
surface area exposed to these environments. The method of calculating SASA 
typically exploits the 'rolling ball' algorithm developed by Shrake & Rupley in 1973 at 
which uses a sphere of solvent with a particular radius to probe the surface of the 
molecule by rolling over the van der Waals surface of the molecule and monitoring the 
areas which contact the sphere. Basically, a probe of radius 1.4 Å is used to simulate a 
water molecule, and calculated for the surface contact area. The contact area is the part 
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of any exposed residue that is capable of making contact with the probe (Figure 5.2). 
Unit of SASA is usually measured as square Ångstroms [100, 101].  
 
 
 
 
 
 
Figure 5.2: Principle of the calculation of solvent accessible surface area. A probe 
(blue) is 'rolled' over the Van der Waals surface of the amino acid residue. The 
surface areas which make contact with the probe are that accessible to solvent are 
called SASA (green). The surface areas which are not accessible to solvent (red) are 
called non-contact surfaces. The re-entrant area which combines surface contact 
areas is shown in yellow. 
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In this experiment, the five recombinant bOBPs; WT, I22C, S24C, F54C, and F91C 
were characterized the binding interaction with a number of ligands at their labelling 
positions. There are two factors determining labelling efficiency: inherent reactivity 
and SASA. In this experiment, the likelihood of being labelled was determined from 
estimation of the SASA at their cysteine residue of the bOBPs, which provided some 
information about how much the labelling residue exposed to the environment and 
interacted with the solvent upon binding to some ligand(s). This could imply how well 
each different bOBP mutant would be labelled.  
 
Eight different files available in PDB database were used to construct the three-
dimensional (3D) models of bOBP-WT, bOBP-I22C, bOBP-S24C, bOBP-F54C, and 
bOBP-F91C in complexes with each of eight different ligands using the SwissPdb 
Viewer. The SASA for each recombinant bOBPs was calculated and weighted relative 
to the size of the residue, which was the specific labelling position of the mutated 
cysteine residue using UCSF Chimera program. Table 5.1 gives the details about the 
3D structures of bOBP complexed with various ligands, which were used in the 
calculation of SASA at the specific labelling position for the recombinant bOBPs.  
 
The result from Figure 5.3 demonstrated that position 24 gave the lowest SASA 
suggesting its buried existence, while position 91 showed the most significantly 
different than other mutants with having the highest SASA, particularly when binding 
to unknown atom or ion (UNX) that was small molecular weight. The order of the 
cysteine-mutated residues from the highest to the lowest SASA was 91C, 54C, 22C, 
and 24C. This may influence how readily they react with fluorescent labels.  
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Table 5.1: Summary of the 3D structures used in the calculation of SASA of the specific cysteine residues in the recombinant 
bOBPs. 
 
No. of binding ligand  PDB ID Ligand Formula Short name Reference 
1 1G85 
1GT5 
1PBO 
1GT4 
1OBP 
1-Octen-3-ol 
Benzophenone 
4-Butyl-5-propyl-1,3-selenazol-2-amine 
Undecanal 
Unknown atom or ion 
C8 H16 O 
C13 H10 O 
C10 H18 N2 Se 
C11 H22 O 
X 
3OL 
BZQ 
SES 
UNA 
UNX 
[54] 
[38] 
[77] 
[38] 
[53] 
2 1HN2 
 
1GT3 
1-Octen-3-ol 
1-Aminoanthracene 
1-Octen-3-ol 
2,6-Dimethyl-7-octen-2-ol 
C8 H16 O 
C14 H11 N 
C8 H16 O 
C10 H20 O 
3OL 
ANC 
3OL 
DHM 
[54] 
 
[38] 
 
3 1GT1 1-Octen-3-ol 
1-Aminoanthracene 
2-Isobutyl-3-methoxypyrazine 
C8 H16 O 
C14 H11 N 
C9 H14 N2 O 
3OL 
ANC 
PRZ 
[38] 
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Figure 5.3: SASA of the specific residues in the recombinant bOBPs complexed with eight different ligands. The analysis was 
undertaken by Swiss-Pdb Viewer and UCSF Chimera programs. 
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5.2 Quantification of Free Thiol Groups Based on the Reaction with 
Ellman’s Reagent  
 
Ellman’s reagent or DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)); MW C14H8N2O8S2 is 
a chemical used for quantitating the number or concentration of thiol groups or 
sulfhydryl groups in a sample [102]. The reaction of the thiol with DTNB involves 
producing the mixed disulfide and 2-nitro-5-thiobenzoic acid (TNB) that ionizes to the 
TNB
2-
 dianion in water at neutral and alkaline conditions (Figure 5.4). This reaction is 
rapid and stoichiometric, with the presence of one mole of thiol generating one mole 
of TNB. This TNB
2-
 ion gives a yellow colour that is quantified by the absorbance at 
412 nm and has different molar extinction coefficient (ɛ) in various solvents as shown 
in Table 5.2. 
 
 
 
 
 
Figure 5.4: Reaction of DTNB with a thiol (R-SH) 
 
 
Table 5.2: Molar extinction coefficients of Ellman’s Reagent in various solvents 
[103]. 
Solvent ɛ at 412 nm 
2% SDS 
0.1 M phosphate, pH 8.0, 1 mM EDTA  
Buffered 6 M guanidine hydrochloride  
6 M guanidine hydrochloride  
8 M urea  
12,500 
14,150 
13,700 
13,880 
14,290 
 
Mixed disulfide TNB Thiol DTNB 
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Sulfhydryl groups can be estimated in a sample by comparison to a standard curve 
composed of known concentrations of a sulfhydryl-containing compound such as 
cysteine. Alternatively, sulfhydryl groups can also be quantitated by reference to the ɛ 
of TNB. 
 
Firstly, it was found that there was no reaction of all five native recombinant proteins 
with DTNB solution. Instead of changing to the yellow colour of TNB
2-
 as expected, 
the transparent colour of DTNB solution became cloudy and the reactions were 
precipitated, despite varying the concentration of DTNB (10 – 100 µM) and PBS (0.01 
– 1X) in the presence of 10 µM bOBPs, which indicated that the DTNB solution could 
not access the thiol groups on the proteins.  
 
Hence, it is necessary to expose thiol groups, which are buried in the interior of the 
protein. The denaturation process induced by 8M urea (in PBS, pH 7.4, containing 
1mM EDTA) was accomplished and found turning to yellow colour of the reaction 
consisted of 10µM bOBPs, 8M urea buffer, 100µM DTNB, and 1% ethanol, which 
indicated exposure of the free thiol groups. The reactions of the thiol with DTNB 
solution in the denaturing condition were found to be fast and stable, that was 
completed in few minutes and did not change over time. The yellow colour of TNB
2-
 
was quantified by the absorbance measurement at 412nm. The absorbance values of 
each mutant bOBP allowed calculation of their thiol concentration based on the Beer-
Lambert’s law (Equation 5.1) using the molar extinction coefficient of TNB2- in this 
buffer system at 412nm = 14,290 M
-1
cm
-1
. From solving the equation 5.1, the 
concentration of free thiol in each mutant bOBP was therefore determined as shown in 
Table 5.3, and indicated that each mutant bOBP had a comparable concentration of 
free thiol and this is consistent with the introduction of a single cysteine residue into 
each recombinant protein mutant. Additionally, the stoichiometric binding between 
bOBP and DTNB compound appeared to be 1:1. 
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A =    ɛ c l 
 
Equation 5.1: Beer-Lambert’s Law.  Where A is absorbance, ɛ is extinction 
coefficient of the chemical species, c is concentration of the species, l is pathlength of 
the light, and  is wavelengt. 
 
 
Table 5.3: Concentration of thiol in each 10 µM mutant bOBP by the Ellman's 
assay. The calculation was based on Beer-Lambert’s law (Equation 5.1) using the 
molar extinction coefficient of TNB at 412 nm (14,290 M
-1
cm
-1
) in 8 M urea buffer 
condition together with their absorbance at 412 nm. 
Residue SH content (per monomer) 
WT 
22C 
24C 
54C 
91C 
0.6 
1.2 
1.2 
1.2 
1.3 
 
 
5.3 Characterization of the Reaction of the Recombinant bOBPs with 
IANBD Amide 
 
A challenge for the development of effective fluorescent protein-based biosensors is 
the signal transduction of the binding events, which is a significant determinant in the 
performance of the biosensors. With the advance in fluorescence technology, 
fluorescent probes have become an essential tool in biological fields that are 
invaluable for exploring the domain function, and structure variation in local regions 
within a single macromolecule, such as DNA or protein. They are widely used instead 
of radioactive probe owing to their preferable advantages, including its easier 
handling, higher stability, lower total costs, re-readability, and fast detection [104]. 
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Types of detection consist of a conventional immunoassay and a molecularly 
integrated assay (Figure 5.5). The conventional immunoassay is a multistep sandwich 
analysis, which involves sample labeling. The target molecule must support two 
distinct binding sites, and separation of free and bound molecules is required after 
each step. Whereas the advanced assay has molecularly integrated the recognition and 
signaling events by the attachment of one or more fluorescent reporter probe(s) to the 
recognition element that allows the probe(s) to respond to analyte binding. This 
requires a fluorophore to possess emission properties which are sensitive to changes in 
the local environment induced by binding to the target molecule [105]. The detection 
can be typically performed by Förster resonance energy transfer (FRET) [106, 107], 
the formation of a nonfluorescent complex [108], fluorescence anisotropy [109], or 
more relevant to this project, the change of emission intensity of a single 
environmentally sensitive fluorophore in the presence of the analyte.  
 
 
 
 
Figure 5.5: Types of detection of fluorescence signal for protein quantification. 
(A) A traditional sandwich assay relies on a labeled reporter molecule for detection. 
(B) A molecularly integrated assay of the recognition and reporting functions provides 
a homogeneous detection [105]. This image has been reproduced with the permission 
of the rights holder, American Chemical Society. 
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Binding of a ligand molecule to a protein molecule can lead to protein structural 
changes that involve domain rearrangement [110], conformational changes of 
secondary structures [111], and residue re-orientation in the local binding site. 
Fluorophores located where the environmental change occurred upon ligand binding, 
results in the modulation of its fluorescence intensity that can be monitored as a 
function of ligand concentration, allowing detection and quantification of an analyte of 
interest. Therefore, the position of the fluorophore where the conformational changes 
occurred is crucial for the ligand-binding detection.  
 
Among fluorescent probes, a class of fluorescent moieties called environmentally 
sensitive fluorophores offers an effective way for targeting the specific region of 
protein and yielding informative data on micro-environmental changes of the region. 
Environmentally sensitive fluorophores are a special class of chromophores that have 
spectroscopic behaviour that is dependent on the physicochemical properties of the 
surrounding environment. Numerous reports have used them to study biochemical 
functions that are related to conformational changes, such as ligand binding.  
 
The widely used site-specific covalent labelling of IANBD amide was chosen as a 
fluorescent reporter probe (Fig. 5.5b) for sensing in this project because of its thiol-
reactive property. The examples of thiols reacting with this probe include cysteine, and 
2-mercaptoethanol. A schematic diagram shows the reaction of the IANBD amide 
fluorophore (its full structure shown in Figure 2.3) with thiol group of cysteine residue 
on protein molecule making the conjugation of NBD with thioether (NBD · thioether) 
by the covalent link of thioether bond (Figure 5.6). In addition, IANBD is an 
environmentally sensitive fluorophore, which emits no significant fluorescent before 
conjugating with a thiol group. Therefore, labelling with IANBD amide fluorescent 
probe was not only to detect the presence of an amount of materials, but also indicate 
response to conformational and environmental changes of the labelled protein upon 
interaction with small molecules, i.e. ligand binding.  
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Figure 5.6: Reaction of IANBD amide with thiol group on protein molecule 
 
 
In these following experiments, IANBD amide was investigated to see if it could be a 
possible good reporting probe for engineering bOBP biosensors. The characterization 
of the ligand binding interaction between the recombinant bOBP and the fluorescent 
IANBD amide has been performed. 
 
 
5.3.1 Reaction of IANBD amide with thiol  
 
IANBD amide (its structure shown in Figure 2.3), a thiol-reactive fluorescent probe, is 
known to emit no significant fluorescent before conjugating with a thiol group in 
solution, and therefore less background fluorescence is supposedly produced by the 
unreacted IANBD amide molecules. 
 
A control experiment was performed in order to investigate the binding of IANBD 
amide as a thiol-reactive fluorescent probe with 2-mercaptoethanol as a thiol. The 
various concentrations of IANBD amide were conjugated with the excess 2-
mercaptoethanol. Their fluorescence intensities were detected at 480 nm for excitation 
wavelength and at 550 nm for maximum emission wavelength. 
 
The result in Figure 5.7 showed that the fluorescence emission intensity increased 
upon the concentration of conjugated NBD, indicating binding of IANBD to thiol 
group of 2-mercaptoethanol and generating the conjugated NBD, which confirmed 
that IANBD amide is a thiol-reactive fluorophore. However, it was found that at high 
Thiol group 
on protein 
IANBD  amide NBD · Thioether 
on fluorescent protein 
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concentrations, the fluorescence intensities were not proportional to the concentrations 
of the conjugated fluorophore. The distortion of the curve shape by decreasing 
intensity of the emitted light in this experiment could have a contribution from an 
inner filtering effect, arising from high concentrations of the fluorophore making the 
intensity of the excitation light not constant throughout the solution. As a result, only a 
small percentage of the excitation light reached the fluorophores that emit the declined 
photons for the detection system. It was found that there was no inner filter effect at 
IANBD ≤ 26µM as shown by a linear curve in Figure 5.7 (inset). 
 
 
 
Figure 5.7: Fluorescence of IANBD amide in the presence of thiol. The curve 
shows inner filter effect when IANBD amide concentrations were >26µM. The various 
concentrations of IANBD amide ranging from 0 to 307.2 µM were conjugated with the 
corresponding 10-fold molar excess 2-mercaptoethanol. The reaction was carried out 
for 1hr in PBS with 10mM EDTA supplement, pH 7.4 with 1% DMSO. The 
fluorescence excitation and emission were 480 nm and 550 nm, respectively. Inset: 
linear curve of IANBD amide in the presence of thiol shows no inner filter effect when 
IANBD amide was ≤ 26µM. 
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5.3.2 Molar binding ratio of IANBD amide and bOBPwt 
 
Conceptually, an environmentally-sensitive fluorophore is a reporter for binding 
between a ligand molecule with a fluorescently labelled protein, which can be due to a 
direct effect of its interaction with the ligand, or an indirect effect through a protein 
conformational change. 
 
It is known that IANBD amide is a thiol-reactive fluorescent probe that can be 
attached to site-specifically mutated cysteine residues in ligand binding proteins e.g. 
periplasmic binding protein (PBP) [112-114]. These labelled proteins show ligand 
dependent changes in the fluorescence of the NBD group.  
 
Likewise, it is proposed that the cysteine mutants of bOBP are specifically labelled 
with the thiol reactive probe IANBD by forming covalent bond with cysteine residues 
on the protein molecule. In this experiment, the extent of the interactions of wild-type 
bOBP (which does not contain cysteine residue) and IANBD amide as a ligand were 
evaluated by determining the molar binding ratio of IANBD amide and the WT 
protein, for which the value was expected to be approximately zero.  
 
The molar binding ratio represents the average number of the fluorescent probe 
molecules conjugated to each protein molecule. The Cf / CP molar ratio is the ratio of 
the binding interaction between fluorophore and protein concentrations, which can be 
determined based on the Beer-Lambert’s Law (Equation 5.2). Two parameters are 
needed: the molar extinction coefficients of the IANBD amide (given in the handbook 
of manufacturer) is 25,000 M
−1
cm
−1
 at 480 nm, and the molar extinction coefficient of 
47,000 M
−1
cm
−1
/ bOBP dimer at 280 nm [54].  
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The experiment was carried out by incubating 100µM bOBPwt with a 10-fold molar 
excess of IANBD amide, followed by removing the excess unbound fluorophore in the 
reaction in order to decrease non-specific binding, and leave only the fluorescent 
probe that conjugated to bOBPwt. The absorbance at 480 and 280nm of the binding 
solution was measured to determine the concentration of the fluorophore and the 
protein after binding and removing excess IANBD amide. 
 
 
 Fluorophore binding ratio     =     Concentration of Fluorophore     =    A480 / ε480 
       Concentration of Protein            A280 / ε280 
 
Equation 5.2: Fluorophore binding ratio.  Where A is absorbance at a certain 
wavelength and ɛ is extinction coefficient at a certain wavelength for the fluorophore 
or protein. 
 
 
The result from the calculation of the average molar binding ratio of the interaction 
between IANBD amide and the wild type bOBP was 0.27 ± 0.01, indicating that the 
interaction between the IANBD amide and bOBPwt was existed and was significant. 
This could be due to the IANBD amide non-site specific covalently reacting with other 
residues (such as methionine [115], histidine [115], and tyrosine [116]) inside the 
ligand binding cavity of bOBP. However, it might be a non-covalent complex being 
formed, so the next experiment involving the reaction of IANBD amide with wild type 
bOBP was performed in order to examine any non-covalent interactions of the IANBD 
amide with the protein. 
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5.3.3 Reaction of IANBD amide with bOBPwt 
 
The formation of non-covalent bonding in the interaction of the IANBD amide 
fluorescent probe with bOBP was investigated by eliminating the non-site specifically 
covalent bonding in the reaction of IANBD amide with 2-mercaptoethanol, and then 
evaluating any non-covalent interaction of the IANBD amide with the wild type bOBP 
that might occur. A binding study with constant conjugated NBD concentration and 
variable bOBPwt concentration was thus performed. 2µM IANBD amide was 
covalently conjugated with the 10-fold excess molar 2-mercaptoethanol (20µM), and 
titrated with increasing bOBPwt concentrations from 0 to 40.96µM.  
 
The fluorescence intensity at 550nm as a function of bOBPwt concentration at 
constant conjugated NBD was plotted. The result in Figure 5.8 showed the increase of 
IANBD amide fluorescence emission intensity in the presence of the wild type bOBP 
upon excitation at 480nm, indicating non-covalent bonding existed in the interaction 
between IANBD amide and bOBP, as they could form a complex, resulting in an 
enhancement of the fluorescence emission as the protein concentrations increased until 
all of the fluorophore was bound to the protein.  
 
A saturation binding curve was derived by fitting to hyperbolic equation (Equation 
5.3) to determine the equilibrium dissociation constant (Kd) value of non-covalently 
bound complex of bOBP and IANBD amide by which Kd = 25 ± 6 μM was obtained. 
The Fmax (maximal fluorescence value of bOBPwt bound conjugated NBD: FI) was 
found to be 748µM
-1
, whereas fluorescence value of IANBD(SH) (FI∙P) was 26µM
-1
 
(derived from the section 5.3.1: Reaction of IANBD amide with thiol), making µM 
Fluorescence (FI / FI∙P) = 29-fold enhancement. 
 
 
F = Fmax * [bOBP] 
  Kd + [bOBP] 
 
Equation 5.3: Hyperbolic equation. 
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Figure 5.8: Binding curve of non-covalently bound complex of bOBPwt and 
conjugated IANBD amide. 2µM IANBD amide was conjugated with 20µM 2-
mercaptoethanol, and titrated with increasing bOBPwt concentrations ranging from 0 
to 40.96µM. The reaction was in PBS with 10mM EDTA supplement, pH 7.4 with 1% 
DMSO. The fluorescence excitation and emission were 480nm and 550nm, 
respectively. 
 
 
Although four cysteine bOBP mutants were made and characterised, the non-covalent 
binding of IANBD amide made it difficult to distinguish ligand dependent 
conformational changes from ligand dependent displacement. Therefore, no further 
work was carried out on IANBD/thiol mutants and a simpler fluorophore that provided 
ligand displacement was studied. The following chapter describe a ligand 
displacement sensing with 1-aminoanthracene (1-AMA) as a fluorescent reporter 
molecule. 
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CHAPTER 6 
 
FLUORESCENCE AND ABSORBANCE SPECTROSCOPY OF 
bOBP-LIGAND INTEREACTIONS 
 
 
6.1 Fluorescence-Binding Assay 
 
Biomolecules such as proteins and nucleic acids can be labelled with optical probes to 
allow for their detection. Covalent labelling is by the reaction of an appropriately 
functionalized dye molecule with a reactive group on the protein or other biomolecule. 
However, the binding of IANBD to bOBP described in Chapter 4 showed that a 
mixture of covalent and non-covalent bonding was occurring.  
 
In some cases, non-covalent label is known to bind and yield a fluorescent complex. A 
non-protein example of this is staining DNA with ethidium bromide or SYBR Gold. 
Although the interactions arising from non-covalent labelling are considerably less 
stable than the covalent linkages, the important benefit of non-covalent labelling is 
that it affects the functional activity of the biomolecule to a lesser extent. This is 
because the interactions happen at a faster rate and at a physiological pH range. 
Additionally, purification steps are generally unnecessary when the stoichiometry of 
the complex is known. Finally, non-covalent labels regularly are shielded by the 
biomolecule from those quenching effects [117-119]. 
 
1-aminoanthracene (1-AMA) is a polarity-sensitive hydrophobic probe that has been 
used previously to investigate binding in the lipocalin family of protein cavities as 
well as to study interaction between these different proteins and their ligands, 
particularly odorant binding proteins (OBPs) and hydrophobic ligands such as 2-iso-
butyl-3-metoxypyrazine (IBMP), dihydromyrcenol (DHM) or benzophenone (BZP) 
[38, 46, 54, 65, 87, 88, 90, 120-123]. This fluorescent ligand as a substitute for the 
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tritium-labelled 2-isobuthyl-3-methoxypyrazine (PYR) is often used to monitor the 
functional state of OBPs and is also applied in competitive binding assays [88, 124].  
 
A simplified model of competitive binding strategy is illustrated in Figure 6.1. In 
general, 1-AMA shows enhanced fluorescence intensity when complexed with OBPs. 
When hydrophobic ligands are added to OBPs/1-AMA complex, bound 1-AMA is 
displaced by these ligands in competitive binding assays. Binding of these ligands to 
the proteins is indicated by a decrease in the fluorescence intensity of bound 1-AMA. 
This allows a fluorescence assay based on 1-AMA and bOBP should be useful for 
compound screening and hence biosensor engineering. 
 
 
 
 
 
 
 
 
Figure 6.1: Simplified model of competitive binding strategy. OBPs ( ), 1-AMA 
( ), ligands (     ). 
 
 
The three-dimensional structure of the 1-AMA/bOBP complex determined by x-ray 
crystallography is illustrated in Figure 6.2, revealing two very well ordered 1-AMA 
molecules in the buried cavities [54] where the natural ligand (1-octen-3-ol) binds [46, 
53]. Two molecules of 1-AMA are bound per dimer, that is one to each bOBP β-barrel 
[54]. These β-barrels are known to be the general binding site of bOBP [54] as 
similarly in pOBP [48, 59]. 
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Figure 6.2: Three-dimensional structure of 1-AMA/bOBP complex. Two 1-AMA 
molecules are bound in the internal binding site of bOBP. 
 
 
6.1.1 A binding assay based on 1-AMA 
 
The ligand, 1-aminoanthracene (1-AMA) (its structure shown in Figure 2.4) has been 
demonstrated in the binding in the internal cavities of the bOBP protein, and used for 
measurement of the bOBP functionality [54]. Thus, the recombinant bOBPwt was 
characterized in its binding interaction with 1-AMA.  
 
The maximum wavelengths of excitation and emission spectra for the bOBP/1-AMA 
complex were monitored and the result was that the bound complex exhibited a 
fluorescence maximum emission wavelength at 490nm with a 390nm maximum 
excitation wavelength (Figure 6.3 – 6.4). The position of the 1-AMA emission peak 
shifted from 570nm to 490nm in binding to bOBP, as also found in [125]. 
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Figure 6.3: Fluorescence emission spectra of unbound 1-AMA (blue diamond) 
and 1-AMA complexed with bOBPwt (red square). Excitation wavelength was 
390nm. bOBPwt was 100μM and 1-AMA 100μM in both cases. The reactions were in 
PBS with 1mM EDTA supplement, pH 7.4.  
 
 
 
Figure 6.4: Fluorescence excitation spectra of unbound 1-AMA (blue diamond) 
and 1-AMA complexed with bOBPwt (red square). Emission wavelength was 
490nm. bOBPwt was 100μM and 1-AMA 100μM in both cases. The reactions were in 
PBS with 1mM EDTA supplement, pH 7.4.  
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The binding affinity of 1-AMA for the recombinant bOBPwt was determined by direct 
titration of 0.5µM of bOBPwt using 1-AMA concentrations that ranged from 0 to 
12.8µM. The result indicated that the increase in fluorescence signal of 1-AMA upon 
complexation to the protein was the result of the formation of the bOBPwt/1-AMA 
complex (Figure 6.5; blue point). Corrected emission fluorescence intensity of the 
recombinant bOBPwt with 1-AMA was obtained from fluorescence intensities of 1-
AMA bound to bOBP when corrected for contributions from unbound 1-AMA (Figure 
6.6). The titration curve of the bOBPwt with 1-AMA was used to determine their 
equilibrium dissociation constant (Kd) of the 1-AMA/bOBPwt complex using a single-
site specific binding model (Equation 6.1).  
 
Y = Bmax  *  X  
Kd  +  X 
Equation 6.1: Single-site specific binding model. Where Y is the corrected 
fluorescence intensity, Bmax is the maximal Y value, X is the concentration of 1-AMA, 
and Kd is the concentration of 1-AMA required to reach half-maximal binding. 
 
 
It was found that the dose-response curve gave a Kd value of 0.16 ± 0.023 μM for 1-
AMA to bOBP, indicating bOBP is functional and able to bind 1-AMA. This value is 
comparable with the one of Mazzini et al. 2007 (0.23 ± 0.01 μM) [87]. Typical values 
that have been reported by others are between 0.66 - 1μM for either recombinant or 
natural bOBPwt [38, 46, 54, 62, 126, 127].  
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Figure 6.5: Fluorescence binding curve of the recombinant bOBPwt with the 
ligand 1-AMA (blue point). 0.5µM bOBPwt monomer concentration was titrated 
with 1-AMA from 0 to 12.8µM in PBS with 1mM EDTA supplement, pH 7.4, with 0.1% 
DMSO. Fluorescence intensity of 1-AMA was measured at 490nm with excitation at 
390nm, 1 hour after addition of the probe to the protein. Unbound 1-AMA (red point) 
was represented as a background.  
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Figure 6.6: Corrected emission fluorescence intensity of the recombinant 
bOBPwt with 1-AMA. The curve was obtained from intensities of bOBP/1-AMA 
complex (in Figure 6.5) with subtraction of unbound 1-AMA background.  
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6.1.2 Competitive binding assays with 1-AMA 
 
Since x-ray crystallography experiments demonstrated that 1-AMA binds in the 
internal β-barrels of bOBP (Figure 6.2) as well as the fluorescence binding assays that 
showed bOBP dimer binds two 1-AMA molecules, then competitive binding of other 
ligand should displace the 1-AMA and so reduce its fluorescence [54]. 
 
Competitive titrations between 1-AMA and several known or possible ligands,  
thymol, bromocresol green, malachite green, and methyl salicylate, were set up to 
determine their binding affinities. In the competitive binding assays, a fixed 
concentration of 1µM bOBPwt was incubated with a fixed amount of 1µM 1-AMA in 
the presence of increasing concentrations of each ligand (0–100µM) in the reaction 
containing PBS with 1mM EDTA supplement, pH 7.4 with the final concentration of 
0.1% (V/V) DMSO solvent and 0.1% (V/V) absolute ethanol. The decrease of 
competitive 1-AMA fluorescence at 490nm was recorded as a function of ligand 
concentration.  
 
It was found that the fluorescence intensities decreased on the addition of thymol, 
bromocresol green, and malachite green, in a hyperbolic fashion (Figure 6.7; A-C).  
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Figure 6.7: Competitive binding curves of various ligands with 1-AMA on bOBP. 
The fluorescence of 1-AMA decreases when displaced by the ligands; (A) Thymol, (B) 
Bromocresol green, (C) Malachite green, and (D) Methyl salicylate. Y-axis is 
fluorescence intensity of bound 1-AMA at 490nm. X-axis is the micromolar 
concentration of total ligand competing for binding. bOBP and 1-AMA were used at 1 
μM concentration.  
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The fluorescent emission data obtained were transformed into the fractional occupancy 
(f), the concentration of protein-ligand complexes in the total protein concentration by 
using Equation 6.2.  
 
              
 -  
    -  
      6.2 
Where f is fraction of ligand binding sites filled with ligand, F is fluorescence 
intensity, Fo is fluorescence intensity in the absence of ligand, and Fmax is fluorescence 
intensity in the excess of ligand. 
 
The dependence of f on ligand concentration was used to determine the apparent Kd 
(Kd
app
) for each ligand from the single-site specific binding equation (Equation 6.1). 
The corrected Kd value (Kd
corr
) for each ligand was then calculated from the Kd
app
 using 
the formula [54] shown in Equation 6.3 with Kd of 1-AMA for bOBP was 0.16 μM, 
and the 1-AMA concentration was 1 μM.  
 
Kd
corr
     =     Kd
app
    *                         1    6.3 
                 1 + ( 1 / Kd
AMA
 * [AMA] ) 
Where Kd
AMA 
is the dissociation constant of the 1-AMA/OBP complex. 
 
The results of the Kd
app
 and Kd
corr
 values for thymol, bromocresol green, and malachite 
green are listed in Table 6.1, and the values indicated that 1-AMA was the best ligand. 
Thymol and bromocresol green had comparable affinity constant values to bOBPwt, 
although both are very different in their chemical structures. The Kd value of thymol 
for bOBP was 0.58 ± 0.28 µM, which is in agreement with the compounds listed as 
‘strong ligands’ for bOBP usually bind with Kd between 0.1 and 1 µM [36]. 
Surprisingly, it was found that methyl salicylate that is a wintergreen-scented chemical 
used to provide fragrance to various products, did not show competitive displacement 
with 1-AMA to bOBPwt as shown in Figure 5.21; D. Thus, no special characteristic 
could be attributed to the good binders upon interaction with all ligands [38].  
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Table 6.1: Apparent dissociation constants (Kd
app
) and Equilibrium dissociation 
constants (Kd
corr
) values of ligands for bOBPwt derived from competitive binding 
assays with 1-AMA. Each value of Kd is the average of a minimum of three and a 
maximum of thirteen (thymol) independent determinations. 
  
Ligand Kd
app
 (µM) Kd
corr
 (µM) 
Thymol 
Bromocresol green 
Malachite green 
4.17 ± 2.04 
3.25 ± 0.51 
5.86 ± 3.18 
0.58 ± 0.28 
0.45 ± 0.07 
0.81 ± 0.48 
 
 
6.1.3 Dual ligand titration with 1-AMA  
 
All of previous OBPs/1-AMA reports determine Kd values of a system in which two 
alternative substrates compete for the same protein-binding site by titrating the fixed 
concentrations of protein and 1-AMA at 1:1, and then varying concentrations of 
another ligand competitor. 
 
In this study, the analysis of the effect of two ligands, 1-AMA and another ligand 
competitor in competitive binding assay was presented in order to estimate the 
equilibrium Kd value of ligand with improved accuracy compared to typical methods 
that fix 1-AMA concentration. The experimental set up involved with titrating a fixed 
concentration of 0.5µM bOBPwt with varying 1-AMA and thymol concentrations. 
The procedure was performed by the addition of a concentration of thymol in a set of a 
standard single ligand titration of 0.5µM bOBPwt with 1-AMA ranging from 0–
12.8µM. The concentration of thymol used in each set of experiments was 0, 0.1, 10, 
25, 50, and 100µM.  
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The titration curves between the fluorescence intensities of 1-AMA/ bOBPwt complex 
with the presence of each thymol concentration against the concentrations of 1-AMA 
were plotted (Figure 6.8) and used to determine the Kd values of the 1-AMA/ bOBPwt 
complexes based on the single-site specific binding model (Equation 6.1). Next, the 
curve of -log Kd of 1-AMA with the presence of each thymol concentration was 
plotted against their corresponding thymol concentrations (Figure 6.9). The 
equilibrium Kd value for thymol from the dual ligand titrations was analysed based on 
global nonlinear regression method of Lew and Angus (Equation 6.4) [79].  
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Figure 6.8: Dual ligand titration using 1-AMA and thymol. Standard titration 
assays were to add thymol to bOBPwt in the presence of increasing amounts of 1-
AMA. The concentrations of thymol used in these experiments were 0, 0.1, 1, 10, 50, 
100µM. The data for each titration curve of the bOBPwt with 1-AMA was used to 
determine the Kd value of the 1-AMA/bOBPwt complex with the presence of each 
thymol concentration based on the single-site specific binding model (Equation 6.1). 
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Figure 6.9: Plot of -log Kd of 1-AMA with the presence of various thymol 
concentrations against their corresponding thymol concentrations. This plot was 
used for determining the equilibrium Kd value for thymol from the dual ligand 
titrations. The calculation was based on global nonlinear regression method of Lew 
and Angus; -log Kd
AMA
   =  - log ([L] + 10
log (Kd)
) + C (Equation 6.4) [79], by using 
either SciDAVis or Prism 5.0 software. 
 
 
- log Kd
AMA
     =    - log ([L] + 10 
log (Kd)
)  +  C   6.4  
Where Kd
AMA
 are dissociation constants of 1-AMA at various concentrations of 
antagonist (including 0), [L] is the antagonist concentration corresponding to Kd
AMA
, 
Kd is dissociation constant of antagonist, and C is a constant value [79]. 
 
 
The data shown in Figure 6.9 were calculated using either SciDAVis or Prism 5.0 
software. The Kd value of thymol for bOBPwt was found to be 1.03 ± 0.153 µM, 
which is slightly different from that obtained with single ligand titrations (0.58 ± 0.28 
µM) and that determined by CD spectroscopy (0.75 μM). 
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In order to illustrate the competitive type of ligands and 1-AMA for binding to bOBP, 
the double reciprocal plot has been applied; this is used to distinguish competitive, 
non-competitive, and uncompetitive ligands. It is created by taking the reciprocal of 
both sides of hyperbolic binding function (Equation 6.1).  
 
Thus, the data of dual ligand titration using 1-AMA and thymol (Figure 6.8) was used 
to produce the double reciprocal curves whereby 1/ [1-AMA] was plotted against -1/ 
[Thymol]. It was shown that each line of thymol concentration has the same y-
intercept, but there were different slopes and x-intercepts between the data sets (Figure 
6.10). The pattern of lines was in accordance with a model in which the binding of 1-
AMA and thymol was competitive for binding to bOBPwt, since the maximum 
concentration of thymol bound is unaffected by competitive inhibitors.  
 
 
 
 
Figure 6.10: Double-reciprocal plots showing competitive type of reversible 
ligand inhibitor. 
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In conclusion, the functionality of bOBPwt was analysed by binding assays with 1-
AMA, and resulting in a good affinity with the Kd value of 0.16 ± 0.023 μM. Four 
different ligands, namely thymol, bromocresol green, malachite green, and methyl 
salicylate were investigated in competitive ligand-binding experiments with the 
purified recombinant bOBP. Most of the ligands examined were found to be good 
ligands with the Kd values in the micromolar range, but methyl salicylate was found 
not to bind to this protein. The significant differences of ligand binding affinity 
confirmed the broad binding specificity of OBPs. Finally, the data showed that the 
fluorescent ligand 1-AMA is a suitable ligand used to observe the functionality of 
bOBP through fluorescence analysis, and also indicated the possibility of using 1-
AMA with the competitive binding strategy as a probe in building biosensors based on 
this recombinant bOBPwt that have applications in ligand discrimination for pre-
screening some chemical substances. 
 
 
6.2 Absorbance-Binding Assay 
 
It has been shown in Section 6.1 that the strategy of competitive displacement 
labelling of 1-AMA was successful. Thus in this experiment, the light absorption 
characteristics based on this competitive strategy were investigated  in order to find a 
chromophore that could be used as a probe other than the fluorophore 1-AMA that 
although it is sensitive, can photobleach.  
 
Fifteen chromophores in the laboratory including DTNB, bromocresol green, cibacron 
blue, thionin, benzohydroxamic acid, nickel(II) chloride, p-nitroaniline, potassium 
permanganate, 1,2-phenylenediamine dihydrochloride, potassium chromate, 3,4-
dinitrotoluene, copper(II) nitrate, iodine, 4-nitrophenol, and 1-AMA, were then 
screened to examine for the binding property to bOBP by changes in their UV–vis 
absorption spectra. It was found that some of them, for example bromocresol green 
(BG), bound to bOBP as the absoption spectra increased with increasing protein 
concentration, as seen by the peak at 625nm (Figure 6.11). Likewise, Figure 6.12 
illustrates the increase in absorbance at 625nm of bromocresol green as a function of 
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bOBP concentration indicated the increase in the amount of the bromocresol green/ 
bOBPwt complex before reaching to the binding saturation. In addition, this curve also 
provided information about the stoichiometric binding ratio between bOBP and 
bromocresol green, which was found to be 1.25: 2. 
 
 
 
 
Figure 6.11: Titration absorption spectra of binding 2μM bromocresol green to 
various concentrations of bOBPwt ranging from 0-19.2 μM. The reaction was in 
PBS with 1mM EDTA supplement, pH 7.4 with 1%DMSO. 
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Figure 6.12: Absorbance titration curve at 625nm of binding of bromocresol 
green to bOBPwt in PBS with 1mM EDTA supplement, pH 7.4. Bromocresol 
green concentration was fixed at 2μM and the bOBPwt concentrations were varied 
from 0 to 19.2μM. 
 
 
Those chromophores (including bromocresol green) that bound bOBPwt were then 
tested in competitive binding assays. The displacement of bromocresol green by 
various thymol concentrations with 1.25μM bOBPwt was executed. The absorbance at 
625nm of bromocresol green bound to bOBP was measured as a function of thymol 
concentration. It was found that none of the probes were displaced by thymol in 
competitive binding, as their absorbance didn’t drop (Figure 6.13). The result was 
confirmed by repeating the assays, in which the protein concentration was increased 
up to 12.5-100μM, the amount of bromocresol green was raised up to 20-100μM and 
the thymol concentration was widely varied at 0.0001-100μM, irrespective of a 1-hour 
incubation time. 
 
 
 
Figure 6.13: Competitive binding curve between 2μM bromocresol green and 
various thymol concentrations on 1.25μM bOBPwt. The absorbance at 625nm of 
bromocresol green bound to bOBP is plotted as a function of the concentration of 
thymol. 
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Therefore, those chromophores were checked for their ability to be displaced for 
bOBP when the fluorophore 1-AMA was used as a probe in this competition. The 
displacement of 1µM bromocresol green bound to 1µM bOBP was carried out when 
100µM 1-AMA was added to the bOBP/BG complex. Competitive binding of 1-AMA 
to the protein was then reported by analyzing the fluorescence emission intensity at 
490nm of bound 1-AMA. As shown in Figure 6.14, it was found that the increase of 
fluorescence signal in the displacement reaction of 1µM bOBP + 1µM BG + 100µM 
1-AMA when compared to the background reaction of 1µM bOBP + 1µM BG. This 
indicated that the bound BG was released from the binding site on bOBP, and 
displaced by 1-AMA. Conversely, the displacement of 1µM 1-AMA bound to 1µM 
bOBP by 100µM bromocresol green was also performed and found the releasing of 
bound 1-AMA. As shown in Figure 6.15, the fluorescence of 1-AMA bound to bOBP 
in the displacement reaction of 1µM bOBP + 1µM 1-AMA + 100µM BG decreased 
when compared to the background reaction of 1µM bOBP + 1µM 1-AMA. 
 
 
 
Figure 6.14: Bromocresol green displacement by 1-AMA (1µM bOBP + 1µM 
bromocresol green + 100µM 1-AMA). Two reactions, including 1µM bOBP + 
100µM 1-AMA and 1µM bOBP + 1µM bromocresol green, were represented as 
backgrounds. Fluorescence emission intensities of bound 1-AMA were measured at 
490nm with excitation at 390nm. 
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Figure 6.15: 1-AMA displacement by bromocresol green (1µM bOBP + 1µM 1-
AMA + 100µM bromocresol green). The reaction of 1µM bOBP + 1µM 1-AMA was 
represented as background. Fluorescence emission intensities of bound 1-AMA were 
measured at 490nm with excitation at 390nm. 
 
 
The results from the competitive binding assays of bromocresol green to bOBP by 
using the fluorophore 1-AMA as a probe indicated that bromocresol green had the 
ability to bind, release and displace on bOBP, at which its Kd value and that of 
malachite green, another chromophore were then reported in Section 6.1. However, 
bromocresol green couldn’t be used as a probe in the competitive binding assays due 
to inability to detect absorbance change during the displacement. This is because the 
signal from absorption spectroscopy is low when compared to that of fluorescence. 
Fluorescence labelling techniques offers a much greater sensitivity as well as 
application range than the measurements based on absorption [117, 119, 128]. They 
have become increasingly popular in the labelling field in recent years, since they 
require just a small amount of samples to be labelled [119]. 
 
In conclusion, a number of chromophores in the laboratory have been investigated the 
ability to be used as a probe in the competitive binding to bOBP based on absorbance 
spectrophotometry, and found that none of them gave a signal in the displacement 
analysis. Thus, the fluorophore 1-AMA has been used to detect ligand binding events 
for bOBP biosensors in this study.  
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CHAPTER 7 
 
IMMOBILIZATION OF bOBP ON SOLID SURFACES 
 
 
In chapter 6, 1-AMA was shown to be a useful probe for sensing with bOBP in a 
competitive binding strategy. In this chapter, immobilization of bOBP on different 
polymer surfaces is demonstrated. 
 
Immobilization is perhaps the biggest challenge in the development of a biosensor. 
Since one of problems is that many proteins undergo irreversible conformational 
changes upon binding to surfaces, causing denaturation of a proportion of the protein 
at the surface or having a random surface orientation resulting in a portion of the 
protein being orientated such that it is non-functional. Another problem is leaching of 
the bound protein. Thus, protein immobilization on solid supports, while potentially 
preserving function over a long period of time is widely used in biosensor applications 
[129].  
 
In addition to implanted biosensors, immobilization is also essential for ones operating 
in on-line system for continuous sensing. For instance, glucose binding polypeptide 
elements were immobilized in a polyacrylamide hydrogel matrix placed on the tip of 
an optical fibre for continuous glucose monitoring [130]. Recombinant E. coli were 
immobilized on antibody modified solid substrates and used as disposable or multiple 
bioluminescent sensors [131]. These make the choice of the surface material an 
important factor to consider.  
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A variety of methods are available for immobilizing proteins, with the coupling 
chemistry often being classified into three major groups. (i) The most commonly used 
method relies on the nonspecific physical adsorption of the protein to a solid support 
through electrostatic and hydrophobic interactions [132]. Typical surfaces include 
membranes made of polyvinylidene difluoride (PVDF), nylon, polyethersulfone 
(PES), and nitrocellulose. Non-covalent binding of proteins is simple and may allow 
the conformation of the immobilized protein to remain intact [133]. Additionally, it 
has a particularly low background on glass surface, with high capacity and retention of 
protein activity [134]. However, this method gives random orientation [133, 135], 
leading to the possibility of protein denaturation on the surface or perhaps desorption 
under assay or storage conditions [136]. 
 
The direct adsorption of proteins in polymer (polyvinyl chloride and polystyrene) 96-
well microplates is very well established in Enzyme-Linked Immunosorbent Assay 
(ELISA) owing to its simplicity and automatization [137]. For example, the detection 
and quantitative assay of plant viruses that are involved with virus in the test sample is 
selectively trapped and immobilized by specific antibody adsorbed on a polystyrene 
microtitre plates [138, 139]. In an attempt to increase the yield per plate, decrease 
reaction volumes, and thereby operating cost per plate, formats of the 384 and 1536-
well microplates have been then developed. 1536-well plate are called “High 
throughput screening” (HTS) approach because of being conducted by dedicated 
robotic systems. The next generation assay platform of a novel microfluidic ELISA 
microplate that has been applied for the unparalleled assay performances was designed 
by connecting a microfluidic channel to each well of a 96-well micro-titter plate where 
binding events occur [140]. 
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Interestingly, a leading trend in protein microarray development is the shift from 
planar substrates to three-dimensional materials [141, 142]. Instead of immobilizing 
only in the two dimensions available on a planar substrate, the additional capture 
molecules can be immobilized within the depth of the three dimensional support [143]. 
Commercially available examples of the protein microarray approach employ 
nitrocellulose pads fixed onto the surface of a glass supported FAST
TM
 slide and 
PATH
TM
 slide, or three-dimensional hydrophilic polyacrylamide surfaced HydroGel
TM
 
slides. 
 
(ii) Covalent linkage through a specific chemical reaction with reactive groups within 
proteins has also been used to immobilize proteins to chemically activated surfaces 
containing complementary reactive groups such as aldehyde, epoxy, amine, and active 
esters [144-146], for example epoxysilane coated slide (Figure 7.1). This stable bond 
formation permits somewhat random orientation of immobilized protein [135]. 
Furthermore, chemical modification of proteins results in loss of function and low 
immobilization efficiency [133].  
 
 
                                                                
                 
Figure 7.1: Schematic representation of an amino group coupling to epoxysilane 
coated slide [147]. 
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(iii) Another type of protein immobilization has been achieved by the affinity tag 
method such as the streptavidin-biotin interaction (streptavidin slide) [148-150]. 
Biotinylation or bio-tag of proteins through the use of peptide tags can occur either in 
vivo or in vitro [151]. One is an in vivo genetic introduction of the natural biotinylated 
protein (biotin carboxyl carrier protein, BCCP) with more than 87 amino acids [152] 
to fuse with the target protein in bacteria. The other is an in vitro chemical 
modification with biotin derivative [153]. The other example of the recombinant tag 
methods is the polyhistidine tagged protein and nickel modified surfaces (Ni-NTA 
coated microtitre plate) [150, 154]. The protein tag carrying methods require a genetic 
modification of each prospective target [155]. They create a stable linkage and bind 
protein specifically in a reproducible orientation [133], improving the functionality 
and accessibility of immobilized proteins [156-158]. 
 
It is believed that an oriented immobilization provides a superior binding mode as 
compared to random immobilisation as it is thought to lead to better retention of 
function [159-161]. However, no actual improvement in performance was detected in 
some instances [162, 163]. In addition, there are some reports of low and non-
homogeneous protein deposition [164], lower binding affinities or reduced 
specificities with modified antibodies [162, 165], changes in specificity and affinity of 
the capture antibody [150], expensive and time consuming manipulations of ligands 
[162, 163], and in the case of single histidine tags, they are prone to leaching [166]. 
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7.1 Screening of Solid Surfaces for Immobilization of bOBP  
 
The properties of the support will play crucial roles in the quality and performance of 
the immobilized bOBP biosensors. Firstly, polymer supports for the bOBP biosensors 
were examined for their biocompatibility with bOBP function using 1-AMA as a 
probe. Ten different commercially available solid supports were selected to represent 
different coupling chemistries. These included epoxysilane coated slide, 
polyvinylidene difluoride (PVDF) membranes (hydrophobic and hydrophilic type), 
glass fibre membrane, nylon membranes (neutral and positively charge), 
polyethersulfone (PES) membrane, nickel coated plate, mixed cellulose ester (MCE) 
membrane, and nitrocellulose membrane. The details of the ten different substrates 
used to immobilize bOBP such as their trade names, wettability, pore sizes, and 
particularly binding mechanisms are shown in Table 7.1. These surfaces were 
evaluated by measuring the signal to background ratios (S/B). Signal was defined as 
the fluorescence intensity from immobilizing 100µM bOBP and treating with 100µM 
1-AMA, while the background was the fluorescence intensity after treating the 
material with 100µM 1-AMA. 
 
It was found that most of the supports gave a high background, presumably due to 
adsorption of 1-AMA. Polymer surfaces made of nitrocellulose or MCE exhibited the 
best S/B (Figure 7.2), indicating that immobilization on these membranes allowed 
bOBP to retain its ability to bind 1-AMA as seen by the enhancement of 1-AMA 
fluorescence. Due to its ready availability, the nitrocellulose membrane was then used 
for immobilizing the bOBP in this project.  
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Table 7.1: Information of the ten different commercially available solid surfaces used to immobilize bOBP. 
 
No. Substrates Forms of surface Trade Name Wettability Pore Size (µM) Binding mechanism 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Epoxysilane coated 
Polyvinylidene difluoride (PVDF) 
Polyvinylidene difluoride (PVDF) 
Glass fibre 
Nylon - neutral charge 
Nylon - positive charge 
Polyethersulfone (PES) 
Nickel coated 
Mixed cellulose ester (MCE) 
Nitrocellulose 
Slide 
Membrane 
Membrane 
Membrane 
Membrane 
Membrane 
Membrane 
96-well 
microtitreplate 
Membrane 
Nexterion® Slide E 
Immobilon-P 
Millipore 
Metrigard 
Hybond-N 
Nytran SPC 
Supor-200 
HIS-Select
®
 High Capacity 
Millipore 
Protran
TM
 (Whatman) 
Hydrophobic 
Hydrophobic 
Hydrophilic 
Hydrophilic 
Hydrophilic 
Hydrophilic 
Hydrophilic 
- 
Hydrophilic 
Hydrophilic 
- 
0.45 
0.45 
0.50 
0.45 
0.45 
0.20 
- 
0.45 
0.45 
Covalent binding 
Adsorption 
Adsorption 
Adsorption 
Adsorption 
Adsorption 
Adsorption 
Affinity binding 
Adsorption 
Adsorption 
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Figure 7.2: Signal to background ratio of the immobilization on ten different 
commercially available solid supports. Signal is defined as the fluorescence intensity 
from the material after treating with 25µl of 100µM bOBP for 5min and rinsing with 
25µl of PBS solution containing 1mM EDTA, pH 7.4, then followed by treating with 
25µl of 100µM 1-AMA for 5min and rinsing with 25µl of PBS solution containing 
1mM EDTA, pH 7.4. While the background is that after treating with 25µl of 100µM 
1-AMA for 5min and rinsing with 25µl of PBS solution containing 1mM EDTA, pH 
7.4.  
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The nitrocellulose layer immobilizes proteins through physical non-covalent 
adsorption in a non-orientated but irreversible and quantitative manner, resulting in 
reproducible results. Figure 7.3 illustrates the 3-D micro-porous matrix (sponge 
structure) of nitrocellulose membrane that provides a much larger surface area for 
protein binding compared with 2-D surfaces. It is because protein can be deposited for 
many layers through matrix in comparison to just one layer on the surface of an 
impermeable support. This 3-D micro-porous surface also serves as an environment 
for immobilized protein molecules that is the most similar to that in free solution. This 
helps to preserve the protein conformation and then retains biological activity. In 
addition, Protran™ is a hydrophilic material that is expected not to bind 1-AMA, 
which is a hydrophobic molecule. As a result, it gave the lowest background signal, 
therefore showed the highest S/B among the supports [147, 167-169].  
 
 
 
 
Figure 7.3: Nitrocellulose surface demonstrating microporous 3-D matrix. The 
structure responsible for the high-binding capacity of nitrocellulose was imaged by 
means of scanning electron microscopy. This image is taken from reference [167]. 
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7.2 Amount of bOBP Immobilized on Nitrocellulose  
 
In order to determine the extent of protein binding to the nitrocellulose membrane, 
25µl of bOBP solution with various concentrations ranging from 0 - 100µM was 
adsorbed on the membrane for 5min. The volume and A280 of the bOBP solution were 
then measured before and after adsorption. It is noted that the volume and A280 of the 
bOBP solution before and after protein immobilization referred to those of the total 
protein applied to nitrocellulose and the unbound protein, respectively.  
 
The concentration in µM of unbound protein was then calculated by using Equation 
7.1. 
 
  (       )   
    (     )       (     )
    (      )
     7.1 
 
Next, the concentrations in µM of the total and unbound protein were converted into 
nmole by using Equation 7.2. 
 
        
               
         
        7.2
  
Therefore, nmole of the immobilized protein were obtained from the subtraction of 
nmole between the total and unbound protein as shown in Equation 7.3. 
 
     (           )         (     ) -      (       )   7.3 
 
The calculated result was plotted as a Langmuir Isotherm of the amount of bOBP 
(nmol) immobilized on nitrocellulose as a function of the total protein applied (Figure 
7.4 and Equation 7.4).  
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Figure 7.4: Amount of bOBP (nmol) immobilized on nitrocellulose as a function 
of the total protein applied. The Protran
TM
 nitrocellulose membrane with 0.5-cm 
diameter was placed in 25µl of bOBP solution with each concentration of 0, 1, 10, 40, 
70 and 100µM, and allowed binding for 5min. The volume and OD280 of the bOBP 
solution before and after immobilization were then measured and calculated. 
 
 
        
        
     
        7.4 
  
Where Bound is the amount of bOBP (nmol) bound to nitrocellulose, Bmax is the 
maximum amount of bOBP (nmol) bound to nitrocellulose that is equivalent to 
2.5nmol, X is the amount of bOBP (nmol) added to nitrocellulose, and Kd is the 
amount of bOBP added required to reach half-maximal binding of bOBP to 
nitrocellulose that is equivalent to 1.8nmol. 
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7.3 Titration of bOBP and 1-AMA on Nitrocellulose 
 
As the membrane contained both bOBP and 1-AMA, the fluorescence response of the 
protein biosensor system is expected to be influenced by their respective 
concentrations. Titrations of the concentrations of bOBP and 1-AMA were therefore 
carried out on nitrocellulose in order to illustrate their optimum operating 
concentrations immobilized on nitrocellulose for the bOBP biosensor.  
 
The nitrocellulose membrane was incubated with a concentration of bOBP solution (0, 
1, 10, 40, 70, 100µM) for 5min and rinsed with PBS solution containing 1mM EDTA, 
pH 7.4. Each concentration of the immobilized bOBP was then immersed in a 
concentration of 1-AMA solution (0, 1, 10, 40, 70, 100µM) for 5min and washed with 
PBS solution containing 1mM EDTA, pH 7.4. The effect of these factors was then 
investigated on analytical fluorescence signal at 490nm with excitation at 390nm.  
 
It was found that increasing the concentrations of bOBP and 1-AMA resulted in an 
increase in the fluorescence signal as a hyperbolic function shown in Figure 7.5. The 
fluorescence response that may imply the sensitivity of the biosensor indicated the 
amount of the functional bOBP/1-AMA complex formed. The maximum fluorescence 
intensity was demonstrated at the concentrations of 100µM bOBP and 100µM 1-AMA 
(corresponding to 1.4nmol of bOBP immobilized on 0.5-cm diameter nitrocellulose) in 
PBS containing 1mM EDTA, pH 7.4 with 0.1% DMSO. Therefore, 100µM bOBP and 
100µM 1-AMA as the reagent phase were selected and used for subsequent studies on 
nitrocellulose membrane.  
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Figure 7.5: Fluorescence titration curve of bOBP with 1-AMA on nitrocellulose 
membrane. The Protran
TM
 nitrocellulose membrane (0.5-cm diameter) was placed in 
25µl of a concentration of bOBP solution (0, 1, 10, 40, 70, 100µM) for 5min and 
washed with 25µl of PBS solution containing 1mM EDTA, pH 7.4. Each concentration 
of the immobilized bOBP was then incubated with 25µl of a concentration of 1-AMA 
solution (0, 1, 10, 40, 70, 100µM) for 5min and washed with 25µl of PBS solution 
containing 1mM EDTA, pH 7.4. Fluorescence measurement was recorded at 490nm 
with excitation at 390nm. 
 
 
7.4 Amount of Functional bOBP Immobilized on Nitrocellulose  
 
The quantity of functional bOBP immobilized on nitrocellulose was determined by 
relating the fluorescence intensity upon the stoichiometric binding of bOBP with 1-
AMA on nitrocellulose and that in the solution phase. The fluorescence calibration 
curve of that in the solution phase was carried out by incubating the binding reactions 
of 1-AMA and bOBP with the stoichiometric final concentration of 0, 1, 10, 40, 70, 
and 100µM for 5min at room temperature. The fluorescence emission intensity at 
490nm was recorded at a fixed excitation wavelength of 390nm. The fluorescence 
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intensities of the bOBP·AMA complex formation were then corrected by subtracting 
that of the backgrounds of both bOBP and 1-AMA individually at their corresponding 
concentrations. This calibration curve of that in the solution phase was found to be 
linear from 0 to 70µM of bOBP and 1-AMA (Figure 7.6), with a slope of 129µM
-1
. 
 
 
 
 
Figure 7.6: Fluorescence calibration curve of the bOBP/1-AMA binding reaction 
in solution phase. The linear curve (blue line) is the proportional relationship of the 
fluorescence intensity and the stoichiometric bOBP and 1-AMA concentrations at 0, 1, 
10, 40 and 70µM. The red curve shows the inner filter effect occurred at >70µM 
stoichiometric bOBP and 1-AMA concentrations It is noted that the inner filtering 
effect will present when absorbance of the solution is greater than 0.2.  
 
 
The concentration of functional bOBP applied to nitrocellulose was then determined 
from the slope of the calibration curve in Figure 7.6 Next, the amount in nmole of total 
functional bOBP applied to nitrocellulose was calculated by using Equation 7.5. 
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Finally, the amount in nmole of functional bOBP immobilized on nitrocellulose was 
therefore obtained by using the Langmuir Isotherm of Equation 7.4. Figure 7.7 showed 
this result plotted as a curve of the amount of functional bOBP (nmol) immobilized on 
nitrocellulose relative to the stoichiometric bOBP and 1-AMA concentrations that 
were applied to the nitrocellulose membrane. 
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Figure 7.7: Amount of functional bOBP (nmol) immobilized on nitrocellulose 
relative to the stoichiometric bOBP and 1-AMA concentrations that were applied 
to the nitrocellulose membrane. The Protran
TM
 nitrocellulose membrane with 0.5-cm 
diameter was immersed into 25µl of a concentration of bOBP solution (0, 1, 10, 40, 70 
and 100µM) for 5min, and washed with 25µl of PBS solution containing 1mM EDTA, 
pH 7.4. 25µl of the stoichiometric 1-AMA was then added to the membranes for 5min, 
and washed again with 25µl of PBS solution containing 1mM EDTA, pH 7.4. The 
membranes were measured the emission intensity at 490nm with a SPECTRAmax 
GEMINI XS spectrofluorometer at a fixed excitation wavelength of 390nm. 
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From section 7.2 - 7.4, it was found that at 2.5nmol (or 100µM) of total protein 
applied yielded greater amount of bOBP immobilized on 0.5-cm diameter 
nitrocellulose (1.4 ± 0.01 nmol) than other concentrations used (Figure 7.4), which 
was calculated as 7 ± 0.1 nmol bOBP per cm
2
 of membrane, and had 55 ± 1% of 
bOBP immobilized on nitrocellulose relative to total protein applied (Figure 7.8). 
Additionally, it was found that the reaction comprising of 100µM bOBP (2.5nmol) 
and 100µM 1-AMA exhibited the highest fluorescence intensity (Figure 7.5) as well as 
the highest quantity of functional bOBP immobilized on 0.5-cm diameter 
nitrocellulose (1 ± 0.1 nmol) among other stoichiometric compositions of bOBP and 
1-AMA (Figure 7.7). This reaction composition on the membrane yielded 5 ± 0.4 
nmol of functional bOBP per cm
2
 of membrane, which equaled to 41 ± 3% of 
functional bOBP immobilized on nitrocellulose relative to total protein applied.  In 
order to easily see the comparison of the amounts of the total and the functional bOBP 
immobilized on nitrocellulose relative to the amounts added, both curves of section 7.2 
(Figure 7.4) and section 7.4 (Figure 7.7) were plotted in the same graph as shown in 
Figure 7.8. 
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Figure 7.8: Amounts of bOBP (nmol) immobilized on nitrocellulose membrane 
relative to the total bOBP applied. Total immobilized bOBP is represented as black 
squares, and the functional immobilized bOBP is represented as red circles.  
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7.5 Effect of Immobilization Method for bOBP and 1-AMA on 
Nitrocellulose  
 
It is expected that the method of immobilization of bOBP and 1-AMA on 
nitrocellulose is a factor affecting the fluorescence response of the protein biosensor. 
In this experiment, two different methods of immobilizing bOBP and 1-AMA on 
nitrocellulose were examined in order to obtain the optimum immobilization method 
for the bOBP biosensor.  
 
The first method was individual immobilization of bOBP and 1-AMA step by step as 
the same as previously treated in section 7.1 – 7.4. The nitrocellulose membrane was 
immersed in 100µM bOBP solution for 5min and washed with PBS solution 
containing 1mM EDTA, pH 7.4. The immobilized bOBP was then immersed in 
100µM 1-AMA solution for 5min and washed again with PBS solution containing 
1mM EDTA, pH 7.4. The second method was the immobilization of bOBP/1-AMA 
complex by which the solution of 100µM bOBP/100µM 1-AMA mixture was used in 
adsorption to nitrocellulose for 5min. Then the membrane was washed with PBS 
solution containing 1mM EDTA, pH 7.4. The influence of this factor was evaluated by 
measuring S/B ratio with which all three different backgrounds, including PBS 
(containing 1mM EDTA, pH 7.4), 100µM 1-AMA, and 100µM bOBP backgrounds 
were considered in this matter. 
 
The result demonstrated in Figure 7.9 that immobilization of bOBP/1-AMA complex 
gave approximately two-fold better S/B ratio than individual immobilization of bOBP 
and 1-AMA for all three backgrounds, indicating higher amount of the bound protein 
immobilized on nitrocellulose due to more conformational stabilization induced by 1-
AMA, and/or higher amount of functional protein immobilized on nitrocellulose due 
to the better binding capability of solution-phase protein to 1-AMA. Therefore, 
incubation of nitrocellulose with the complex of bOBP and 1-AMA solution was used 
as the immobilization method for bOBP biosensors. The extent of the functional bOBP 
on nitrocellulose immobilized by this method was found to be 1.4 ± 0.1 nmol per 0.5-
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cm diameter disk, or 7 ± 0.4 nmol per cm
2 
of membrane, which was equivalent to 54 ± 
3% of functional bOBP immobilized on nitrocellulose relative to total protein applied.   
 
 
 
 
Figure 7.9: S/B ratio showing the effect of the two different immobilization 
methods on nitrocellulose for three different backgrounds. The first method was 
individual immobilization of 100µM bOBP and 100µM 1-AMA step by step on 
nitrocellulose. The second method was the immobilization of 100µM bOBP/100µM 1-
AMA complex on nitrocellulose. Background no.1 is PBS (containing 1mM EDTA, pH 
7.4) background (0µM bOBP and 0µM 1-AMA); Background no.2 is 1-AMA 
background (0µM bOBP and 100µM 1-AMA); and Background no.3 is bOBP 
background (100µM bOBP + 0µM 1-AMA). The emission fluorescence intensity at 
490nm was measured by the SPECTRAmax GEMINI XS spectrofluorometer with 
excitation at 390nm.  
 
 
Based on the results in this chapter, nitrocellulose was chosen as the best membrane 
for immobilization and the next chapter describes the development of a fibre-optic 
sensor. 
 
0
20
40
60
80
100
120
140
160
1 2 3
S
/B
 r
at
io
 (
fo
ld
) 
Backgrounds 
Individual
Complex
  
149 
 
CHAPTER 8 
 
DEVELOPMENT OF FIBRE-OPTIC SENSOR BASED ON bOBP 
 
 
In chapters 6 and 7, the sensing of bOBP both in solution and when immobilized using 
the microtiter plate spectrofluorimeter for detection was demonstrated. In this chapter, 
the development of the immobilized bOBP sensing format into a fibre-optic sensor is 
described.  
 
The microplate format is not suitable for either remote or continuous monitoring, thus 
optical fibre was selected as the signal transducer for engineering bOBP biosensors as 
they have been widely used in optical sensing, for example the measurement of change 
in absorption or emission [170].  
 
An optical fibre is a long, thin, flexible, and transparent strand made of glass (silica) or 
plastic about the diameter of a human hair (Figure 8.1A). Optical fibres consist of core 
and cladding, the core is center of the fibre where the light is transmitted, and the 
cladding is material around the core where the light reflects back into the core. 
Protective coating is plastic or acrylate coating that surrounds the cladding protecting 
the fibre from damage and moisture (Figure 8.1B) [171].   
 
Optical fibres transmit light between the two ends of the fibre since the light waves are 
propagated along the fibre by total internal reflection (TIR) as illustrated in Figure 8.2 
[172-174]. TIR occurs when n1 > n2 [175], and when light enters the core of the optical 
fibre and strikes the core/cladding interface at an angle θ, such that sinθ > n2/n1 [174], 
where n1, n2 are refractive indexes of the core and cladding, respectively, and θ is an 
angle made by the incident ray. 
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      (A)            (B) 
 
Figure 8.1: Optical fibre. (A) Image of a bundle of optical fibres [176], (B) 
Components of an optical fibre. Core - centre of the glass fibre where the light 
travels; Cladding - Outer glass material around the core where the light reflects back 
into the core.; Protective coating - Plastic or acrylate coating that surrounds the 
cladding protecting the fibre from damage and moisture [171].  
 
 
 
 
  
 
 
 
 
 
Figure 8.2: Illustration of total internal reflection in a single-core optical fibre, 
showing the trajectory for bound rays. The ray of light will be reflected back into 
the core then experiencing total internal reflection at n1 > n2 as well as at sinθ  >  
n2/n1, where n1, n2 are refractive indexes of the core and cladding, respectively, and θ 
is an angle made by the incident ray [174, 175].  
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Fibre optics refers to the technology that uses optical fibres to carry digital information 
over long distances. Fibre optic systems have many attractive properties that are 
superior to electrical systems. These include improved system performance with a 
larger amount of bandwidth, and lower signal attenuation (loss) over a greater distance 
at faster speeds. They can be used in harsh environments and are immune to noise 
including electrical noise, electromagnetic interference [EMI] and radio-frequency 
interference [RFI], making them ideal for real-time use. In addition, they are 
intrinsically safe, chemically inert, non-toxic, non-conductive, and non-flammable due 
to no electrical power needed. Other advantages include reduced size and weight, 
taking up less space in the ground. Next, they have environmental protection that is 
resistant to radiation and corrosion, and temperature variations. Finally, they are 
overall system economy. However, they are expensive to install, fragile and difficult 
to splice [177]. 
 
Fibre optic cables are widely used in telecommunications and computer networking as 
a replacement for conventional metal (copper) wires. Optical fibres are also employed 
in other applications, including medical imaging, mechanical engineering inspection, 
plumbing inspection, lasers, and sensors [173, 178]. One particularly useful feature of 
their applications is fibre-optic sensors that can provide remote sensing.  
 
Fibre-optic sensors typically comprise a light source, optical fibre, detector, and 
transducer (Figure 8.3), and can be used in association with different types of 
spectroscopic technique, of which the most common are absorption and fluorescence 
[172].  
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Figure 8.3: Schematic representation of a fibre-optic biosensor. Optical fibres 
guide the light from the source to a sample located at the tip of an optical fibre. This 
light will then be filtered and delivered to the detector located remotely.  
 
 
Fibre-optic sensors can be basically divided into two groups: intrinsic or extrinsic 
(Figure 8.4). In an intrinsic fibre-optic sensor, sensing takes place on the surface of the 
fibre itself [179]. The cladding is stripped from the fibre and sensing dye or 
fluorophore immobilized on the surface of the core [170]. An example of this type of 
sensor is a chemical sensor for the detection of cocaine by using a fluorescent 
molecularly imprinted polymer (MIP) covalently attached to the core of an optical 
fibre (Figure 8.5A). The sensor showed an increase in fluorescence intensity in 
response to cocaine in the concentration range of 0 - 500µM in aqueous acetonitrile 
mixtures with good reproducibility over one month [180]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.4: Two basic types of fibre-optic sensors. (A) Intrinsic devices sense 
directly on the fibre itself, whereas (B) Extrinsic devices relay via a transducer.  
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(A)                         (B) 
 
Figure 8.5: Designs of intrinsic (A) and extrinsic (B) fibre-optic sensors. (A) 
Intrinsic fluorescence-based optical fibre sensor for cocaine using a molecularly 
imprinted polymer (MIP) as the recognition element. A MIP was attached to the 
surface of the optical fibre for cocaine sensing [180]. This image has been reproduced 
with the permission of the rights holder, IEEE. (B) Biochemical gas sensor (bio-
sniffer) for ultrahigh-sensitivity gaseous formaldehyde monitoring. A flow cell with 
FALDH immobilized PTFE membrane was attached onto the optical fibre probe with 
having the phosphate buffer containing NAD(+) circulation [181]. This image has 
been reproduced with the permission of the rights holder, Elsevier. 
 
 
In an extrinsic fibre optic sensor, the sensing occurs in a region outside the fibre that is 
on a transducer, and the optical fibre transmits light to and from the sensing location 
[182]. Various types of membrane support have been utilized to attach to the external 
transducer including nitrocellulose, polyvinylchloride, polyamide, silicone, etc [183]. 
For example, the construction of an ultrahigh-sensitive fibre-optic biochemical gas 
sensor (bio-sniffer) for continuous monitoring of indoor gaseous formaldehyde that 
was measured as fluorescence of nicotinamide adenine dinucleotide (NADH), which is 
the product of formaldehyde dehydrogenase (FALDH) reaction. The bio-sniffer device 
was built by attaching a flow cell with a FALDH immobilized PTFE membrane onto 
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FALDH 
the optical fibre probe, with which phosphate buffer containing NAD(+) was 
circulated inside the flow cell (Figure 8.5B).  
  
Formaldehyde  +  NAD
+
  +  H2O  Formic acid  +  NADH  +  H
+
 
 
The calibration range of the FALDH bio-sniffer for formaldehyde concentration was 
from 2.5ppb to 10ppm, which covers the guideline value of the World Health 
Organization (80 ppb) [181]. 
 
 
One of the major advantages of this type of sensor is that it permits sample analysis to 
be done over long distances and this has important implications for field monitoring, 
for example in potentially explosive situations where electrochemical equipment 
would present a hazard [170, 173]. Additionally, they can be easily miniaturized and 
integrated for the determination of different target compounds, which could benefit in 
a wide range of application fields, including industrial process, environmental 
monitoring, food processing, DNA analysis, drug discovery, and medical diagnostics, 
as well as in protection against bioterrorism [173]. However, the main drawback is 
possibility of photobleaching or indicator wash out. Others can be limited availability 
of optimized commercial accessories, as well as limited stability of the immobilized 
biological component, however this would also be a hindrance for other types of 
transducer [172]. 
 
Fibre-optic biosensors are under continuous research and development in order to 
improve the sensors’ performance, such as selectivity, stability, leaching, response 
time, repeatability, in some cases reversibility, and particularly sensitivity; several 
papers reported sensors with detection limits comparable to more sophisticated large 
bench-top analytical instrumentation. Therefore, immobilization protocols have been a 
common focus for this area [173, 184]. 
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8.1 Construction of Fibre-Optic Biosensor Based on bOBP 
 
The sensing of bOBP in solution and immobilized formats on a 96-well plate reader 
was described in chapters 6 and 7. The next step was the development of a fibre-optic 
biosensor based on bOBP that could be used for testing of samples.   
 
The fibre-optic biosensor based on bOBP was constructed as shown in Figure 8.6. 
This is an extrinsic sensor with bOBP immobilized on a nitrocellulose membrane disk 
and mounted to the front surface of the probe at the end of a bifurcated bundle of 
optical fibres that was in turn connected to the light source and the spectrometer. Light 
from the LLS-385 light-emitting diode (LED) light source (at 385nm) was directed 
through one leg of a bifurcated bundle of optical fibres to the probe tip where the 
bOBP is immobilized on a membrane disk. The light intensity emitted by the bOBP 
immobilized membrane was monitored by transmission through the second leg of 
silica fibre and reflecting onto the 2048-element CCD array detector system of a 
HR2000 high-resolution spectrometer covering a wavelength range of 200nm to 
643nm, with a 50µm entrance slit and an L2 detector collection lens. The HR2000 
spectrometer was connected to a laptop with the supplied SpectraSuite software. The 
fluorescence emission signal was collected at 490nm. The integration time was set at 1 
second. 
 
All experiments were carried out in the dark in order to avoid ambient light 
interference. For the reduction of possible photobleaching of 1-AMA, the light source 
was switched on only when readings were being taken.  
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Figure 8.6: Fibre-optic biosensor setup. The instrumental configuration consisted of 
(A) bOBP immobilized membrane. (B) LED light source (LLS-385, Ocean Optics; 
3.86mW at 385nm). (C) Bundle of 7 pure silica optical fibres in a stainless steel 
ferrule (6 illumination fibres around 1 read fibre) (Ocean Optics; 2m long, 400µm 
diameter). (D) 2048-element CCD array detector system (Sony, product no. ILX511) 
of a high-resolution spectrometer (HR2000, Ocean Optics). (E) Reflection probe 
(Ocean Optics; 76.2mm long for probe ferrule), and (F) Laptop (HP 6360b) with 
SpectraSuite software. 
 
 
 
 
 
 
 
A 
 B 
 
C 
D
D
H 
E 
n1 
 
F 
  
157 
8.2 Signal to Background Ratio of Fibre-Optic Biosensor Based on 
bOBP 
 
The fibre-optic bOBP biosensor initially had its S/B ratio determined for based on 
three different backgrounds, which were PBS containing 1mM EDTA (pH 7.4), 1-
AMA, and bOBP. The fibre-optic bOBP biosensor was compared to both the solution 
measurements and the membrane bound protein in a microplate reader. 
 
The results of S/B ratio range for all three different bOBP biosensing formats 
concerning their three different backgrounds were collected in Table 8.1, and Figure 
8.7 was presented in order to easily see the comparison among them and moreover the 
effect of backgrounds on bOBP biosensing formats was also shown. It was found that 
based on all three different backgrounds, the S/B ratios obtained using the fibre-optic 
system were lower than that obtained using the microplate reader by about a factor of 
three. In addition, there was no effect of different backgrounds on S/B ratios obtained 
from biosensing formats of bOBP immobilized membrane on microplate reader as 
well as the fibre-optic biosensor. However, it was found that for the solution phase 
format, the high 1-AMA background contributed to approximately two-fold lower S/B 
ratio than the other two backgrounds.  
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Table 8.1: Range of S/B ratios obtained from three different bOBP biosensing 
formats regarding their three different backgrounds. bOBP solution phase in 
microplate spectrofluorometric format contained 100µ1 of 1µM bOBP/1µM 1-AMA 
mixture, bOBP immobilized membrane in microplate spectrofluorometric format and 
fibre-optic biosensor format contained 25µ1 of 100µM bOBP/25µ1 of 100µM 1-AMA 
mixture. 
Background 
S/B ratio (fold) of bOBP biosensing formats 
Solution phase Immobilized membrane Fibre-optic biosensor 
PBS 60 - 79 118 - 147 29 - 44 
1-AMA 25 - 36 98 - 118 36 - 62 
bOBP 54 - 83 91 - 134 28 - 52 
 
 
 
Figure 8.7: Comparison of S/B ratios obtained using three different bOBP 
biosensing formats for their three different backgrounds. bOBP sensing format 
no.1 is solution-phase protein on microplate spectrofluorometer (100µ1 of 1µM 
bOBP/1µM 1-AMA mixture; n=3), bOBP sensing format no.2 is protein immobilized 
membrane on microplate spectrofluorometer (25µ1 of 100µM bOBP/25µ1 of 100µM 
1-AMA mixture; n=6), and bOBP sensing format no.3 is fibre-optic biosensor with 
protein immobilized membrane attachment (25µ1 of 100µM bOBP/25µ1 of 100µM 1-
AMA mixture; n=6). 
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8.3 Limit-of-Detection (LOD) of Fibre-Optic Biosensor Based on 
bOBP for Liquid-Phase Thymol  
 
The limit-of-detection (LOD) for thymol in the liquid phase was determined to provide 
a quantitative comparison of the utility of the fibre-optic bOBP biosensor with other 
two bOBP biosensing formats. The competitive binding assays with thymol in the 
liquid phase have been accomplished on the solution-phase and the immobilized 
protein. Different concentrations of thymol solution ranging from 0-100µM were 
added to each biosensing formats in triplicate and then incubated for 1 hour at room 
temperature.  
 
The effect of thymol concentration on the response of these biosensing formats was 
shown in Figure 8.8, showing average fluorescence plotted in relation to the 
concentration of thymol in the liquid phase. The response curves of all three different 
bOBP biosensing formats to thymol in the liquid phase showed quenching of the 
fluorescence signal that increased with increasing concentrations of thymol, indicating 
the increasing amounts of thymol binding to bOBP. The LODs to thymol in the liquid 
phase were found to be 0.5 ± 0.2 µM, 5 ± 2 µM, and 14 ± 6 µM for solution, 
immobilized, and fibre-optic formats, respectively. The LOD is defined as the 
concentration of thymol required to produce a decrease in fluorescence signal that 
yields a signal-to-noise (S/N) ratio of 3 where the noise is taken as the standard 
deviation of the intensity for five separate measurements of a blank (without thymol). 
The one-sided t-test was then used to check and confirm the statistically significant 
difference of blank signal and LOD signal where p-value is not more than 0.05.  
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Figure 8.8: Response curve and LOD of three different bOBP biosensing formats 
for liquid phase thymol. Different concentrations of thymol solution ranging from 0-
100µM were added to each biosensing formats in triplicate and incubated for 1 hour 
at room temperature. The 1-AMA fluorescence signal was then measured at 490nm 
emission. (A) bOBP solution phase using microplate reader (100µ1 of 1µM bOBP and 
1µM 1-AMA; 10 independent determinations). (B) bOBP immobilized membrane 
using microplate reader (25µ1 of 100µM bOBP/25µ1 of 100µM 1-AMA mixture; 9 
independent determinations) and (C) Fibre-optic biosensor with bOBP immobilized 
membrane attachment (25µ1 of 100µM bOBP/25µ1 of 100µM 1-AMA mixture; 8 
independent determinations).  
 
 
The immobilized protein formats (Figure 8.8B and 8.8C) showed LOD values that 
were poorer than that obtained for the free protein in solution by about a factor of ten 
(Figure 8.8A). This might be due to the effect of a higher background from membrane 
scattering. In addition, the fibre-optic system exhibited approximately three-fold 
reduced sensitivity when compared to that obtained from the microplate reader; this is 
likely to be a result of different configurations of optical detection. 
 
The current fibre-optic bOBP biosensor has a LOD of 14 ± 6 µM, which can be 
compared with U.S. Environmental Protection Agency mammalian toxicity data for 
thymol  as shown in Table 8.2 [185]. The LOD for the bOBP biosensor is still 
significantly lower than the LD50 for inhaled thymol (33 µM). 
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Table 8.2: Mammalian toxicity data for thymol [185]. 
 
Acute toxicity LD50 MRID NO.* 
Oral 
 
 
640 mg/kg 
(4 mM) 
National Library of Medicine SIS ChemiID Plus; 
NIOSH RTECS; Stammati et.al, 1999; Aldrich 
Chemical Corp. MSDS 
Dermal 1,049 mg/kg 
(7 mM) 
EPA Thymol RED; ERMA (2005)  
 
Inhalation >5 mg/l 
(33 µM) 
Food and Drug Administration, April 10, 1997, 
NADA, Freedom of Information Summary, p3 
*  Note that: Master Record Identification Number (MRID NO.) is a unique cataloging 
number assigned to an individual pesticide study at the time of its submission to the 
Agency [186]. 
 
 
8.4 Ability to Sense Thymol Vapour of Fibre-Optic Biosensor Based 
on bOBP 
 
The ability to sense thymol vapour of the fibre-optic biosensor based on bOBP was 
then investigated. A simple preliminary experiment was set up by 0.5-cm bOBP 
immobilized nitrocellulose membrane disk containing 25µ1 of 100µM bOBP/25µ1 of 
100µM 1-AMA mixture that was stuck at the lid of a 0.5-ml tube was incubated in 
triplicate for 1 hr at room temperature with thymol vapour produced from different 
concentrations of 50µl thymol solution ranging from 0-25mM at the bottom of the 
tube. Thymol solution was dissolved in PBS containing 1mM EDTA (pH 7.4) that had 
0.1% ethanol final concentration. Blank comprised of five separate measurements of 
the bOBP immobilized membrane at the top of the tube incubating with 50µl of PBS 
containing 1mM EDTA (pH 7.4) and 0.1% ethanol at the bottom of the tube. The 
bOBP immobilized membrane was then attached to the edge of the fibre bundle, and 
the emission fluorescence intensity was measured at 490nm.  
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A response curve of the fibre-optic bOBP biosensor to thymol vapour in Figure 8.9 
showed that the 1-AMA signal significantly decreased as thymol concentration was 
increased indicating the increasing amounts of thymol vapour binding to bOBP. 
However, the LOD to thymol vapour by using this biosensor for detection could not 
yet be reported correctly from this non-equilibrium experimental set-up. Therefore, the 
next experiment was performed in order to investigate the construction of a closed 
equilibrium system for the quantification of thymol vapour. 
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Figure 8.9: Response curve of fibre-optic biosensor based on bOBP for thymol 
vapour. 0.5-cm bOBP immobilized nitrocellulose membrane disk at the lid of a 0.5-ml 
tube was incubated in triplicate for 1 hr at room temperature with thymol vapour 
produced from different concentrations of 50µl thymol solution ranging from 0-25mM 
at the bottom of the tube. The bOBP immobilized membrane was then attached to the 
edge of the fibre bundle, and the emission fluorescence intensity was measured at 
490nm.  
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8.5 Analysis of Thymol Vapour by Fibre-Optic Biosensor based on 
bOBP 
 
The construction of the equilibrium system for the quantification of thymol vapour 
was planned by the fibre-optic probe consisting of one bOBP immobilized membrane 
inserted into one neck of a closed 2-neck round bottom flask in order to continuously 
monitor fluorescence changes as increasing concentrations of thymol vapour that will 
be injected into another neck of the flask. This meant that only one immobilized 
membrane will be used in monitoring changes of concentrations of thymol vapour 
throughout the experiment, and then one membrane (that also contained 1-AMA) must 
be measured or excited the 1-AMA fluorescence by the LED light source for at least 
five times (for five different concentrations of thymol vapour) during the experiment.  
 
Therefore in this experiment, the photostability of the bOBP immobilized membrane 
was investigated by monitoring %fluorescence remaining of the bOBP immobilized 
membrane containing 25µ1 of 100µM bOBP/25µ1 of 100µM 1-AMA mixture that 
was mounted to the reflection probe at the end of the fibre bundle, and flashed using 
the fibre-optic system (Figure 8.6). The experiment was carried out in the dark room in 
order to avoid ambient light interference. The LLS-385 LED light source (Ocean 
Optics; 3.86mW at 385nm) excited the membrane at 385nm, and was switched on 
only when readings were being taken. The emission fluorescence signal was collected 
at 490nm. The integration time was set at 1 second.  
 
The result shown in Figure 8.10 was %fluorescence remaining of the bOBP 
immobilized membrane was significantly decreased after the light exposures by 
having less than 40% at four shots, indicating photobleaching of the bOBP 
immobilized membrane caused by exposure to high level of near-UV radiation from 
the light source of the fibre-optic system. Even though the intensity of light that 
exposed to the immobilized membrane was reduced to the minimum level, 
photobleaching was still existent. It is noted that 1-sec integration time has already 
been the minimum and optimum level. On the contrary, Figure 8.11 showed there was 
no photobleaching of the bOBP immobilized membrane when using microplate reader 
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(SPECTRAmax
TM
 GEMINI XS spectrofluorometer) for detection as %fluorescence 
remaining of the immobilized membrane was comparable at illumination of 2, 5, 7, 
and 61 times. 
 
 
 
 
Figure 8.10: %Fluorescence remaining of bOBP immobilized membrane that was 
monitored by using the fibre-optic system. %fluorescence remaining of the bOBP 
immobilized membrane containing 25µ1 of 100µM bOBP/25µ1 of 100µM 1-AMA 
mixture was mounted to the reflection probe at the end of the fibre bundle was 
illuminated using the fibre-optic system. The LLS-385 LED light source (Ocean 
Optics; 3.86mW at 385nm) excited the membrane at 385nm, and was switched on just 
only when readings were being taken. The emission fluorescence signal was collected 
at 490nm. The integration time was set at 1 second.  
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Figure 8.11: %Fluorescence remaining of bOBP immobilized membrane that was 
monitored by using SPECTRAmax
TM
 GEMINI XS spectrofluorometer. 
%fluorescence remaining of the bOBP immobilized membrane containing 25µ1 of 
100µM bOBP/25µ1 of 100µM 1-AMA mixture was illuminated using the microplate 
reader at 390nm excitation and at 490nm emission with 9-nm bandwidth. General 
photometric performance of SPECTRAmax
TM
 GEMINI XS microplate reader included 
xenon flash lamp (1 joule/flash) as a light source, photomultiplier (R-3896) as a 
detector, and approximately 0.16 second read time. Data points were collected for 1 
hour as follow: 2-flash exposure was at time 0 and 1 hour; 5-flash exposure was at 
time 0 and then every 15 minutes; 7-flash exposure was at time 0 and then every 10 
minutes; and 61-flash exposure was at time 0 and then every 1 minute.  
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Nevertheless, after discussing the photobleaching problem caused by the fibre-optic 
system with the senior business development manager from Ocean Optics Inc. (Dr. 
Nick Barnett), it was more likely due to the too small-sized entrance slit (50µm) of the 
HR2000 spectrometer; hence a higher LED intensity than was necessary was causing 
the photobleaching. Consequently, one of the main further optimization of this fibre-
optic bOBP biosensor will importantly be reconfiguration of HR2000 with a larger 
entrance slit. Alternatively, a neutral density filter could be used to reduce the intensity 
of the excitation light. Moreover, the use of a more robust photostable fluorophores 
e.g. Alexa Fluors or DyLight Fluors may be tried. 
 
Therefore, the fibre-optic bOBP biosensor developed at this stage has not yet been 
able to achieve continuous monitoring using a single membrane. Conclusions and 
future works including applications of the biosensor are discussed in the next chapter. 
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CHAPTER 9 
 
CONCLUSIONS AND FUTURE WORK 
 
 
9.1 Conclusions 
 
A fibre-optic biosensor based on bOBP has been constructed. The instrument used a 
bifurcated bundle of silica optical fibres for both delivery of excitation light from the 
LLS-385 LED light source to the 1-AMA-bound bOBP immobilized onto the distal 
end of the fibres via entrapment onto nitrocellulose membrane disk, and emission from 
the immobilized bOBP to the 2048-element CCD array detector system of a HR2000 
spectrometer. The method employed competitive binding of 1-AMA to quantify 
thymol concentration. Using 100µM bOBP/100µM 1-AMA immobilized on 0.5cm-
diameter nitrocellulose membrane as a sensing material, this biosensor could measure 
thymol in the liquid phase at 14 ± 6 µM. In addition, it was capable of sensing thymol 
in the vapour phase. 
 
 
In the first stage of the thesis, wild-type and five cysteine mutants of bOBP were 
expressed in E. coli BL21(DE3) in soluble form and purified by using Ni-NTA 
sepharose affinity chromatographic column with total yield comprised between 13 and 
691 mg.  
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The purified wild type bOBP in solution phase was then characterized the binding 
interaction with thymol; a ligand for bOBP [34, 36] by means of CD spectroscopy. 
The near- and far-UV CD spectroscopy was performed at the temperature of 20
o
C, and 
the structural information upon the binding was obtained that the secondary and 
tertiary structures of bOBP are largely maintained on binding to thymol, suggesting 
the presence of thymol in the interior cavity of bOBP did not perturb the protein 
structure. This finding was in good agreement with several previous studies that 
reported on bOBP and porcine odorant-binding protein (pOBP) [38, 85, 87, 88].  
 
The role of the ligand binding interaction on the protein thermal stability was studied 
via thermal unfolding, which was carried out by monitoring the protein far-UV CD 
signal at 195nm. It was found that bOBPwt was highly thermostable with Tm of the 
unfolding transition of 74 ± 0.3°C in the absence of thymol, which is considerably 
lower than that observed in the presence of thymol at 82 ± 0.4°C, consistent with a 
stabilizing role played by bound thymol. The phenomenon found was similar to those 
already described for the mutant bOBP [64, 90], as well as natural pOBP [88]. 
Additionally, the Tm in this finding was in a similar range of temperature as two other 
reports of thermal denaturation of bOBPwt at 75 - 85
o
C [63] and pOBP at 69°C [85]. 
Furthermore, the high thermal stability of bOBP found in this study has been similar to 
those reported in the mutant bOBP [64] and pOBP [88], demonstrating the suitability 
to use it for construction of biosensors as for monitoring samples, possibly where 
temperatures can be high. 
 
Thermodynamic parameters of unfolding consisting of the enthalpy (ΔH), the free 
energy (ΔG), the entropy (ΔS) of unfolding and binding, and the dissociation constant 
(Kd) for the binding of bOBP to thymol were calculated. CD measurements indicated 
that the unfolding of bOBP in the absence and presence of thymol were entropically 
driven (+ΔSU) and energetically favourable (−ΔGU). The positive ΔH and ΔS in both 
cases were attributed to the release of ordered water molecules and the associated 
entropy gain (due to the hydrophobic effect). The data were consistent with the notion 
that exposing of the hydrophobic core of the β-barrel structure was the main driving 
force for bOBP thermal unfolding. The results implied systems that strongly distorted 
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the protein had net unfavourable ΔH as a result of molecular strain, primarily 
associated with the bonding destacking, so ΔS were net favourable.  
 
While the binding interaction of bOBPwt with thymol was enthalpically driven (-ΔHB) 
with an unfavourable change of entropy (-ΔSB). Therefore, the mechanism of binding 
of thymol to bOBP is not dominated by a hydrophobic effect related to any change in 
the hydration state of protein and ligand groups but, most likely, is driven by van der 
Waals and polar interactions, and hydrogen bonding. This finding is in agreement with 
that of pOBP either binding to IBMP or DMO, which was characterized by isothermal 
titration calorimetry (ITC) [85]. 
 
The five recombinant bOBP mutants of WT, I22C, S24C, F54C, and F91C were 
characterized the binding interaction with eight different ligands at their labelling 
positions by calculation of SASA at their cysteine residue in order to obtain 
information for the likelihood of the labelling efficiency of mutant bOBPs. It was 
found that the order of the cysteine-mutated residues from the highest to the lowest 
SASA was 91C, 54C, 22C, and 24C. 
 
The five recombinant bOBP mutants were characterized in quantifying free thiol 
groups based on the reaction with Ellman’s reagent and also investigation of the 
reactivity of DTNB with the proteins. It was found that the DTNB solution could not 
access to the thiol groups on the proteins. Nevertheless, this compound could interact 
with the thiols in denatured-phase protein. The concentration of free thiol in each 
mutant bOBP was therefore determined, and indicated that each mutant bOBP had a 
comparable concentration of free thiol and this is consistent with the introduction of a 
single cysteine residue into each recombinant protein mutant. Additionally, the 
stoichiometric binding between bOBP and DTNB compound appeared to be 1:1. 
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In order to investigate whether IANBD amide could be a possible good reporting 
probe for engineering bOBP biosensor, the characterization of the ligand binding 
interaction between the recombinant bOBP and the fluorescent IANBD amide has 
been performed. It was found that a mixture of covalent and non-covalent bonding 
existed in the interaction between IANBD amide and bOBP, making it difficult to 
distinguish ligand dependent conformational changes from ligand dependent 
displacement. Therefore, no further work was carried out on IANBD/thiol mutants. 
 
A simple fluorophore 1-aminoanthracene (1-AMA) that provided ligand displacement 
was then used in the characterization of binding interaction with the recombinant 
bOBPwt. The functionality of bOBPwt was analysed by binding assays with 1-AMA, 
and resulting in a 1:1 stoichiometry with good affinity with the Kd value of 0.16 ± 
0.023 μM. This value is comparable with the one of Mazzini et al. 2007 (0.23 ± 0.01 
μM) [87], and with which typical values that have been reported by others are between 
0.66 - 1μM for either recombinant or natural bOBPwt [38, 46, 54, 62, 126, 127].  
 
The Kd values for several known or possible ligands including thymol, bromocresol 
green, malachite green, and methyl salicylate were determined by competitive 
titrations with 1-AMA on bOBPwt. It was found that most of the ligands were good 
ligands with the Kd values in the micromolar range, at which 1-AMA was the best 
ligand. However, methyl salicylate was found not to bind to this protein. The 
significant differences of ligand binding affinity confirmed the broad binding 
specificity of OBPs.  
 
In order to present the Kd value of the ligand with improved accuracy, dual ligand 
competitive titration with 1-AMA on bOBPwt that 1-AMA and ligand concentrations 
were varied was also executed, which was compared to typical competitive binding 
methods that only ligand concentration was varied. It was found that the Kd value of 
thymol for bOBPwt obtained by this method was 1.03 ± 0.153 µM, which is slightly 
different from that from the single ligand titration (0.58 ± 0.28 µM) and that 
determined by CD spectroscopy (0.75 μM). 
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A number of chromophores in the laboratory have been investigated for the ability to 
be used as a probe in the competitive binding to bOBP based on absorbance 
spectrophotometry, and it was found that none of them gave a signal in the 
displacement analysis. This is because the signal from absorption spectroscopy is low 
when compared to that of fluorescence. Thus, the fluorophore 1-AMA has been used 
to detect ligand binding events for bOBP biosensors in this study.  
 
Ten different solid supports for the bOBP biosensors were examined for their 
biocompatibility with bOBP function using 1-AMA as a probe, and the result was that 
nitrocellulose was chosen as the best membrane for immobilization. This is probably 
due to the 3-D micro-porous matrix (sponge structure) of nitrocellulose membrane that 
provides a much larger surface area for protein binding compared with 2-D surfaces. 
The optimum operating concentrations of bOBP and 1-AMA immobilized on 
nitrocellulose for the bOBP biosensor were illustrated by titrations of the 
concentrations of bOBP and 1-AMA on nitrocellulose. The result was the 
concentrations of 100µM bOBP and 100µM 1-AMA as the reagent phase were 
selected to use for subsequent studies on nitrocellulose membrane.  
 
It was found that at 100µM (or 2.5nmol) of total protein applied yielded 1.4 ± 0.01 
nmol of bOBP immobilized on 0.5-cm diameter nitrocellulose, which was calculated 
as 7 ± 0.1 nmol bOBP per cm
2
 of membrane, and had 55 ± 1% of bOBP immobilized 
on nitrocellulose relative to total protein applied.  
 
The two different methods of immobilizing bOBP and 1-AMA on nitrocellulose were 
evaluated, and the result was incubation of nitrocellulose with the complex of bOBP 
and 1-AMA solution was chosen as the immobilization method for bOBP biosensors. 
The extent of the functional bOBP on nitrocellulose immobilized by this method was 
found to be 1.4 ± 0.1 nmol on 0.5-cm diameter disk, or 7 ± 0.4 nmol per cm
2 
of 
membrane, which was equivalent to 54 ± 3% of functional bOBP immobilized on 
nitrocellulose relative to total protein applied. 
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In the final chapter of this thesis, the fibre-optic biosensor based on bOBP was 
constructed. It has been an extrinsic sensor with bOBP immobilized on a nitrocellulose 
membrane disk and mounted to the front surface of the probe at the end of a bifurcated 
bundle of optical fibres that was in turn connected to the light source and the 
spectrometer. Light from the LLS-385 light-emitting diode (LED) light source (at 
385nm) was directed through one leg of a bifurcated bundle of optical fibres to the 
probe tip where the bOBP is immobilized membrane disk. The light intensity emitted 
by the bOBP immobilized membrane was monitored by transmission through the 
second leg of silica fibre and reflecting onto the 2048-element CCD array detector 
system of the HR2000 high-resolution spectrometer. The HR2000 spectrometer was 
connected to a laptop with the supplied SpectraSuite software.  
 
Three different biosensing formats– solution-phase bOBP in microplate reader format, 
immobilized bOBP in microplate reader format, and fibre-optic bundle format had 
their S/B ratios determined for based on three different backgrounds, on which the 
effect of 1-AMA background on the solution phase format was shown. In order to 
obtain quantitative information for the utility of the three biosensing systems, the 
systems were used to measure thymol in the liquid phase. The LODs were found to be 
0.5 ± 0.2 µM, 5 ± 2 µM, and 14 ± 6 µM (calculated as S/N = 3), respectively, 
demonstrating the versatility of the system. The differences of LOD values resulted 
from the effect of higher background of membrane scattering as well as configurations 
of optical detection format. The fibre-optic bOBP biosensor with the LOD that is well 
within the working range that is below the guideline values considered toxic to 
humans of the U.S. Environmental Protection Agency [185]. Therefore, this bOBP 
biosensor has been able to be employed for detection of liquid-phase thymol in 
samples that will provide a first warning when levels exceed the allowed limits and 
indicate the necessity of performing more accurate analyses. 
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Besides, it was also found that the fibre-optic biosensor based on bOBP was capable 
of sensing thymol vapour. However, its LOD value could not yet be reported correctly 
from the preliminary non-equilibrium experimental set-up due to photobleaching 
problems arising from using this fibre-optic biosensor. Therefore, the fibre-optic 
bOBP biosensor developed at this stage has not yet been able to achieve continuous 
monitoring using a single membrane, which would establish a closed equilibrium 
system designed for the quantification of thymol vapour. Future improvement is 
necessary to address this problem and will result in the development of a more 
practical sensor system. 
 
 
9.2 Future Work 
 
9.2.1 Optimization of the fibre-optic biosensor based on bOBP 
 
Based on the photobleaching problem found from using the fibre-optic bOBP 
biosensor, it is recommended that the very important further work will be either one or 
combined approaches to the following four different methods; firstly, reconfiguration 
of HR2000 spectrometer with a larger entrance slit, so a lower LED intensity will be 
required. Secondly, the use of a neutral density filter in order to reduce the intensity of 
the excitation light. Thirdly, the replacement of the HR2000 spectrometer with a 
simple photodiode and filter. Lastly, the use of a more robust photostable fluorophore 
e.g. Alexa, DyLight or Atto Fluors may be tried, although these would need to bind 
bOBP. 
 
Further optimization of the fibre-optic bOBP biosensor will be by varying different 
experimental conditions, to increase its sensitivity, such as the use of a higher level of 
immobilized protein, protein immobilization materials (hydrogel). 
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9.2.2 Development of a more practical fibre-optic biosensor based on 
bOBP 
 
After the fibre-optic bOBP biosensor has the photobleaching problem solved and the 
optimization with the sensitivity improved, further work will be in the development of 
a more practical fibre-optic biosensor that will make it more attractive. Therefore, a 
fibre-optic biosensor based on bOBP for continous monitoring of samples either in the 
liquid or particularly vapour phase will be created. Subsequently, an ultimate plan will 
be the invention of an electronic nose. The electronic nose is defined as a fibre-optic 
array biosensor based on bOBPs that employs a number of bOBP mutants as 
‘multichannel recognition elements’ [127]. The instrument will comprise an array of 
optical fibres immobilized with bOBP mutants that have partial specificity and an 
appropriate pattern recognition system, capable of recognizing different types of 
sample vapours. Pattern recognition techniques include artificial neural network 
(ANN), principal components analysis (PCA), discriminant function analysis and 
fuzzy logic. The sensor array will sense the vapours from a sample and provide a 
series of measurements. The pattern recognition system will then compare the 
measurement pattern with known patterns (standards) [187]. 
 
 
9.2.3 Application of the fibre-optic biosensor based on bOBP 
 
The bOBP-based fibre-optic biosensor will be useful for remote sensing in areas not 
easily accessible for testing. Moreover, as the small-sized and lightweight sensor with 
the LED light source (LLS-385) of 5 x 5 x 4.5 inches, 0.34 kg and the spectrometer 
(HR2000) of 5.8 x 4 x 1.8 inches, 0.57 kg (compared to the SPECTRAmax™ 
GEMINI XS microplate spectrofluorometer of 22.8 x 15 x 8.6 inches, 16 kg), and the 
fibre of 400 µM diameter that can also be miniaturized, this test system is easily 
portable for use at on-site testing of samples. Therefore, the application of the system 
for in-situ and remote sensing is a part of future studies. In addition, the fact that 
performance of biosensors is strictly dependent on the affinity and specificity of the 
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recognition element [127], and consequently the binding properties and specificity of 
bOBP are necessary to be investigated to provide the basis of the biosensor [188].  
 
The capability of the bOBP biosensor system for detection of various samples is more 
likely to be applicable, which will therefore need to be investigated. For instance, the 
detection of explosive components [127, 189], pollutants [65], toxic compounds [190], 
foods, fragrances, narcotics, etc.  
 
It has been reported that OBPs that present unique characteristics of thermal and 
chemical stability bind explosive molecules. The binding capacities of pOBP and 
bOBPs (that are wild type, two mutants of a truncated form, and a deswapped 
monomeric form of bOBP) have been shown for the detection of explosive 
components such as diphenylamine, dimethylphthalate, resorcinol and dinitrotoluene 
with affinity constants ranging between 80 nM and 10.6 mM [127, 189].  
 
Polycyclic aromatic hydrocarbons are portion of the most threatening pollutants 
widespread in the environment, nevertheless, the pOBP appeared binding capability 
with good affinities to several aromatic polycyclic compounds, such as benzyl 
benzoate and diphenylketone [65], at which the orientations of such ligands in the 
binding pocket has been visualised in crystallographic studies [59]. 
 
Additionally, it was found the binding capacity and chemical resistance of bOBP and 
pOBP to 4-hydroxy-2-nonenal (HNE); a toxic compound that produced in nasal tissue 
in consequence of oxidative stress, with Kd values of 4.9 and 9.0 µM for pOBP and 
bOBP, respectively [190].  
 
Several papers reported the property of bOBP in odor sensing. For example, 
development of a bOBP-based affinity matrix for odorants by bOBP that coupled to 
CNBr-sepharose resin and packed into columns shows high specificity and affinity for 
odorants, including 2-isobutyl-3-methoxy pyrazine (bell pepper odorant), geosmin 
(earthy odorant), (-)-carvone (minthy odorant), and thymol (disinfectant odorant) 
[191]. 
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Furthermore, twenty floral smelling tetrahydropyranyl and tetrahydrofuranyl ethers, 
and twelve additional compounds with different odours were tested with bOBP and 
pOBP. It was found that most of them are good ligands for both proteins with Kd 
values in the µM range. The data confirm the broad binding specificity of OBPs and 
indicate the possibility of using these olfactory proteins in biosensors for 
discriminating odours and other volatile chemicals. Their proposed biosensors were 
designed by the incorporation of several types of OBPs with different and broad 
overlapping specificities for recognizing a great variety of odours [34]. 
 
Lastly, a study reported the binding capacity of bOBP and pOBP to nutty and green-
smelling pyrazines and thiazoles. From testing thirty-two green and nutty-smelling 
compounds by ligand binding assays, it was shown that all the green odorants are good 
ligands for both proteins, while the nutty ones are not [192]. 
 
The evidence of the OBPs binding capacities indicated that the biosensors based on 
OBPs should be able to detect and identify substances that allow continuous 
monitoring and measurements taken in real time. Finally, the system described here 
can be generalized to use any forms of OBP that have remarkable differences in their 
binding spectrum. This would be virtually useful for detection of all types of 
molecules.  
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APPENDIX A 
DNA AND AMINO ACID SEQUENCE OF bOBP-WT 
 
The verified sequence shows flanking regions of Bam HI and Eco RI cloning sites to be inserted into pET24a, T7 tag at N-terminus, and 
Histidine tag at C-terminus. 
 EcoRI 
       1 AATTCCTAAT GATGATGATG ATGATGATGA TGATGATGTT CAGGGTGGGG ATGGTTTTCA TTTTCCAAGA AATTCACAAC GTTTTTCTTG TCAATTCCTT 
 TTAAGGATTA CTACTACTAC TACTACTACT ACTACTACAA GTCCCACCCC TACCAAAAGT AAAAGGTTCT TTAAGTGTTG CAAAAAGAAC AGTTAAGGAA 
 3’ E  *  H   H  H  H   H  H  H  H   H  H  E   P  H  P   H  N  E  N   E  L  F   N  V  V   N  K  K  D   I  G  K · 
     101 TGTCTTCCGT CAGCTTCCAG AATTTCTCCA AGTCTTCATC TTCAACATTC AGTTTAACAA ACAGTCCGGT GAGCTCTGTC TTCTGGCCGT GCTTATCCAC 
 ACAGAAGGCA GTCGAAGGTC TTAAAGAGGT TCAGAAGTAG AAGTTGTAAG TCAAATTGTT TGTCAGGCCA CTCGAGACAG AAGACCGGCA CGAATAGGTG 
 . D  E  T   L  K  W  F   K  E  L   D  E  D   E  V  N  L   K  V  F   L  G  T   L  E  T  K   Q  G  H   K  D  V 
     201 GTTGATGTTA TGTGCTACCA GATGCGTCCT CGACAGAGAG ACAATTTTAA AAACGTTTTG ACCCTCATAG TCAGCAACAT AAGTACCATC GTCTTGCTTT 
 CAACTACAAT ACACGATGGT CTACGCAGGA GCTGTCTCTC TGTTAAAATT TTTGCAAAAC TGGGAGTATC AGTCGTTGTA TTCATGGTAG CAGAACGAAA 
  N  I  N  H   A  V  L   H  T  R   S  L  S  V   I  K  F   V  N  Q   G  E  Y  D   A  V  Y   T  G  D   D  Q  K  T · 
     301 GTAGCCTTGA CATGTACATT CTTCCATTTT CCATCCCGCT TGACAGAAAA GTAAAAGTCC ACCGTGCCCT TTTCATCATC AAACACAAGT TCACGGAAGT 
 CATCGGAACT GTACATGTAA GAAGGTAAAA GGTAGGGCGA ACTGTCTTTT CATTTTCAGG TGGCACGGGA AAAGTAGTAG TTTGTGTTCA AGTGCCTTCA 
 .. A  K  V   H  V  N   K  W  K  G   D  R  K   V  S  F   Y  F  D  V   T  G  K   E  D  D   F  V  L  E   R  F  Y ·                                                                        
     401 AAGTCCTGAA TGGTCCATTC TCCTGGATTT TCTCTGGGTT GGTCGACCCA ATGTACACTG TTCTCCATGG TCCTGAAAGC TCTGAGAGAT TTTGCTCAGC 
 TTCAGGACTT ACCAGGTAAG AGGACCTAAA AGAGACCCAA CCAGCTGGGT TACATGTGAC AAGAGGTACC AGGACTTTCG AGACTCTCTA AAACGAGTCG 
 . T  R  F   P  G  N  E   Q  I  K   E  P  N   T  S  G  I   Y  V  T   R  W  P   G  S  L  E   S  L  N   Q  E  A 
                    BamHI 
     501 TTCCTCCTCT TGCGCCCAGG ATCCGCGACC CATTTGCTGT CCACCAGTCA TGCTAGCCAT                                             
 AAGGAGGAGA ACGCGGGTCC TAGGCGCTGG GTAAACGACA GGTGGTCAGT ACGATCGGTA                                             
  E  E  E  Q   A  W  S   G  R  G   M  Q  Q  G   G  T  M   S  A  M   5’ 
       T7 tag 
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